1	Available	JJ	O	available	amod	2	SENT_1	[p1l667t82r819b111],
2	online	NN	O	online	_	0	SENT_1	[p1l831t82r930b111],
3	at	IN	O	at	_	0	SENT_1	[p1l943t84r974b111],
4	wvvw.sciencedirect.com	NNP	O	wvvw.sciencedirect.com	prep_at	2	SENT_1	[p1l984t82r1375b111],

1	9	CD	NUMBER	9	nsubj	5	SENT_2	[p1l760t131r876b157],
2	"	``	O	"	punct	5	SENT_2	[p1l760t131r876b157],
3	’	CD	NUMBER	’	dep	5	SENT_2	[p1l760t131r876b157],
4	°	CD	NUMBER	°	num	5	SENT_2	[p1l734t156r843b225],
5	°	NN	O	°	_	0	SENT_2	[p1l734t156r843b225],
6	.	.	O	.	_	0	SENT_2	[p1l734t156r843b225],
7	"	''	O	"	punct	5	SENT_2	[p1l734t156r843b225],

1	ScienceDirect	NNP	O	ScienceDirect	nn	3	SENT_3	[p1l880t162r1309b222],
2	Leukemia	NNP	O	Leukemia	nn	3	SENT_3	[p1l1783t143r2126b207],
3	Research	NNP	O	Research	_	0	SENT_3	[p1l1804t212r2106b279],
4	www.e1seVier.com/locate/leukres	NNS	O	www.e1sevier.com/locate/leukres	dep	3	SENT_3	[p1l1682t347r2126b371],

1	ELSEVIER	NNP	ORGANIZATION	ELSEVIER	nn	3	SENT_4	[p1l37t296r256b331],
2	Leukemia	NNP	ORGANIZATION	Leukemia	nn	3	SENT_4	[p1l738t307r871b331],
3	Research	NNP	ORGANIZATION	Research	_	0	SENT_4	[p1l879t307r1000b331],
4	31	CD	NUMBER	31	number	5	SENT_4	[p1l1010t307r1039b331],
5	(	CD	NUMBER	(	dep	3	SENT_4	[p1l1052t307r1138b336],
6	2007	CD	DATE	2007	dep	5	SENT_4	[p1l1052t307r1138b336],
7	)	CD	NUMBER	)	num	8	SENT_4	[p1l1052t307r1138b336],
8	1023-1028	CD	DATE	1023-1028	dep	3	SENT_4	[p1l1151t307r1295b331],

1	Letters	NNS	O	letter	_	0	SENT_5	[p1l879t421r1016b455],
2	to	TO	O	to	_	0	SENT_5	[p1l1031t425r1067b455],
3	the	DT	O	the	det	4	SENT_5	[p1l1082t420r1141b455],
4	Editor	NNP	O	Editor	prep_to	1	SENT_5	[p1l1155t420r1279b455],

1	Therapeutic	JJ	O	therapeutic	amod	2	SENT_6	[p1l9t616r471b697],
2	responses	NNS	O	response	_	0	SENT_6	[p1l511t636r872b697],
3	in	IN	O	in	_	0	SENT_6	[p1l912t616r985b679],
4	childhood	NN	O	childhood	nn	10	SENT_6	[p1l1025t616r1398b680],
5	acute	JJ	O	acute	amod	10	SENT_6	[p1l1439t622r1638b680],
6	lymphoblastic	JJ	O	lymphoblastic	amod	10	SENT_6	[p1l1678t618r2145b697, p1l8t723r99b787],
7	leukemia	NN	O	leukemia	nn	10	SENT_6	[p1l132t723r475b787],
8	(	CD	NUMBER	(	num	10	SENT_6	[p1l510t723r746b800],
9	ALL	NN	O	all	nn	10	SENT_6	[p1l510t723r746b800],
10	)	NN	O	)	prep_in	2	SENT_6	[p1l510t723r746b800],
11	and	CC	O	and	_	0	SENT_6	[p1l781t724r921b787],
12	haplotypes	NNS	O	haplotype	conj_and	10	SENT_6	[p1l954t724r1362b804],
13	of	IN	O	of	_	0	SENT_6	[p1l1396t723r1474b787],
14	gamma	NN	O	gamma	nn	16	SENT_6	[p1l1501t742r1780b804],
15	glutamyl	NN	O	glutamyl	nn	16	SENT_6	[p1l1813t724r2147b804],
16	hydrolase	NN	O	hydrolase	prep_of	12	SENT_6	[p1l7t833r374b912],
17	(	CD	NUMBER	(	num	20	SENT_6	[p1l401t832r662b909],
18	GGH	NN	O	ggh	nn	20	SENT_6	[p1l401t832r662b909],
19	)	NN	O	)	nn	20	SENT_6	[p1l401t832r662b909],
20	gene	NN	O	gene	dep	2	SENT_6	[p1l690t851r859b912],

1	Methotrexate	NNP	O	Methotrexate	nsubj	13	SENT_7	[p1l114t1047r586b1109],
2	(	CD	NUMBER	(	num	1	SENT_7	[p1l613t1047r884b1124],
3	MTX	NNP	O	MTX	dep	1	SENT_7	[p1l613t1047r884b1124],
4	)	CD	NUMBER	)	num	3	SENT_7	[p1l613t1047r884b1124],
5	,	,	O	,	_	0	SENT_7	[p1l613t1047r884b1124],
6	a	DT	O	a	det	8	SENT_7	[p1l913t1066r950b1109],
7	folate	JJ	O	folate	amod	8	SENT_7	[p1l972t1046r1172b1109],
8	antagonist	NN	O	antagonist	appos	1	SENT_7	[p1l1198t1047r1580b1128],
9	,	,	O	,	_	0	SENT_7	[p1l1198t1047r1580b1128],
10	is	VBZ	O	be	cop	13	SENT_7	[p1l1607t1047r1662b1109],
11	a	DT	O	a	det	13	SENT_7	[p1l1689t1066r1726b1109],
12	key	JJ	O	key	amod	13	SENT_7	[p1l1747t1047r1871b1128],
13	drug	NN	O	drug	_	0	SENT_7	[p1l1896t1047r2055b1128],
14	in	IN	O	in	_	0	SENT_7	[p1l2080t1047r2147b1108],
15	the	DT	O	the	det	16	SENT_7	[p1l7t1154r114b1217],
16	chemotherapy	NN	O	chemotherapy	prep_in	13	SENT_7	[p1l130t1154r631b1235],
17	of	IN	O	of	_	0	SENT_7	[p1l648t1154r724b1217],
18	childhood	NN	O	childhood	nn	21	SENT_7	[p1l735t1154r1089b1217],
19	acute	JJ	O	acute	amod	21	SENT_7	[p1l1106t1164r1289b1217],
20	lymphoblastic	JJ	O	lymphoblastic	amod	21	SENT_7	[p1l1305t1154r1806b1235],
21	leukemia	NN	O	leukemia	prep_of	16	SENT_7	[p1l1824t1154r2149b1217],
22	(	CD	NUMBER	(	num	24	SENT_7	[p1l10t1262r256b1338],
23	ALL	NN	O	all	nn	24	SENT_7	[p1l10t1262r256b1338],
24	)	NN	O	)	dep	21	SENT_7	[p1l10t1262r256b1338],
25	.	.	O	.	_	0	SENT_7	[p1l10t1262r256b1338],

1	Nevertheless	RB	O	nevertheless	advmod	12	SENT_8	[p1l313t1261r788b1335],
2	,	,	O	,	_	0	SENT_8	[p1l313t1261r788b1335],
3	resistance	NN	O	resistance	nsubj	12	SENT_8	[p1l843t1261r1193b1324],
4	to	TO	O	to	_	0	SENT_8	[p1l1247t1271r1313b1324],
5	MTX	NNP	O	MTX	prep_to	3	SENT_8	[p1l1367t1263r1563b1323],
6	and	CC	O	and	_	0	SENT_8	[p1l1618t1261r1744b1324],
7	the	DT	O	the	det	10	SENT_8	[p1l1796t1261r1902b1324],
8	drugassociated	JJ	O	drugassociated	amod	10	SENT_8	[p1l1957t1261r2144b1342, p1l9t1367r373b1429],
9	side	NN	O	side	nn	10	SENT_8	[p1l412t1367r550b1429],
10	effects	NNS	O	effect	conj_and	5	SENT_8	[p1l589t1366r819b1429],
11	still	RB	O	still	advmod	12	SENT_8	[p1l862t1367r990b1429],
12	represent	VBP	O	represent	_	0	SENT_8	[p1l1027t1376r1354b1448],
13	important	JJ	O	important	amod	14	SENT_8	[p1l1391t1367r1736b1448],
14	challenges	NNS	O	challenge	dobj	12	SENT_8	[p1l1773t1367r2145b1448],
15	in	IN	O	in	_	0	SENT_8	[p1l7t1475r75b1537],
16	the	DT	O	the	det	18	SENT_8	[p1l101t1475r207b1538],
17	ALL	NN	O	all	nn	18	SENT_8	[p1l234t1476r406b1537],
18	treatment	NN	O	treatment	prep_in	14	SENT_8	[p1l432t1485r785b1538],
19	.	.	O	.	_	0	SENT_8	[p1l432t1485r785b1538],

1	MTX	NNP	O	MTX	nsubj	2	SENT_9	[p1l815t1477r1012b1537],
2	undergoes	VBZ	O	undergo	dep	7	SENT_9	[p1l1038t1475r1399b1556],
3	intracellular	JJ	O	intracellular	amod	4	SENT_9	[p1l1428t1475r1859b1538],
4	conversion	NN	O	conversion	dobj	2	SENT_9	[p1l1884t1495r2144b1538, p1l10t1582r154b1644],
5	to	TO	O	to	_	0	SENT_9	[p1l188t1591r254b1644],
6	MTX	NN	O	mtx	prep_to	2	SENT_9	[p1l289t1583r485b1644],
7	polyglutamates	VBZ	O	polyglutamate	_	0	SENT_9	[p1l519t1582r1061b1663],
8	(	CD	NUMBER	(	num	9	SENT_9	[p1l1100t1582r1493b1659],
9	MTX	NN	O	mtx	nsubj	7	SENT_9	[p1l1100t1582r1493b1659],
10	.	.	O	.	_	0	SENT_9	[p1l1100t1582r1493b1659],

1	—	NN	O	—	_	0	SENT_10	[p1l1100t1582r1493b1659],
2	.	.	O	.	_	0	SENT_10	[p1l1100t1582r1493b1659],

1	PG	NN	O	pg	_	0	SENT_11	[p1l1100t1582r1493b1659],
2	)	CD	NUMBER	)	num	1	SENT_11	[p1l1100t1582r1493b1659],
3	which	WDT	O	which	dep	16	SENT_11	[p1l1531t1582r1746b1645],
4	via	IN	O	via	_	0	SENT_11	[p1l1781t1582r1889b1645],
5	longer	JJR	O	longer	amod	7	SENT_11	[p1l1922t1582r2149b1663],
6	cellular	JJ	O	cellular	amod	7	SENT_11	[p1l8t1689r274b1752],
7	retention	NN	O	retention	prep_via	16	SENT_11	[p1l312t1689r628b1752],
8	and	CC	O	and	_	0	SENT_11	[p1l670t1689r796b1752],
9	direct	JJ	O	direct	amod	10	SENT_11	[p1l837t1689r1038b1752],
10	blockage	NN	O	blockage	prep_via	16	SENT_11	[p1l1076t1689r1396b1770],
11	of	IN	O	of	_	0	SENT_11	[p1l1438t1689r1515b1752],
12	folate	NN	O	folate	nn	15	SENT_11	[p1l1550t1689r2149b1770],
13	—	NN	O	—	nn	15	SENT_11	[p1l1550t1689r2149b1770],
14	dependent	JJ	O	dependent	amod	15	SENT_11	[p1l1550t1689r2149b1770],
15	enzymes	NNS	O	enzyme	prep_of	10	SENT_11	[p1l8t1816r315b1877],
16	lead	VBP	O	lead	dep	1	SENT_11	[p1l345t1796r492b1859],
17	to	TO	O	to	_	0	SENT_11	[p1l518t1805r584b1859],
18	a	DT	O	a	det	21	SENT_11	[p1l614t1816r651b1859],
19	more	RBR	O	more	advmod	20	SENT_11	[p1l677t1816r858b1859],
20	potent	JJ	O	potent	amod	21	SENT_11	[p1l884t1805r1108b1877],
21	inhibition	NN	O	inhibition	prep_to	16	SENT_11	[p1l1134t1796r1479b1859],
22	of	IN	O	of	_	0	SENT_11	[p1l1507t1796r1583b1859],
23	de	FW	O	de	nn	25	SENT_11	[p1l1605t1796r1686b1859],
24	novo	FW	O	novo	nn	25	SENT_11	[p1l1714t1817r1883b1859],
25	thymidine	NN	O	thymidine	prep_of	21	SENT_11	[p1l1912t1796r2145b1877, p1l8t1902r158b1964],
26	and	CC	O	and	_	0	SENT_11	[p1l199t1902r324b1964],
27	purine	NN	O	purine	nn	29	SENT_11	[p1l361t1902r587b1983],
28	synthesis	NN	O	synthesis	nn	29	SENT_11	[p1l629t1902r948b1983],
29	[	NN	O	[	prep_of	21	SENT_11	[p1l995t1902r1108b1977],
30	1	CD	NUMBER	1	num	31	SENT_11	[p1l995t1902r1108b1977],
31	]	NN	O	]	nsubj	16	SENT_11	[p1l995t1902r1108b1977],
32	.	.	O	.	_	0	SENT_11	[p1l995t1902r1108b1977],

1	Lysosomal	JJ	O	lysosomal	amod	4	SENT_12	[p1l1151t1902r1535b1983],
2	enzyme	NN	O	enzyme	nn	4	SENT_12	[p1l1574t1921r1848b1983],
3	gamma	NN	O	gamma	nn	4	SENT_12	[p1l1888t1921r2149b1983],
4	glutamate	NN	O	glutamate	nsubj	22	SENT_12	[p1l8t2010r356b2091],
5	hydrolase	NN	O	hydrolase	nn	8	SENT_12	[p1l390t2010r734b2091],
6	(	CD	NUMBER	(	num	8	SENT_12	[p1l770t2011r1015b2088],
7	GGH	NN	O	ggh	nn	8	SENT_12	[p1l770t2011r1015b2088],
8	)	NN	O	)	dep	4	SENT_12	[p1l770t2011r1015b2088],
9	metabolizes	VBZ	O	metabolize	_	0	SENT_12	[p1l1051t2010r1473b2073],
10	MT	NNP	O	MT	nn	11	SENT_12	[p1l1508t2012r1640b2072],
11	X-PG	NN	O	x-pg	dobj	9	SENT_12	[p1l1641t2011r1848b2073],
12	back	RB	O	back	advmod	9	SENT_12	[p1l1880t2010r2049b2073],
13	to	TO	O	to	_	0	SENT_12	[p1l2080t2020r2146b2073],
14	MTX	NN	O	mtx	prep_to	9	SENT_12	[p1l7t2119r203b2179],
15	which	WDT	O	which	nsubj	17	SENT_12	[p1l226t2117r442b2180],
16	may	MD	O	may	aux	17	SENT_12	[p1l464t2137r615b2198],
17	result	VB	O	result	rcmod	14	SENT_12	[p1l637t2117r835b2180],
18	in	IN	O	in	_	0	SENT_12	[p1l856t2117r923b2179],
19	higher	JJR	O	higher	amod	20	SENT_12	[p1l945t2117r1173b2198],
20	efﬂux	NN	O	efﬂux	prep_in	17	SENT_12	[p1l1195t2117r1397b2180],
21	and	CC	O	and	_	0	SENT_12	[p1l1422t2117r1547b2180],
22	diminished	VBN	O	diminish	conj_and	9	SENT_12	[p1l1570t2117r1964b2180],
23	drug	NN	O	drug	nn	24	SENT_12	[p1l1987t2117r2146b2198],
24	efﬁcacy	NN	O	efﬁcacy	dobj	22	SENT_12	[p1l8t2223r296b2304],
25	.	.	O	.	_	0	SENT_12	[p1l8t2223r296b2304],

1	Several	JJ	O	several	amod	2	SENT_13	[p1l347t2223r605b2286],
2	polymorphisms	NNS	O	polymorphism	nsubj	3	SENT_13	[p1l649t2222r1201b2304],
3	(	VBP	O	(	_	0	SENT_13	[p1l1250t2223r1535b2300],
4	.	.	O	.	_	0	SENT_13	[p1l1250t2223r1535b2300],

1	—	NN	O	—	_	0	SENT_14	[p1l1250t2223r1535b2300],
2	.	.	O	.	_	0	SENT_14	[p1l1250t2223r1535b2300],

1	40lC	NN	O	40lc	nsubjpass	29	SENT_15	[p1l1250t2223r1535b2300],
2	>	JJR	O	>	amod	3	SENT_15	[p1l1555t2238r1601b2285],
3	T	NN	O	t	dep	1	SENT_15	[p1l1620t2224r1684b2297],
4	,	,	O	,	_	0	SENT_15	[p1l1620t2224r1684b2297],
5	—	CD	NUMBER	—	num	6	SENT_15	[p1l1737t2222r2061b2286],
6	354G	NN	O	354g	conj_and	1	SENT_15	[p1l1737t2222r2061b2286],
7	>	JJR	O	>	amod	8	SENT_15	[p1l1737t2222r2061b2286],
8	T	NN	O	t	dep	6	SENT_15	[p1l2080t2224r2144b2297],
9	,	,	O	,	_	0	SENT_15	[p1l2080t2224r2144b2297],
10	—	CD	NUMBER	—	num	11	SENT_15	[p1l13t2366r69b2371],
11	124T	NN	O	124t	conj_and	1	SENT_15	[p1l86t2331r263b2391],
12	>	JJR	O	>	amod	13	SENT_15	[p1l281t2345r327b2392],
13	G	NN	O	g	dep	11	SENT_15	[p1l347t2331r426b2404],
14	,	,	O	,	_	0	SENT_15	[p1l347t2331r426b2404],
15	16T	NN	O	16t	nsubjpass	29	SENT_15	[p1l475t2330r607b2392],
16	>	JJR	O	>	amod	17	SENT_15	[p1l626t2345r672b2392],
17	C	NN	O	c	dep	15	SENT_15	[p1l691t2331r766b2403],
18	,	,	O	,	_	0	SENT_15	[p1l691t2331r766b2403],
19	452C	NN	O	452c	nsubjpass	29	SENT_15	[p1l805t2330r995b2392],
20	>	JJR	O	>	amod	21	SENT_15	[p1l1015t2345r1061b2391],
21	T	NN	O	t	dep	19	SENT_15	[p1l1079t2332r1132b2391],
22	and	CC	O	and	_	0	SENT_15	[p1l1170t2330r1295b2392],
23	1102A	NN	O	1102a	nsubjpass	29	SENT_15	[p1l1339t2331r1572b2392],
24	>	JJR	O	>	amod	26	SENT_15	[p1l1589t2345r1635b2392],
25	G	NN	O	g	nn	26	SENT_15	[p1l1655t2331r1743b2407],
26	)	NNS	O	)	dep	23	SENT_15	[p1l1655t2331r1743b2407],
27	have	VBP	O	have	aux	29	SENT_15	[p1l1781t2330r1945b2392],
28	been	VBN	O	be	auxpass	29	SENT_15	[p1l1980t2330r2148b2392],
29	described	VBN	O	describe	_	0	SENT_15	[p1l8t2437r348b2499],
30	in	IN	O	in	_	0	SENT_15	[p1l374t2437r441b2499],
31	GGH	NN	O	ggh	nn	33	SENT_15	[p1l469t2437r658b2500],
32	gene	NN	O	gene	nn	33	SENT_15	[p1l686t2456r850b2518],
33	[	NN	O	[	prep_in	29	SENT_15	[p1l884t2437r997b2513],
34	2	CD	NUMBER	2	num	35	SENT_15	[p1l884t2437r997b2513],
35	]	NN	O	]	dep	33	SENT_15	[p1l884t2437r997b2513],
36	.	.	O	.	_	0	SENT_15	[p1l884t2437r997b2513],

1	We	PRP	O	we	nsubj	10	SENT_16	[p1l1028t2438r1143b2500],
2	assessed	VBD	O	assess	_	0	SENT_16	[p1l1171t2437r1471b2499],
3	here	RB	O	here	iobj	2	SENT_16	[p1l1496t2437r1647b2499],
4	the	DT	O	the	det	5	SENT_16	[p1l1674t2437r1780b2499],
5	impact	NN	O	impact	dobj	2	SENT_16	[p1l1808t2437r2050b2518],
6	of	IN	O	of	_	0	SENT_16	[p1l2076t2437r2153b2499],
7	these	DT	O	these	det	8	SENT_16	[p1l7t2544r188b2607],
8	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_16	[p1l221t2544r773b2625],
9	and	CC	O	and	_	0	SENT_16	[p1l810t2544r935b2607],
10	derived	VBN	O	derive	conj_and	2	SENT_16	[p1l969t2544r1231b2607],
11	haplotypes	NNS	O	haplotype	dobj	10	SENT_16	[p1l1263t2544r1646b2625],
12	on	IN	O	on	_	0	SENT_16	[p1l1682t2564r1768b2607],
13	ALL	NN	O	all	nn	14	SENT_16	[p1l1801t2545r1972b2606],
14	outcome	NN	O	outcome	prep_on	10	SENT_16	[p1l2007t2554r2145b2607, p1l8t2671r198b2714],
15	and	CC	O	and	_	0	SENT_16	[p1l225t2651r350b2714],
16	chemotherapy	NN	O	chemotherapy	nn	17	SENT_16	[p1l375t2651r876b2732],
17	toxicities	NNS	O	toxicity	prep_on	10	SENT_16	[p1l901t2651r1244b2714],
18	.	.	O	.	_	0	SENT_16	[p1l901t2651r1244b2714],

1	Details	NNS	O	detail	nsubjpass	9	SENT_17	[p1l114t2757r363b2819],
2	of	IN	O	of	_	0	SENT_17	[p1l386t2756r463b2819],
3	treatment	NN	O	treatment	nn	6	SENT_17	[p1l477t2766r813b2819],
4	and	CC	O	and	_	0	SENT_17	[p1l834t2757r959b2819],
5	study	NN	O	study	nn	6	SENT_17	[p1l981t2757r1168b2838],
6	population	NN	O	population	prep_of	1	SENT_17	[p1l1188t2757r1569b2838],
7	are	VBP	O	be	auxpass	9	SENT_17	[p1l1591t2776r1695b2819],
8	as	IN	O	as	advmod	9	SENT_17	[p1l1717t2776r1785b2819],
9	described	VBN	O	describe	_	0	SENT_17	[p1l1809t2757r2148b2819],
10	previously	RB	DATE	previously	advmod	9	SENT_17	[p1l6t2865r379b2946],
11	[	CD	NUMBER	[	number	12	SENT_17	[p1l420t2866r533b2941],
12	3	CD	NUMBER	3	num	13	SENT_17	[p1l420t2866r533b2941],
13	]	NN	O	]	dobj	9	SENT_17	[p1l420t2866r533b2941],
14	.	.	O	.	_	0	SENT_17	[p1l420t2866r533b2941],

1	Patients	NNS	O	patient	nsubj	3	SENT_18	[p1l572t2865r849b2928],
2	are	VBP	O	be	cop	3	SENT_18	[p1l887t2885r992b2928],
3	children	NNS	O	child	_	0	SENT_18	[p1l1027t2865r1317b2928],
4	(	VBP	O	(	rcmod	3	SENT_18	[p1l1354t2866r1664b2943],
5	n	NN	O	n	nsubj	12	SENT_18	[p1l1354t2866r1664b2943],
6	=	JJ	O	=	dep	12	SENT_18	[p1l1354t2866r1664b2943],
7	239	CD	NUMBER	239	num	8	SENT_18	[p1l1354t2866r1664b2943],
8	)	NN	O	)	nsubj	12	SENT_18	[p1l1354t2866r1664b2943],
9	of	IN	O	of	_	0	SENT_18	[p1l1702t2865r1779b2928],
10	European	JJ	MISC	european	amod	11	SENT_18	[p1l1807t2867r2147b2946],
11	descent	NN	O	descent	prep_of	8	SENT_18	[p1l8t2972r274b3035],
12	diagnosed	VBD	O	diagnose	xcomp	4	SENT_18	[p1l302t2972r661b3053],
13	with	IN	O	with	_	0	SENT_18	[p1l689t2972r845b3035],
14	ALL	NN	O	all	prep_with	12	SENT_18	[p1l873t2973r1045b3034],
15	at	IN	O	at	_	0	SENT_18	[p1l1075t2981r1136b3035],
16	the	DT	O	the	det	17	SENT_18	[p1l1163t2972r1269b3035],
17	Sainte	NNP	O	Sainte	prep_at	12	SENT_18	[p1l1300t2972r1796b3035],
18	.	.	O	.	_	0	SENT_18	[p1l1300t2972r1796b3035],

1	—	NN	O	—	_	0	SENT_19	[p1l1300t2972r1796b3035],
2	.	.	O	.	_	0	SENT_19	[p1l1300t2972r1796b3035],

1	Justine	NNP	PERSON	Justine	nn	2	SENT_20	[p1l1300t2972r1796b3035],
2	Hospital	NNP	PERSON	Hospital	_	0	SENT_20	[p1l1825t2972r2144b3053],
3	,	,	O	,	_	0	SENT_20	[p1l1825t2972r2144b3053],
4	Montreal	NNP	LOCATION	Montreal	appos	2	SENT_20	[p1l7t3079r351b3153],
5	,	,	O	,	_	0	SENT_20	[p1l7t3079r351b3153],
6	Canada	NNP	LOCATION	Canada	appos	4	SENT_20	[p1l380t3079r663b3153],
7	,	,	O	,	_	0	SENT_20	[p1l380t3079r663b3153],
8	between	IN	O	between	_	0	SENT_20	[p1l690t3079r986b3141],
9	1989	CD	DATE	1989	prep_between	6	SENT_20	[p1l1019t3079r1184b3142],
10	and	CC	DATE	and	_	0	SENT_20	[p1l1213t3079r1338b3141],
11	July	NNP	DATE	July	prep_between	6	SENT_20	[p1l1362t3079r1508b3160],
12	2002	CD	DATE	2002	num	11	SENT_20	[p1l1534t3079r1728b3153],
13	,	,	O	,	_	0	SENT_20	[p1l1534t3079r1728b3153],
14	and	CC	O	and	_	0	SENT_20	[p1l1757t3079r1883b3141],
15	treated	VBN	O	treat	conj_and	6	SENT_20	[p1l1907t3079r2148b3141],
16	with	IN	O	with	_	0	SENT_20	[p1l8t3186r164b3249],
17	DFCI	NN	ORGANIZATION	dfcus	prep_with	15	SENT_20	[p1l191t3187r392b3249],
18	87-01	CD	NUMBER	87-01	num	17	SENT_20	[p1l423t3187r644b3260],
19	,	,	O	,	_	0	SENT_20	[p1l423t3187r644b3260],
20	91-01	CD	NUMBER	91-01	conj_or	17	SENT_20	[p1l676t3187r899b3260],
21	,	,	O	,	_	0	SENT_20	[p1l676t3187r899b3260],
22	95-01	CD	NUMBER	95-01	prep_with	15	SENT_20	[p1l931t3186r1127b3250],
23	or	CC	O	or	_	0	SENT_20	[p1l1164t3206r1236b3249],
24	2000-01	CD	DATE	2000-01	num	25	SENT_20	[p1l1263t3187r1549b3249],
25	protocols	NNS	O	protocol	prep_with	15	SENT_20	[p1l1583t3186r1912b3267],
26	of	IN	O	of	_	0	SENT_20	[p1l1942t3186r2019b3249],
27	the	DT	O	the	det	28	SENT_20	[p1l2040t3186r2147b3249],
28	Dana	NNP	PERSON	Dana	prep_of	25	SENT_20	[p1l7t3293r456b3355],
29	.	.	O	.	_	0	SENT_20	[p1l7t3293r456b3355],

1	—	NN	O	—	_	0	SENT_21	[p1l7t3293r456b3355],
2	.	.	O	.	_	0	SENT_21	[p1l7t3293r456b3355],

1	Farber	NNP	ORGANIZATION	Farber	nn	3	SENT_22	[p1l7t3293r456b3355],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_22	[p1l476t3293r728b3356],
3	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_22	[p1l747t3293r1054b3355],
4	.	.	O	.	_	0	SENT_22	[p1l747t3293r1054b3355],

1	Patient	NN	O	patient	nn	2	SENT_23	[p1l1079t3293r1325b3355],
2	samples	NNS	O	sample	nsubjpass	4	SENT_23	[p1l1348t3293r1628b3374],
3	were	VBD	O	be	auxpass	4	SENT_23	[p1l1651t3312r1821b3356],
4	obtained	VBN	O	obtain	_	0	SENT_23	[p1l1843t3293r2148b3355],
5	at	IN	O	at	_	0	SENT_23	[p1l9t3410r71b3463],
6	diagnosis	NN	O	diagnosis	prep_at	4	SENT_23	[p1l107t3400r439b3481],
7	and	CC	O	and	_	0	SENT_23	[p1l480t3400r605b3463],
8	at	IN	O	at	_	0	SENT_23	[p1l643t3410r705b3463],
9	remission	NN	O	remission	prep_at	4	SENT_23	[p1l739t3400r1085b3463],
10	after	IN	O	after	_	0	SENT_23	[p1l1123t3400r1284b3463],
11	informed	VBN	O	inform	amod	12	SENT_23	[p1l1320t3400r1645b3463],
12	consent	NN	O	consent	prep_after	4	SENT_23	[p1l1682t3410r1969b3463],
13	.	.	O	.	_	0	SENT_23	[p1l1682t3410r1969b3463],

1	The	DT	O	the	det	4	SENT_24	[p1l2011t3400r2147b3463],
2	Hospital	NNP	ORGANIZATION	Hospital	nn	4	SENT_24	[p1l8t3507r307b3588],
3	Ethical	NNP	ORGANIZATION	Ethical	nn	4	SENT_24	[p1l332t3507r582b3570],
4	Committee	NNP	ORGANIZATION	Committee	nsubj	5	SENT_24	[p1l608t3507r1001b3570],
5	approved	VBD	O	approve	_	0	SENT_24	[p1l1028t3507r1354b3588],
6	the	DT	O	the	det	8	SENT_24	[p1l1378t3507r1484b3570],
7	study	NN	O	study	nn	8	SENT_24	[p1l1513t3507r1700b3588],
8	protocol	NN	O	protocol	dobj	5	SENT_24	[p1l1724t3507r2038b3588],
9	.	.	O	.	_	0	SENT_24	[p1l1724t3507r2038b3588],

1	The	DT	O	the	det	2	SENT_25	[p1l114t3613r250b3675],
2	sequence	NN	O	sequence	dep	3	SENT_25	[p1l288t3632r609b3694],
3	of	IN	O	of	_	0	SENT_25	[p1l645t3613r722b3675],
4	forward	RB	O	forward	pcomp	3	SENT_25	[p1l751t3613r1031b3676],
5	and	CC	O	and	_	0	SENT_25	[p1l1066t3613r1191b3675],
6	reverse	VB	O	reverse	conj_and	3	SENT_25	[p1l1224t3632r1476b3675],
7	primer	NN	O	primer	nn	8	SENT_25	[p1l1510t3613r1748b3694],
8	pairs	NNS	O	pair	dobj	6	SENT_25	[p1l1779t3613r1950b3694],
9	used	VBN	O	use	partmod	8	SENT_25	[p1l1985t3613r2148b3675],
10	for	IN	O	for	_	0	SENT_25	[p1l8t3721r111b3784],
11	ampliﬁcation	NN	O	ampliﬁcation	prep_for	9	SENT_25	[p1l149t3721r616b3802],
12	of	IN	O	of	_	0	SENT_25	[p1l655t3721r731b3784],
13	each	DT	O	each	det	14	SENT_25	[p1l764t3721r924b3784],
14	fragment	NN	O	fragment	prep_of	11	SENT_25	[p1l963t3721r1283b3802],
15	containing	VBG	O	contain	xcomp	9	SENT_25	[p1l1321t3721r1693b3802],
16	GGH	NN	O	ggh	nsubj	17	SENT_25	[p1l1734t3722r1923b3784],
17	polymorphic	JJ	O	polymorphic	xcomp	15	SENT_25	[p1l1960t3721r2145b3802, p2l7t19r301b100],

1	site	NN	O	site	nsubj	2	SENT_26	[p2l337t19r455b82],
2	is	VBZ	O	be	_	0	SENT_26	[p2l487t19r542b82],
3	as	IN	O	as	mark	4	SENT_26	[p2l578t39r646b82],
4	described	VBN	O	describe	advcl	2	SENT_26	[p2l680t19r1020b82],
5	in	IN	O	in	_	0	SENT_26	[p2l1050t19r1118b81],
6	Chave	NNP	LOCATION	Chave	prep_in	4	SENT_26	[p2l1150t19r1371b82],
7	et	FW	O	et	dobj	4	SENT_26	[p2l1404t28r1466b82],
8	al.	FW	O	al.	nn	9	SENT_26	[p2l1498t19r1576b82],
9	[	FW	O	[	dep	7	SENT_26	[p2l1619t20r1732b95],
10	2	CD	NUMBER	2	number	11	SENT_26	[p2l1619t20r1732b95],
11	]	CD	NUMBER	]	dep	9	SENT_26	[p2l1619t20r1732b95],
12	.	.	O	.	_	0	SENT_26	[p2l1619t20r1732b95],

1	Genotypes	NNS	O	genotype	nsubjpass	3	SENT_27	[p2l1769t19r2145b100],
2	were	VBD	O	be	auxpass	3	SENT_27	[p2l8t144r178b188],
3	revealed	VBN	O	reveal	_	0	SENT_27	[p2l212t125r510b187],
4	by	IN	O	by	_	0	SENT_27	[p2l543t125r630b206],
5	allele	NN	O	allele	nn	8	SENT_27	[p2l667t125r856b187],
6	speciﬁc	NN	O	speciﬁc	nn	8	SENT_27	[p2l894t125r1159b206],
7	oligonucleotide	NN	O	oligonucleotide	nn	8	SENT_27	[p2l1196t124r1748b206],
8	hybridization	NN	O	hybridization	agent	3	SENT_27	[p2l1782t125r2145b206, p2l7t233r144b296],
9	as	IN	O	as	mark	10	SENT_27	[p2l167t253r235b296],
10	described	VBN	O	describe	advcl	3	SENT_27	[p2l260t233r599b296],
11	previously	RB	DATE	previously	advmod	10	SENT_27	[p2l619t233r991b314],
12	[	CD	NUMBER	[	number	13	SENT_27	[p2l1020t234r1132b309],
13	3	CD	NUMBER	3	num	14	SENT_27	[p2l1020t234r1132b309],
14	]	NN	O	]	pobj	11	SENT_27	[p2l1020t234r1132b309],
15	.	.	O	.	_	0	SENT_27	[p2l1020t234r1132b309],

1	Respective	JJ	O	respective	amod	3	SENT_28	[p2l1158t233r1544b314],
2	probe	NN	O	probe	nn	3	SENT_28	[p2l1564t233r1766b314],
3	sequences	NNS	O	sequence	nsubjpass	5	SENT_28	[p2l1791t253r2145b314],
4	are	VBP	O	be	auxpass	5	SENT_28	[p2l9t359r113b402],
5	given	VBN	O	give	_	0	SENT_28	[p2l139t340r331b421],
6	in	IN	O	in	_	0	SENT_28	[p2l356t340r423b402],
7	Fig	NN	O	fig	prep_in	5	SENT_28	[p2l447t340r581b421],
8	.	.	O	.	_	0	SENT_28	[p2l447t340r581b421],

1	1	LS	NUMBER	1	_	0	SENT_29	[p2l620t340r671b403],
2	.	.	O	.	_	0	SENT_29	[p2l620t340r671b403],

1	The	DT	O	the	det	2	SENT_30	[p2l114t447r250b510],
2	estimates	NNS	O	estimate	nsubjpass	26	SENT_30	[p2l290t447r617b510],
3	of	IN	O	of	_	0	SENT_30	[p2l658t447r735b510],
4	linkage	NN	O	linkage	nn	5	SENT_30	[p2l768t447r1027b528],
5	disequilibrium	NN	O	disequilibrium	prep_of	2	SENT_30	[p2l1067t447r1586b528],
6	between	IN	O	between	_	0	SENT_30	[p2l1622t447r1918b510],
7	GGH	NN	O	ggh	nn	9	SENT_30	[p2l1957t448r2147b510],
8	polymorphic	JJ	O	polymorphic	amod	9	SENT_30	[p2l6t554r460b635],
9	sites	NNS	O	site	prep_between	5	SENT_30	[p2l508t554r680b628],
10	,	,	O	,	_	0	SENT_30	[p2l508t554r680b628],
11	maximum	NN	O	maximum	nn	13	SENT_30	[p2l727t554r1088b617],
12	likelihood	NN	O	likelihood	nn	13	SENT_30	[p2l1130t554r1489b617],
13	estimates	NNS	O	estimate	appos	9	SENT_30	[p2l1533t554r1860b617],
14	of	IN	O	of	_	0	SENT_30	[p2l1907t554r1983b617],
15	frequencies	NNS	O	frequency	prep_of	13	SENT_30	[p2l2021t554r2144b617, p2l8t660r315b741],
16	of	IN	O	of	_	0	SENT_30	[p2l364t660r440b722],
17	underlying	VBG	O	underlie	amod	18	SENT_30	[p2l479t660r863b741],
18	haplotypes	NNS	O	haplotype	prep_of	15	SENT_30	[p2l909t660r1291b741],
19	as	RB	O	as	_	0	SENT_30	[p2l1341t679r1408b722],
20	well	RB	O	well	_	0	SENT_30	[p2l1456t660r1607b722],
21	as	IN	O	as	_	0	SENT_30	[p2l1654t679r1722b722],
22	the	DT	O	the	det	24	SENT_30	[p2l1769t660r1876b722],
23	haplotype	NN	O	haplotype	nn	24	SENT_30	[p2l1921t660r2144b741, p2l7t778r158b849],
24	phase	NN	O	phase	prep_of	13	SENT_30	[p2l187t768r389b849],
25	were	VBD	O	be	auxpass	26	SENT_30	[p2l420t788r590b831],
26	obtained	VBN	O	obtain	_	0	SENT_30	[p2l621t768r926b831],
27	by	IN	O	by	_	0	SENT_30	[p2l954t768r1041b849],
28	PHASE	NN	O	phase	nn	29	SENT_30	[p2l1071t769r1352b831],
29	software	NN	O	software	agent	26	SENT_30	[p2l1385t768r1705b843],
30	,	,	O	,	_	0	SENT_30	[p2l1385t768r1705b843],
31	Version	NNP	O	Version	appos	29	SENT_30	[p2l1738t768r2008b831],
32	2.0	CD	NUMBER	2.0	number	33	SENT_30	[p2l2039t769r2147b831],
33	[	CD	NUMBER	[	dep	31	SENT_30	[p2l14t875r127b951],
34	4	CD	NUMBER	4	num	35	SENT_30	[p2l14t875r127b951],
35	]	NN	O	]	dep	33	SENT_30	[p2l14t875r127b951],
36	.	.	O	.	_	0	SENT_30	[p2l14t875r127b951],

1	Only	RB	O	only	advmod	3	SENT_31	[p2l164t875r337b956],
2	the	DT	O	the	det	3	SENT_31	[p2l369t875r475b938],
3	individuals	NNS	O	individual	nsubjpass	10	SENT_31	[p2l506t875r896b938],
4	with	IN	O	with	_	0	SENT_31	[p2l930t875r1086b938],
5	non	JJ	O	non	amod	8	SENT_31	[p2l1116t875r1554b956],
6	—	NN	O	—	nn	8	SENT_31	[p2l1116t875r1554b956],
7	missing	VBG	O	miss	amod	8	SENT_31	[p2l1116t875r1554b956],
8	genotypes	NNS	O	genotype	prep_with	3	SENT_31	[p2l1587t885r1943b956],
9	were	VBD	O	be	auxpass	10	SENT_31	[p2l1977t895r2147b938],
10	included	VBN	O	include	_	0	SENT_31	[p2l7t981r313b1043],
11	in	IN	O	in	_	0	SENT_31	[p2l327t981r395b1042],
12	the	DT	O	the	det	13	SENT_31	[p2l410t981r516b1043],
13	analysis	NN	O	analysis	prep_in	10	SENT_31	[p2l534t981r835b1062],
14	.	.	O	.	_	0	SENT_31	[p2l534t981r835b1062],

1	Association	NNP	O	Association	dep	8	SENT_32	[p2l854t981r1274b1043],
2	of	IN	O	of	_	0	SENT_32	[p2l1290t981r1366b1043],
3	genotypes/haplotypes	NNS	O	genotypes/haplotypes	prep_of	1	SENT_32	[p2l1377t981r2145b1062],
4	with	IN	O	with	_	0	SENT_32	[p2l8t1089r164b1152],
5	ALL	NN	O	all	nn	6	SENT_32	[p2l194t1090r366b1151],
6	outcome	NN	O	outcome	prep_with	3	SENT_32	[p2l398t1099r701b1152],
7	was	VBD	O	be	auxpass	8	SENT_32	[p2l734t1109r866b1152],
8	assessed	VBN	O	assess	_	0	SENT_32	[p2l901t1089r1200b1152],
9	by	IN	O	by	_	0	SENT_32	[p2l1229t1089r1317b1170],
10	event	NN	O	event	nn	14	SENT_32	[p2l1349t1099r1537b1152],
11	and	CC	O	and	_	0	SENT_32	[p2l1569t1089r1694b1152],
12	disease	NN	O	disease	nn	14	SENT_32	[p2l1725t1089r1979b1152],
13	free	JJ	O	free	amod	14	SENT_32	[p2l2011t1089r2147b1152],
14	survival	NN	O	survival	agent	8	SENT_32	[p2l10t1196r288b1259],
15	(	CD	NUMBER	(	num	16	SENT_32	[p2l323t1196r497b1273],
16	EFS	NNS	O	ef	dep	14	SENT_32	[p2l323t1196r497b1273],
17	and	CC	O	and	_	0	SENT_32	[p2l535t1196r660b1258],
18	DFS	NN	O	df	nn	19	SENT_32	[p2l691t1196r879b1273],
19	)	NN	O	)	agent	8	SENT_32	[p2l691t1196r879b1273],
20	and	CC	O	and	_	0	SENT_32	[p2l915t1196r1041b1258],
21	overall	JJ	O	overall	amod	22	SENT_32	[p2l1073t1196r1314b1259],
22	survival	NN	O	survival	conj_and	14	SENT_32	[p2l1350t1196r1627b1259],
23	(	CD	NUMBER	(	num	26	SENT_32	[p2l1662t1196r1827b1273],
24	OS	NN	O	os	nn	26	SENT_32	[p2l1662t1196r1827b1273],
25	)	NN	O	)	nn	26	SENT_32	[p2l1662t1196r1827b1273],
26	analysis	NN	O	analysis	nsubjpass	8	SENT_32	[p2l1864t1196r2145b1277],

1	0145-2126	CD	DURATION	0145-2126	_	0	SENT_33	[p2l8t1417r368b1476],
2	/	:	O	/	punct	1	SENT_33	[p2l8t1417r368b1476],
3	$	$	MONEY	$	nsubj	5	SENT_33	[p2l8t1417r368b1476],
4	—	CD	MONEY	—	num	3	SENT_33	[p2l389t1451r425b1456],
5	see	VBP	O	see	dep	1	SENT_33	[p2l446t1436r532b1471],
6	front	JJ	O	front	amod	7	SENT_33	[p2l553t1421r691b1471],
7	matter	NN	O	matter	dobj	5	SENT_33	[p2l709t1428r891b1471],
8	©	CD	NUMBER	©	num	11	SENT_33	[p2l911t1421r960b1471],
9	2006	CD	DATE	2006	num	11	SENT_33	[p2l982t1421r1121b1471],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_33	[p2l1142t1421r1374b1471],
11	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_33	[p2l1392t1421r1504b1471],
12	.	.	O	.	_	0	SENT_33	[p2l1392t1421r1504b1471],

1	All	DT	O	all	det	2	SENT_34	[p2l1527t1421r1617b1470],
2	rights	NNS	O	rights	nsubj	3	SENT_34	[p2l1636t1421r1795b1486],
3	reserved	VBN	O	reserve	_	0	SENT_34	[p2l1816t1421r2070b1471],
4	.	.	O	.	_	0	SENT_34	[p2l1816t1421r2070b1471],

1	as	IN	O	as	mark	2	SENT_35	[p2l9t1666r77b1709],
2	described	VBN	O	describe	_	0	SENT_35	[p2l120t1647r459b1709],
3	previously	RB	DATE	previously	advmod	2	SENT_35	[p2l497t1647r870b1728],
4	[	CD	NUMBER	[	number	5	SENT_35	[p2l917t1647r1030b1723],
5	3	CD	NUMBER	3	num	6	SENT_35	[p2l917t1647r1030b1723],
6	]	NN	O	]	pobj	3	SENT_35	[p2l917t1647r1030b1723],
7	.	.	O	.	_	0	SENT_35	[p2l917t1647r1030b1723],

1	Survival	NN	O	survival	nn	2	SENT_36	[p2l1077t1647r1370b1710],
2	differences	NNS	O	difference	nsubj	3	SENT_36	[p2l1411t1647r1800b1709],
3	obtained	VBN	O	obtain	_	0	SENT_36	[p2l1843t1647r2148b1709],
4	by	IN	O	by	_	0	SENT_36	[p2l6t1753r93b1834],
5	Kaplan	NNP	PERSON	Kaplan	prep_by	3	SENT_36	[p2l126t1753r640b1834],
6	.	.	O	.	_	0	SENT_36	[p2l126t1753r640b1834],

1	—	NN	O	—	_	0	SENT_37	[p2l126t1753r640b1834],
2	.	.	O	.	_	0	SENT_37	[p2l126t1753r640b1834],

1	Meier	JJR	PERSON	meier	amod	2	SENT_38	[p2l126t1753r640b1834],
2	analysis	NN	O	analysis	nsubjpass	9	SENT_38	[p2l671t1752r952b1834],
3	for	IN	O	for	_	0	SENT_38	[p2l986t1752r1089b1815],
4	patients	NNS	O	patient	prep_for	2	SENT_38	[p2l1117t1752r1392b1834],
5	with	IN	O	with	_	0	SENT_38	[p2l1425t1753r1581b1815],
6	different	JJ	O	different	amod	7	SENT_38	[p2l1613t1753r1916b1815],
7	genotypes	NNS	O	genotype	prep_with	4	SENT_38	[p2l1947t1772r2144b1834, p2l7t1871r191b1942],
8	were	VBD	O	be	auxpass	9	SENT_38	[p2l223t1881r393b1924],
9	determined	VBN	O	determine	_	0	SENT_38	[p2l423t1861r822b1924],
10	using	VBG	O	use	xcomp	9	SENT_38	[p2l850t1861r1041b1942],
11	a	DT	O	a	det	15	SENT_38	[p2l1073t1881r1110b1924],
12	log	NN	O	log	nn	15	SENT_38	[p2l1138t1861r1439b1942],
13	—	CD	NUMBER	—	num	15	SENT_38	[p2l1138t1861r1439b1942],
14	rank	NN	O	rank	nn	15	SENT_38	[p2l1138t1861r1439b1942],
15	test	NN	O	test	dobj	10	SENT_38	[p2l1466t1871r1606b1924],
16	.	.	O	.	_	0	SENT_38	[p2l1466t1871r1606b1924],

1	The	DT	O	the	det	2	SENT_39	[p2l1640t1861r1776b1924],
2	risk	NN	O	risk	nsubj	7	SENT_39	[p2l1804t1861r1938b1924],
3	associated	VBN	O	associate	partmod	2	SENT_39	[p2l1968t1881r2144b1924, p2l8t1967r219b2029],
4	with	IN	O	with	_	0	SENT_39	[p2l251t1967r407b2030],
5	genetic	JJ	O	genetic	amod	6	SENT_39	[p2l440t1967r693b2048],
6	variants	NNS	O	variant	prep_with	3	SENT_39	[p2l727t1967r1003b2030],
7	(	VBP	O	(	_	0	SENT_39	[p2l1040t1967r1303b2044],
8	hazard	NN	O	hazard	nn	9	SENT_39	[p2l1040t1967r1303b2044],
9	ratio	NN	O	ratio	nsubj	34	SENT_39	[p2l1334t1967r1515b2041],
10	,	,	O	,	_	0	SENT_39	[p2l1334t1967r1515b2041],
11	HR	NN	DURATION	hr	appos	9	SENT_39	[p2l1551t1968r1691b2041],
12	,	,	O	,	_	0	SENT_39	[p2l1551t1968r1691b2041],
13	with	IN	O	with	_	0	SENT_39	[p2l1728t1967r1884b2030],
14	a	DT	O	a	det	18	SENT_39	[p2l1918t1987r1954b2029],
15	95	CD	PERCENT	95	number	16	SENT_39	[p2l1987t1966r2143b2030],
16	%	NN	PERCENT	%	amod	18	SENT_39	[p2l1987t1966r2143b2030],
17	CI	NN	O	ci	nn	18	SENT_39	[p2l8t2076r121b2153],
18	)	NN	O	)	prep_with	9	SENT_39	[p2l8t2076r121b2153],
19	was	VBD	O	be	auxpass	20	SENT_39	[p2l177t2095r310b2138],
20	estimated	VBN	O	estimate	rcmod	18	SENT_39	[p2l366t2075r706b2138],
21	by	IN	O	by	_	0	SENT_39	[p2l757t2075r845b2156],
22	the	DT	O	the	det	24	SENT_39	[p2l898t2075r1005b2138],
23	Cox	NN	O	cox	nn	24	SENT_39	[p2l1059t2076r1205b2138],
24	regression	NN	O	regression	agent	20	SENT_39	[p2l1257t2075r1640b2156],
25	,	,	O	,	_	0	SENT_39	[p2l1257t2075r1640b2156],
26	without	IN	O	without	_	0	SENT_39	[p2l1697t2075r1968b2138],
27	and	CC	O	and	_	0	SENT_39	[p2l2022t2075r2148b2138],
28	with	IN	O	with	_	0	SENT_39	[p2l8t2182r164b2245],
29	inclusion	NN	O	inclusion	prep_without	20	SENT_39	[p2l208t2182r533b2245],
30	of	IN	O	of	_	0	SENT_39	[p2l579t2182r656b2245],
31	the	DT	O	the	det	33	SENT_39	[p2l695t2182r801b2245],
32	prognostic	JJ	O	prognostic	amod	33	SENT_39	[p2l845t2182r1219b2263],
33	factors	NNS	O	factor	prep_of	18	SENT_39	[p2l1266t2182r1503b2245],
34	(	VBP	O	(	ccomp	7	SENT_39	[p2l1553t2183r1714b2259],
35	sex	NN	O	sex	nsubj	55	SENT_39	[p2l1553t2183r1714b2259],
36	,	,	O	,	_	0	SENT_39	[p2l1553t2183r1714b2259],
37	age	NN	O	age	nsubj	55	SENT_39	[p2l1764t2202r1903b2263],
38	,	,	O	,	_	0	SENT_39	[p2l1764t2202r1903b2263],
39	white	JJ	O	white	amod	42	SENT_39	[p2l1952t2182r2146b2245],
40	blood	NN	O	blood	nn	42	SENT_39	[p2l6t2288r209b2350],
41	cell	NN	O	cell	nn	42	SENT_39	[p2l239t2288r364b2350],
42	count	NN	O	count	nsubj	55	SENT_39	[p2l396t2297r610b2362],
43	,	,	O	,	_	0	SENT_39	[p2l396t2297r610b2362],
44	ALL	NN	O	all	nn	45	SENT_39	[p2l644t2288r816b2349],
45	immunophenotype	NN	O	immunophenotype	nsubj	55	SENT_39	[p2l846t2288r1532b2369],
46	,	,	O	,	_	0	SENT_39	[p2l846t2288r1532b2369],
47	treatment	NN	O	treatment	nn	48	SENT_39	[p2l1566t2297r1902b2350],
48	protocol	NN	O	protocol	nsubj	55	SENT_39	[p2l1930t2297r2144b2369, p2l8t2396r133b2470],
49	,	,	O	,	_	0	SENT_39	[p2l1930t2297r2144b2369, p2l8t2396r133b2470],
50	risk	NN	O	risk	nn	51	SENT_39	[p2l171t2396r305b2459],
51	group	NN	O	group	nsubj	55	SENT_39	[p2l341t2416r544b2477],
52	and	CC	O	and	_	0	SENT_39	[p2l583t2396r708b2459],
53	DNA	NN	MISC	dna	nn	54	SENT_39	[p2l744t2397r932b2459],
54	index	NN	O	index	nsubj	55	SENT_39	[p2l968t2396r1189b2473],
55	)	VBD	O	)	ccomp	34	SENT_39	[p2l968t2396r1189b2473],
56	[	CD	NUMBER	[	number	57	SENT_39	[p2l1234t2397r1347b2472],
57	3	CD	NUMBER	3	num	58	SENT_39	[p2l1234t2397r1347b2472],
58	]	NN	O	]	dobj	55	SENT_39	[p2l1234t2397r1347b2472],
59	.	.	O	.	_	0	SENT_39	[p2l1234t2397r1347b2472],

1	Estimates	NNS	O	estimate	nsubjpass	22	SENT_40	[p2l1387t2396r1731b2459],
2	of	IN	O	of	_	0	SENT_40	[p2l1770t2396r1847b2459],
3	toxicity	NN	O	toxicity	prep_of	1	SENT_40	[p2l1876t2396r2146b2477],
4	on	IN	O	on	_	0	SENT_40	[p2l8t2523r94b2566],
5	bone	NN	O	bone	nn	6	SENT_40	[p2l138t2503r310b2566],
6	marrow	NN	O	marrow	prep_on	22	SENT_40	[p2l357t2523r629b2566],
7	and	CC	O	and	_	0	SENT_40	[p2l677t2503r803b2566],
8	liver	NN	O	liver	nn	9	SENT_40	[p2l848t2503r1007b2566],
9	function	NN	O	function	prep_on	22	SENT_40	[p2l1051t2503r1346b2566],
10	during	IN	O	during	_	0	SENT_40	[p2l1393t2503r1621b2584],
11	consolidation	NN	O	consolidation	nn	14	SENT_40	[p2l1669t2503r2147b2566],
12	and	CC	O	and	_	0	SENT_40	[p2l9t2609r134b2671],
13	maintenance	NN	O	maintenance	conj_and	11	SENT_40	[p2l159t2608r607b2671],
14	treatment	NN	O	treatment	prep_during	6	SENT_40	[p2l632t2618r968b2671],
15	(	CD	NUMBER	(	nsubjpass	22	SENT_40	[p2l995t2608r1337b2686],
16	available	JJ	O	available	amod	15	SENT_40	[p2l995t2608r1337b2686],
17	for	IN	O	for	_	0	SENT_40	[p2l1363t2609r1466b2671],
18	172	CD	NUMBER	172	num	19	SENT_40	[p2l1498t2609r1620b2671],
19	patients	NNS	O	patient	prep_for	16	SENT_40	[p2l1645t2609r1948b2690],
20	)	CD	NUMBER	)	tmod	16	SENT_40	[p2l1645t2609r1948b2690],
21	were	VBD	O	be	auxpass	22	SENT_40	[p2l1976t2628r2146b2672],
22	based	VBN	O	base	_	0	SENT_40	[p2l6t2717r208b2780],
23	on	IN	O	on	_	0	SENT_40	[p2l247t2737r332b2780],
24	the	DT	O	the	det	25	SENT_40	[p2l369t2717r476b2780],
25	reduction	NN	O	reduction	prep_on	22	SENT_40	[p2l513t2717r849b2780],
26	of	IN	O	of	_	0	SENT_40	[p2l887t2717r964b2780],
27	white	JJ	O	white	amod	29	SENT_40	[p2l996t2717r1191b2780],
28	blood	NN	O	blood	nn	29	SENT_40	[p2l1227t2717r1430b2780],
29	cells	NNS	O	cell	prep_of	25	SENT_40	[p2l1468t2717r1647b2791],
30	,	,	O	,	_	0	SENT_40	[p2l1468t2717r1647b2791],
31	platelets	NNS	O	platelet	conj_and	25	SENT_40	[p2l1686t2717r1981b2798],
32	and	CC	O	and	_	0	SENT_40	[p2l2022t2717r2148b2780],
33	absolute	JJ	O	absolute	amod	35	SENT_40	[p2l9t2824r302b2886],
34	neutrophil	NN	O	neutrophil	nn	35	SENT_40	[p2l338t2824r702b2905],
35	count	NN	O	count	conj_and	25	SENT_40	[p2l740t2833r954b2898],
36	,	,	O	,	_	0	SENT_40	[p2l740t2833r954b2898],
37	and	CC	O	and	_	0	SENT_40	[p2l995t2824r1121b2886],
38	elevation	NN	O	elevation	conj_and	25	SENT_40	[p2l1157t2824r1477b2887],
39	of	IN	O	of	_	0	SENT_40	[p2l1514t2824r1591b2886],
40	liver	NN	O	liver	nn	41	SENT_40	[p2l1621t2824r1780b2887],
41	enzymes	NNS	O	enzyme	prep_of	38	SENT_40	[p2l1815t2843r2143b2905],
42	,	,	O	,	_	0	SENT_40	[p2l1815t2843r2143b2905],
43	alanine	NN	O	alanine	nn	44	SENT_40	[p2l9t2931r262b2994],
44	aminotrasferase	NN	O	aminotrasferase	conj_and	41	SENT_40	[p2l309t2931r869b2994],
45	and	CC	O	and	_	0	SENT_40	[p2l916t2931r1042b2994],
46	aspartate	NN	O	aspartate	nn	47	SENT_40	[p2l1087t2941r1400b3012],
47	aminotrasferase	NN	O	aminotrasferase	conj_and	41	SENT_40	[p2l1447t2931r2027b3005],
48	,	,	O	,	_	0	SENT_40	[p2l1447t2931r2027b3005],
49	as	IN	O	as	mark	50	SENT_40	[p2l2077t2951r2145b2994],
50	described	VBN	O	describe	advcl	22	SENT_40	[p2l8t3038r348b3101],
51	previously	RB	DATE	previously	advmod	50	SENT_40	[p2l377t3038r750b3119],
52	[	CD	NUMBER	[	number	53	SENT_40	[p2l789t3038r902b3114],
53	5	CD	NUMBER	5	num	54	SENT_40	[p2l789t3038r902b3114],
54	]	NN	O	]	pobj	51	SENT_40	[p2l789t3038r902b3114],
55	.	.	O	.	_	0	SENT_40	[p2l789t3038r902b3114],

1	The	DT	O	the	det	2	SENT_41	[p2l938t3038r1074b3101],
2	comparison	NN	O	comparison	nsubjpass	12	SENT_41	[p2l1107t3038r1520b3119],
3	of	IN	O	of	_	0	SENT_41	[p2l1553t3038r1630b3101],
4	the	DT	O	the	det	5	SENT_41	[p2l1655t3038r1762b3101],
5	frequency	NN	O	frequency	prep_of	2	SENT_41	[p2l1794t3038r2146b3119],
6	of	IN	O	of	_	0	SENT_41	[p2l8t3144r85b3206],
7	weeks	NNS	DURATION	week	prep_of	5	SENT_41	[p2l100t3144r318b3207],
8	with	IN	O	with	_	0	SENT_41	[p2l341t3144r497b3206],
9	the	DT	O	the	det	10	SENT_41	[p2l518t3144r624b3206],
10	toxicity	NN	O	toxicity	prep_with	7	SENT_41	[p2l645t3144r915b3225],
11	was	VBD	O	be	auxpass	12	SENT_41	[p2l937t3163r1070b3207],
12	performed	VBN	O	perform	_	0	SENT_41	[p2l1092t3144r1463b3225],
13	by	IN	O	by	_	0	SENT_41	[p2l1482t3144r1569b3225],
14	Mann	NNP	PERSON	Mann	agent	12	SENT_41	[p2l1590t3144r2146b3225],
15	.	.	O	.	_	0	SENT_41	[p2l1590t3144r2146b3225],

1	—	NN	O	—	_	0	SENT_42	[p2l1590t3144r2146b3225],
2	.	.	O	.	_	0	SENT_42	[p2l1590t3144r2146b3225],

1	Whitney	NNP	PERSON	Whitney	nsubj	2	SENT_43	[p2l1590t3144r2146b3225],
2	test	NN	O	test	_	0	SENT_43	[p2l7t3261r146b3315],
3	.	.	O	.	_	0	SENT_43	[p2l7t3261r146b3315],

1	All	DT	O	all	det	2	SENT_44	[p2l190t3252r301b3314],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_44	[p2l342t3252r638b3333],
3	were	VBD	O	be	auxpass	4	SENT_44	[p2l680t3272r850b3315],
4	done	VBN	O	do	_	0	SENT_44	[p2l891t3252r1060b3315],
5	by	IN	O	by	_	0	SENT_44	[p2l1098t3252r1186b3333],
6	SPSS	NNP	ORGANIZATION	SPSS	nn	8	SENT_44	[p2l1228t3253r1418b3315],
7	statistical	JJ	O	statistical	amod	8	SENT_44	[p2l1464t3252r1795b3315],
8	package	NN	O	package	agent	4	SENT_44	[p2l1833t3252r2143b3333],
9	,	,	O	,	_	0	SENT_44	[p2l1833t3252r2143b3333],
10	Version	NNP	O	Version	appos	8	SENT_44	[p2l7t3358r277b3420],
11	13.0	CD	NUMBER	13.0	num	10	SENT_44	[p2l311t3358r474b3420],
12	.	.	O	.	_	0	SENT_44	[p2l311t3358r474b3420],

1	Based	VBN	O	base	_	0	SENT_45	[p2l114t3464r331b3526],
2	on	IN	O	on	prepc_based_on	10	SENT_45	[p2l356t3483r442b3526],
3	linkage	NN	O	linkage	nn	5	SENT_45	[p2l467t3464r727b3545],
4	disequilibrium	NN	O	disequilibrium	nn	5	SENT_45	[p2l753t3464r1272b3545],
5	data	NNS	O	datum	pobj	10	SENT_45	[p2l1296t3464r1444b3526],
6	six	CD	NUMBER	six	num	7	SENT_45	[p2l1470t3464r1568b3526],
7	polymorphisms	NNS	O	polymorphism	nsubjpass	10	SENT_45	[p2l1593t3464r2145b3545],
8	can	MD	O	can	aux	10	SENT_45	[p2l8t3591r129b3634],
9	be	VB	O	be	auxpass	10	SENT_45	[p2l162t3571r245b3634],
10	organized	VBN	O	organize	_	0	SENT_45	[p2l281t3571r629b3652],
11	in	IN	O	in	_	0	SENT_45	[p2l663t3571r730b3633],
12	four	CD	NUMBER	four	num	13	SENT_45	[p2l765t3571r912b3634],
13	haplotypes	NNS	O	haplotype	prep_in	10	SENT_45	[p2l945t3571r1328b3652],
14	arbitrarily	RB	O	arbitrarily	advmod	15	SENT_45	[p2l1366t3571r1719b3652],
15	named	VBN	O	name	partmod	13	SENT_45	[p2l1754t3571r1990b3634],
16	*	NN	O	*	nn	17	SENT_45	[p2l2027t3554r2144b3645],
17	A	NN	O	a	dobj	15	SENT_45	[p2l2027t3554r2144b3645],
18	,	,	O	,	_	0	SENT_45	[p2l2027t3554r2144b3645],
19	*	NN	O	*	nn	20	SENT_45	[p2l10t3661r121b3752],
20	B	NN	O	b	conj_and	17	SENT_45	[p2l10t3661r121b3752],
21	,	,	O	,	_	0	SENT_45	[p2l10t3661r121b3752],
22	*	NN	O	*	nn	23	SENT_45	[p2l167t3661r258b3741],
23	C	NN	O	c	dobj	15	SENT_45	[p2l167t3661r258b3741],
24	and	CC	O	and	_	0	SENT_45	[p2l300t3678r425b3740],
25	*	NN	O	*	nn	26	SENT_45	[p2l467t3661r562b3740],
26	D	NN	O	d	dobj	15	SENT_45	[p2l467t3661r562b3740],
27	(	CD	NUMBER	(	num	28	SENT_45	[p2l606t3678r766b3759],
28	Fig	NN	O	fig	dep	26	SENT_45	[p2l606t3678r766b3759],
29	.	.	O	.	_	0	SENT_45	[p2l606t3678r766b3759],

1	1A	NN	O	1a	_	0	SENT_46	[p2l819t3678r964b3755],
2	)	NN	O	)	dep	1	SENT_46	[p2l819t3678r964b3755],
3	.	.	O	.	_	0	SENT_46	[p2l819t3678r964b3755],

1	None	NN	O	none	_	0	SENT_47	[p2l1007t3680r1198b3741],
2	of	IN	O	of	_	0	SENT_47	[p2l1239t3678r1315b3740],
3	the	DT	O	the	det	4	SENT_47	[p2l1348t3678r1454b3741],
4	variants	NNS	O	variant	prep_of	1	SENT_47	[p2l1494t3678r1769b3741],
5	or	CC	O	or	_	0	SENT_47	[p2l1812t3698r1884b3740],
6	haplotypes	NNS	O	haplotype	prep_of	1	SENT_47	[p2l1921t3678r2144b3759, p3l7t30r191b101],

1	tested	VBN	O	test	csubjpass	4	SENT_48	[p3l215t20r422b83],
2	was	VBD	O	be	auxpass	4	SENT_48	[p3l444t40r577b83],
3	signiﬁcantly	RB	O	signiﬁcantly	advmod	4	SENT_48	[p3l605t20r1040b101],
4	associated	VBN	O	associate	_	0	SENT_48	[p3l1065t20r1428b83],
5	with	IN	O	with	_	0	SENT_48	[p3l1450t20r1606b83],
6	EFS	NN	O	ef	prep_with	4	SENT_48	[p3l1628t21r1775b83],
7	or	CC	O	or	_	0	SENT_48	[p3l1803t40r1876b83],
8	DFS	NN	O	df	prep_with	4	SENT_48	[p3l1896t21r2053b83],
9	in	IN	O	in	_	0	SENT_48	[p3l2080t20r2147b82],
10	ALL	NN	O	all	nn	11	SENT_48	[p3l7t128r178b189],
11	patients	NNS	O	patient	prep_in	4	SENT_48	[p3l205t127r499b208],
12	.	.	O	.	_	0	SENT_48	[p3l205t127r499b208],

1	In	IN	O	in	_	0	SENT_49	[p3l530t129r602b189],
2	contrast	NN	O	contrast	prep_in	7	SENT_49	[p3l630t137r929b201],
3	,	,	O	,	_	0	SENT_49	[p3l630t137r929b201],
4	—	CD	NUMBER	—	num	6	SENT_49	[p3l965t127r1215b190],
5	354T	NN	O	354t	nn	6	SENT_49	[p3l965t127r1215b190],
6	carriers	NNS	O	carrier	nsubj	7	SENT_49	[p3l1243t127r1505b190],
7	had	VBD	O	have	dep	21	SENT_49	[p3l1534t127r1662b190],
8	better	RBR	O	better	advmod	9	SENT_49	[p3l1687t127r1891b190],
9	probability	NN	O	probability	dobj	7	SENT_49	[p3l1915t127r2144b208, p3l6t233r192b314],
10	of	IN	O	of	_	0	SENT_49	[p3l223t233r300b295],
11	5-year	JJ	DURATION	5-year	amod	15	SENT_49	[p3l325t232r551b314],
12	post	NN	O	post	nn	15	SENT_49	[p3l577t242r1093b314],
13	—	NN	O	—	nn	15	SENT_49	[p3l577t242r1093b314],
14	treatment	NN	O	treatment	nn	15	SENT_49	[p3l577t242r1093b314],
15	OS	NN	O	os	prep_of	9	SENT_49	[p3l1122t233r1228b296],
16	compared	VBN	O	compare	_	0	SENT_49	[p3l1262t233r1611b314],
17	to	TO	O	to	prepc_compared_to	7	SENT_49	[p3l1640t242r1706b295],
18	other	JJ	O	other	amod	20	SENT_49	[p3l1737t233r1919b295],
19	genotype	NN	O	genotype	nn	20	SENT_49	[p3l1947t252r2144b314, p3l7t351r158b422],
20	groups	NNS	O	group	pobj	7	SENT_49	[p3l191t361r428b422],
21	(	VBP	O	(	_	0	SENT_49	[p3l464t342r788b421],
22	p	NN	O	p	dobj	21	SENT_49	[p3l464t342r788b421],
23	=	JJ	O	=	amod	24	SENT_49	[p3l464t342r788b421],
24	0.04	CD	NUMBER	0.04	nsubj	21	SENT_49	[p3l464t342r788b421],
25	,	,	O	,	_	0	SENT_49	[p3l464t342r788b421],
26	Fig	NN	O	fig	appos	24	SENT_49	[p3l822t341r957b422],
27	.	.	O	.	_	0	SENT_49	[p3l822t341r957b422],

1	1B	NN	O	1b	_	0	SENT_50	[p3l1001t342r1142b419],
2	)	NN	O	)	dep	1	SENT_50	[p3l1001t342r1142b419],
3	.	.	O	.	_	0	SENT_50	[p3l1001t342r1142b419],

1	Given	VBN	O	give	dep	17	SENT_51	[p3l1179t341r1390b404],
2	that	IN	O	that	complm	8	SENT_51	[p3l1420t342r1553b404],
3	haplotype	NN	O	haplotype	nn	5	SENT_51	[p3l1582t341r1932b422],
4	*	NN	O	*	nn	5	SENT_51	[p3l1967t324r2054b403],
5	B	NN	O	b	nsubjpass	8	SENT_51	[p3l1967t324r2054b403],
6	is	VBZ	O	be	auxpass	8	SENT_51	[p3l2090t341r2145b404],
7	uniquely	RB	O	uniquely	advmod	8	SENT_51	[p3l7t448r316b529],
8	tagged	VBN	O	tag	pcomp	1	SENT_51	[p3l345t448r581b529],
9	by	IN	O	by	_	0	SENT_51	[p3l607t448r694b529],
10	—	CD	NUMBER	—	num	11	SENT_51	[p3l729t448r991b522],
11	354T	NN	O	354t	agent	8	SENT_51	[p3l729t448r991b522],
12	,	,	O	,	_	0	SENT_51	[p3l729t448r991b522],
13	signiﬁcant	JJ	O	signiﬁcant	amod	14	SENT_51	[p3l1026t448r1393b529],
14	association	NN	O	association	nsubjpass	17	SENT_51	[p3l1422t448r1814b511],
15	was	VBD	O	be	auxpass	17	SENT_51	[p3l1843t468r1976b511],
16	also	RB	O	also	advmod	17	SENT_51	[p3l2008t448r2146b511],
17	found	VBN	O	find	_	0	SENT_51	[p3l8t554r214b616],
18	between	IN	O	between	_	0	SENT_51	[p3l240t554r536b617],
19	haplotype	NN	O	haplotype	nn	21	SENT_51	[p3l563t554r913b635],
20	*	NN	O	*	nn	21	SENT_51	[p3l944t536r1032b615],
21	B	NN	O	b	prep_between	17	SENT_51	[p3l944t536r1032b615],
22	and	CC	O	and	_	0	SENT_51	[p3l1066t554r1192b616],
23	OS	NN	O	os	prep_between	17	SENT_51	[p3l1221t554r1348b617],
24	.	.	O	.	_	0	SENT_51	[p3l1221t554r1348b617],

1	Accordingly	RB	O	accordingly	advmod	7	SENT_52	[p3l1381t554r1838b635],
2	,	,	O	,	_	0	SENT_52	[p3l1381t554r1838b635],
3	individuals	NNS	O	individual	nsubj	7	SENT_52	[p3l1869t554r2144b616, p3l7t662r146b725],
4	with	IN	O	with	_	0	SENT_52	[p3l187t662r343b725],
5	this	DT	O	this	det	6	SENT_52	[p3l380t662r505b725],
6	genotype/haplotype	NN	O	genotype/haplotype	prep_with	3	SENT_52	[p3l546t662r1246b743],
7	were	VBD	O	be	_	0	SENT_52	[p3l1285t682r1455b725],
8	at	IN	O	at	_	0	SENT_52	[p3l1496t672r1557b725],
9	a	DT	O	a	det	11	SENT_52	[p3l1596t682r1633b725],
10	lower	JJR	O	lower	amod	11	SENT_52	[p3l1669t662r1869b725],
11	risk	NN	O	risk	prep_at	7	SENT_52	[p3l1904t662r2039b725],
12	of	IN	O	of	_	0	SENT_52	[p3l2076t662r2153b725],
13	fatal	JJ	O	fatal	amod	16	SENT_52	[p3l8t768r162b831],
14	outcome	NN	O	outcome	nn	16	SENT_52	[p3l196t777r499b831],
15	(	CD	NUMBER	(	num	16	SENT_52	[p3l535t768r894b845],
16	HR	NN	DURATION	hr	prep_of	11	SENT_52	[p3l535t768r894b845],
17	=	JJ	O	=	amod	11	SENT_52	[p3l535t768r894b845],
18	0.4	CD	NUMBER	0.4	tmod	17	SENT_52	[p3l535t768r894b845],
19	,	,	O	,	_	0	SENT_52	[p3l535t768r894b845],
20	95	CD	PERCENT	95	number	21	SENT_52	[p3l931t768r1087b831],
21	%	NN	PERCENT	%	amod	22	SENT_52	[p3l931t768r1087b831],
22	CI	NN	O	ci	appos	11	SENT_52	[p3l1125t768r1229b842],
23	,	,	O	,	_	0	SENT_52	[p3l1125t768r1229b842],
24	0.1-1	CD	NUMBER	0.1-1	num	25	SENT_52	[p3l1266t768r1549b842],
25	.0	CD	NUMBER	.0	appos	11	SENT_52	[p3l1266t768r1549b842],
26	,	,	O	,	_	0	SENT_52	[p3l1266t768r1549b842],
27	p	NN	O	p	appos	25	SENT_52	[p3l1577t768r1911b848],
28	=	JJ	O	=	amod	30	SENT_52	[p3l1577t768r1911b848],
29	0.04	CD	NUMBER	0.04	tmod	28	SENT_52	[p3l1577t768r1911b848],
30	)	NN	O	)	dep	27	SENT_52	[p3l1577t768r1911b848],
31	.	.	O	.	_	0	SENT_52	[p3l1577t768r1911b848],

1	However	RB	O	however	advmod	28	SENT_53	[p3l1949t769r2144b831, p3l8t896r170b950],
2	,	,	O	,	_	0	SENT_53	[p3l1949t769r2144b831, p3l8t896r170b950],
3	when	WRB	O	when	advmod	8	SENT_53	[p3l194t876r385b939],
4	other	JJ	O	other	amod	6	SENT_53	[p3l406t876r588b939],
5	prognostic	JJ	O	prognostic	amod	6	SENT_53	[p3l605t876r979b957],
6	factors	NNS	O	factor	nsubjpass	8	SENT_53	[p3l1001t876r1238b939],
7	were	VBD	O	be	auxpass	8	SENT_53	[p3l1261t896r1432b939],
8	considered	VBN	O	consider	advcl	28	SENT_53	[p3l1453t876r1837b939],
9	together	RB	O	together	_	0	SENT_53	[p3l1857t876r2149b957],
10	with	IN	O	with	_	0	SENT_53	[p3l8t983r164b1046],
11	the	DT	O	the	det	14	SENT_53	[p3l184t983r291b1046],
12	—	CD	NUMBER	—	num	14	SENT_53	[p3l319t983r568b1046],
13	354T	NN	O	354t	nn	14	SENT_53	[p3l319t983r568b1046],
14	variant	NN	O	variant	prep_together_with	8	SENT_53	[p3l590t983r834b1046],
15	in	IN	O	in	_	0	SENT_53	[p3l854t983r921b1045],
16	the	DT	O	the	det	19	SENT_53	[p3l942t983r1049b1046],
17	Cox	NN	O	cox	nn	19	SENT_53	[p3l1072t983r1217b1046],
18	regression	NN	O	regression	nn	19	SENT_53	[p3l1238t983r1602b1064],
19	model	NN	O	model	prep_in	14	SENT_53	[p3l1623t983r1863b1057],
20	,	,	O	,	_	0	SENT_53	[p3l1623t983r1863b1057],
21	the	DT	O	the	det	22	SENT_53	[p3l1887t983r1993b1046],
22	signiﬁcance	NN	O	signiﬁcance	nsubjpass	28	SENT_53	[p3l2018t983r2144b1064, p3l7t1089r327b1151],
23	of	IN	O	of	_	0	SENT_53	[p3l346t1089r423b1151],
24	HR	NN	DURATION	hr	nn	25	SENT_53	[p3l435t1090r558b1150],
25	estimate	NN	O	estimate	prep_of	22	SENT_53	[p3l576t1089r870b1151],
26	was	VBD	O	be	auxpass	28	SENT_53	[p3l889t1108r1021b1151],
27	not	RB	O	not	neg	28	SENT_53	[p3l1042t1098r1155b1151],
28	retained	VBN	O	retain	_	0	SENT_53	[p3l1171t1089r1458b1151],
29	(	CD	NUMBER	(	num	30	SENT_53	[p3l1478t1090r1627b1165],
30	HR	NN	DURATION	hr	dobj	28	SENT_53	[p3l1478t1090r1627b1165],
31	=	JJ	O	=	amod	30	SENT_53	[p3l1644t1115r1690b1139],
32	0.5	CD	NUMBER	0.5	tmod	31	SENT_53	[p3l1709t1089r1837b1162],
33	,	,	O	,	_	0	SENT_53	[p3l1709t1089r1837b1162],
34	95	CD	PERCENT	95	number	35	SENT_53	[p3l1859t1089r2016b1152],
35	%	NN	PERCENT	%	amod	36	SENT_53	[p3l1859t1089r2016b1152],
36	CI	NN	O	ci	appos	30	SENT_53	[p3l2039t1089r2144b1162],
37	,	,	O	,	_	0	SENT_53	[p3l2039t1089r2144b1162],
38	0.2-1	CD	NUMBER	0.2-1	num	39	SENT_53	[p3l8t1197r197b1259],
39	.3	NN	NUMBER	.3	appos	30	SENT_53	[p3l213t1197r353b1276],
40	,	,	O	,	_	0	SENT_53	[p3l213t1197r353b1276],
41	p	NN	O	p	appos	39	SENT_53	[p3l213t1197r353b1276],
42	=	JJ	O	=	advmod	45	SENT_53	[p3l373t1223r419b1247],
43	0.1	CD	NUMBER	0.1	num	44	SENT_53	[p3l438t1197r573b1274],
44	)	CD	NUMBER	)	dep	42	SENT_53	[p3l438t1197r573b1274],
45	suggesting	VBG	O	suggest	partmod	41	SENT_53	[p3l597t1196r972b1277],
46	minor	JJ	O	minor	amod	47	SENT_53	[p3l991t1196r1203b1259],
47	role	NN	O	role	dobj	45	SENT_53	[p3l1218t1196r1354b1259],
48	of	IN	O	of	_	0	SENT_53	[p3l1374t1196r1450b1259],
49	this	DT	O	this	det	50	SENT_53	[p3l1462t1196r1587b1259],
50	polymorphism	NN	O	polymorphism	prep_of	47	SENT_53	[p3l1605t1196r2142b1277],
51	.	.	O	.	_	0	SENT_53	[p3l1605t1196r2142b1277],

1	The	DT	O	the	det	2	SENT_54	[p3l7t1303r143b1366],
2	comparison	NN	O	comparison	nsubj	14	SENT_54	[p3l169t1303r583b1384],
3	of	IN	O	of	_	0	SENT_54	[p3l609t1303r686b1366],
4	the	DT	O	the	det	6	SENT_54	[p3l705t1303r811b1366],
5	chemotherapy	NN	O	chemotherapy	nn	6	SENT_54	[p3l838t1303r1339b1384],
6	toxicity	NN	O	toxicity	prep_of	2	SENT_54	[p3l1365t1303r1634b1384],
7	between	IN	O	between	_	0	SENT_54	[p3l1659t1303r1955b1366],
8	individuals	NNS	O	individual	prep_between	6	SENT_54	[p3l1981t1303r2144b1366, p3l7t1409r260b1471],
9	with	IN	O	with	_	0	SENT_54	[p3l278t1409r434b1471],
10	and	CC	O	and	_	0	SENT_54	[p3l451t1409r576b1471],
11	without	IN	O	without	_	0	SENT_54	[p3l591t1409r862b1471],
12	GGH	NN	O	ggh	nn	13	SENT_54	[p3l878t1409r1067b1472],
13	genotypes	NNS	O	genotype	prep_without	8	SENT_54	[p3l1083t1418r1439b1490],
14	showed	VBD	O	show	dep	41	SENT_54	[p3l1460t1409r1725b1471],
15	higher	JJR	O	higher	amod	16	SENT_54	[p3l1739t1409r1967b1490],
16	rates	NNS	O	rate	dep	25	SENT_54	[p3l1980t1418r2145b1471],
17	of	IN	O	of	_	0	SENT_54	[p3l8t1516r85b1579],
18	thrombocytopenia	NN	O	thrombocytopenia	nn	19	SENT_54	[p3l106t1516r753b1597],
19	grade	NN	O	grade	prep_of	16	SENT_54	[p3l781t1516r975b1597],
20	2	CD	NUMBER	2	number	21	SENT_54	[p3l1004t1517r1044b1578],
21	(	CD	NUMBER	(	num	19	SENT_54	[p3l1075t1516r1379b1594],
22	(	NN	O	(	dep	25	SENT_54	[p3l1075t1516r1379b1594],
23	50-75	CD	NUMBER	50-75	num	22	SENT_54	[p3l1075t1516r1379b1594],
24	)	CD	NUMBER	)	num	25	SENT_54	[p3l1075t1516r1379b1594],
25	x	NN	O	x	dep	14	SENT_54	[p3l1410t1536r1456b1577],
26	109	CD	NUMBER	109	num	27	SENT_54	[p3l1493t1499r1604b1579],
27	L	NN	O	l	dep	25	SENT_54	[p3l1626t1499r1797b1593],
28	‘	CD	NUMBER	‘	number	29	SENT_54	[p3l1626t1499r1797b1593],
29	1	CD	NUMBER	1	num	30	SENT_54	[p3l1626t1499r1797b1593],
30	)	NN	O	)	dobj	14	SENT_54	[p3l1626t1499r1797b1593],
31	for	IN	O	for	_	0	SENT_54	[p3l1827t1516r1931b1579],
32	carriers	NNS	O	carrier	prep_for	30	SENT_54	[p3l1957t1516r2144b1579, p3l8t1643r106b1686],
33	of	IN	O	of	_	0	SENT_54	[p3l144t1624r221b1686],
34	GGH	NN	O	ggh	nn	36	SENT_54	[p3l250t1624r439b1687],
35	+452	CD	NUMBER	+452	num	36	SENT_54	[p3l475t1624r710b1687],
36	T	NN	O	t	prep_of	32	SENT_54	[p3l475t1624r710b1687],
37	and	CC	O	and	_	0	SENT_54	[p3l746t1624r871b1686],
38	+1102	CD	NUMBER	+1102	num	40	SENT_54	[p3l906t1624r1195b1687],
39	G	NN	O	g	nn	40	SENT_54	[p3l906t1624r1195b1687],
40	polymorphisms	NNS	O	polymorphism	conj_and	36	SENT_54	[p3l1228t1624r1780b1705],
41	(	VBP	O	(	_	0	SENT_54	[p3l1819t1624r2144b1704],
42	p	NN	O	p	dobj	41	SENT_54	[p3l1819t1624r2144b1704],
43	=	JJ	O	=	amod	44	SENT_54	[p3l1819t1624r2144b1704],
44	0.05	CD	NUMBER	0.05	nsubj	41	SENT_54	[p3l1819t1624r2144b1704],
45	,	,	O	,	_	0	SENT_54	[p3l1819t1624r2144b1704],
46	Fig	NN	O	fig	appos	44	SENT_54	[p3l7t1731r141b1812],
47	.	.	O	.	_	0	SENT_54	[p3l7t1731r141b1812],

1	1C	NN	O	1c	_	0	SENT_55	[p3l186t1732r326b1809],
2	)	NN	O	)	dep	1	SENT_55	[p3l186t1732r326b1809],
3	.	.	O	.	_	0	SENT_55	[p3l186t1732r326b1809],

1	These	DT	O	these	det	3	SENT_56	[p3l362t1732r572b1794],
2	two	CD	NUMBER	two	num	3	SENT_56	[p3l604t1741r733b1794],
3	variants	NNS	O	variant	nsubj	5	SENT_56	[p3l766t1731r1041b1794],
4	are	VBP	O	be	aux	5	SENT_56	[p3l1076t1751r1180b1794],
5	tagging	VBG	O	tag	_	0	SENT_56	[p3l1212t1731r1476b1812],
6	haplotype	NN	O	haplotype	nn	8	SENT_56	[p3l1508t1731r1857b1812],
7	*	NN	O	*	nn	8	SENT_56	[p3l1892t1714r1988b1793],
8	D	NN	O	d	dobj	5	SENT_56	[p3l1892t1714r1988b1793],
9	and	CC	O	and	_	0	SENT_56	[p3l2022t1731r2148b1794],
10	hence	RB	O	hence	advmod	13	SENT_56	[p3l7t1838r212b1901],
11	the	DT	O	the	det	13	SENT_56	[p3l249t1838r356b1901],
12	same	JJ	O	same	amod	13	SENT_56	[p3l396t1858r573b1901],
13	association	NN	O	association	nsubjpass	18	SENT_56	[p3l612t1838r1005b1901],
14	of	IN	O	of	_	0	SENT_56	[p3l1042t1838r1119b1901],
15	borderline	JJ	O	borderline	amod	16	SENT_56	[p3l1149t1838r1514b1901],
16	signiﬁcance	NN	O	signiﬁcance	prep_of	13	SENT_56	[p3l1554t1838r1974b1919],
17	was	VBD	O	be	auxpass	18	SENT_56	[p3l2012t1858r2145b1901],
18	observed	VBN	O	observe	conj_and	5	SENT_56	[p3l8t1945r327b2008],
19	for	IN	O	for	_	0	SENT_56	[p3l351t1945r454b2007],
20	this	DT	O	this	det	21	SENT_56	[p3l477t1945r601b2007],
21	haplotype	NN	O	haplotype	prep_for	18	SENT_56	[p3l627t1945r995b2026],
22	.	.	O	.	_	0	SENT_56	[p3l627t1945r995b2026],

1	Our	PRP$	O	we	poss	2	SENT_57	[p3l116t2053r252b2115],
2	analysis	NN	O	analysis	nsubj	3	SENT_57	[p3l292t2052r573b2133],
3	showed	VBD	O	show	_	0	SENT_57	[p3l618t2052r883b2115],
4	the	DT	O	the	det	7	SENT_57	[p3l922t2052r1029b2115],
5	strong	JJ	O	strong	amod	7	SENT_57	[p3l1071t2062r1288b2133],
6	linkage	NN	O	linkage	nn	7	SENT_57	[p3l1329t2052r1589b2133],
7	disequilibrium	NN	O	disequilibrium	dobj	3	SENT_57	[p3l1629t2052r2148b2133],
8	between	IN	O	between	_	0	SENT_57	[p3l6t2159r302b2222],
9	GGH	NN	O	ggh	nn	10	SENT_57	[p3l351t2159r540b2222],
10	variants	NNS	O	variant	prep_between	7	SENT_57	[p3l588t2159r884b2222],
11	:	:	O	:	_	0	SENT_57	[p3l588t2159r884b2222],
12	only	RB	O	only	advmod	14	SENT_57	[p3l939t2159r1094b2240],
13	four	CD	NUMBER	four	num	14	SENT_57	[p3l1142t2159r1290b2222],
14	haplotypes	NNS	O	haplotype	nsubjpass	16	SENT_57	[p3l1335t2159r1718b2240],
15	are	VBP	O	be	auxpass	16	SENT_57	[p3l1769t2179r1873b2222],
16	distinguished	VBN	O	distinguish	parataxis	3	SENT_57	[p3l1922t2159r2144b2222, p3l8t2265r300b2346],
17	.	.	O	.	_	0	SENT_57	[p3l1922t2159r2144b2222, p3l8t2265r300b2346],

1	This	DT	O	this	nsubj	2	SENT_58	[p3l328t2265r482b2327],
2	is	VBZ	O	be	_	0	SENT_58	[p3l508t2265r563b2327],
3	in	IN	O	in	_	0	SENT_58	[p3l589t2265r656b2326],
4	accordance	NN	O	accordance	_	0	SENT_58	[p3l681t2265r1077b2327],
5	with	IN	O	with	_	0	SENT_58	[p3l1102t2265r1258b2328],
6	previous	JJ	O	previous	amod	8	SENT_58	[p3l1280t2265r1582b2346],
7	study	NN	O	study	nn	8	SENT_58	[p3l1611t2265r1798b2346],
8	reporting	NN	O	reporting	prep_in_accordance_with	2	SENT_58	[p3l1821t2265r2146b2346],

1	1024	CD	NUMBER	1024	num	2	SENT_59	[p3l169t2421r231b2445],
2	Letters	NNS	O	letter	_	0	SENT_59	[p3l787t2422r878b2445],
3	to	TO	O	to	_	0	SENT_59	[p3l888t2426r912b2445],
4	the	DT	O	the	det	5	SENT_59	[p3l923t2421r961b2445],
5	Editor	NNP	O	Editor	prep_to	2	SENT_59	[p3l970t2421r1076b2445],
6	/	:	O	/	punct	2	SENT_59	[p3l970t2421r1076b2445],
7	Leukemia	NNP	ORGANIZATION	Leukemia	nn	8	SENT_59	[p3l1081t2421r1209b2445],
8	Research	NNP	ORGANIZATION	Research	dep	2	SENT_59	[p3l1217t2421r1339b2445],
9	31	CD	NUMBER	31	number	10	SENT_59	[p3l1349t2421r1379b2444],
10	(	CD	NUMBER	(	num	11	SENT_59	[p3l1391t2421r1477b2450],
11	2007	CD	DATE	2007	dep	8	SENT_59	[p3l1391t2421r1477b2450],
12	)	CD	NUMBER	)	number	13	SENT_59	[p3l1391t2421r1477b2450],
13	1023-1028	CD	DATE	1023-1028	num	11	SENT_59	[p3l1488t2421r1636b2444],

1	-401	CD	NUMBER	-401	num	2	SENT_60	[p3l341t2472r401b2499],
2	C	NN	O	c	dep	8	SENT_60	[p3l416t2473r485b2500],
3	>	JJR	O	>	amod	4	SENT_60	[p3l416t2473r485b2500],
4	T	NN	O	t	dep	2	SENT_60	[p3l416t2473r485b2500],
5	-124	CD	NUMBER	-124	num	6	SENT_60	[p3l636t2473r700b2499],
6	T	NN	O	t	dep	8	SENT_60	[p3l711t2472r782b2500],
7	>	JJR	O	>	amod	8	SENT_60	[p3l711t2472r782b2500],
8	G	NN	O	g	dep	15	SENT_60	[p3l711t2472r782b2500],
9	1	CD	NUMBER	1	number	10	SENT_60	[p3l935t2481r947b2507],
10	2	CD	NUMBER	2	num	12	SENT_60	[p3l1025t2481r1041b2507],
11	3	CD	NUMBER	3	number	12	SENT_60	[p3l1133t2481r1148b2507],
12	4	CD	NUMBER	4	dep	8	SENT_60	[p3l1240t2482r1257b2507],
13	5	CD	NUMBER	5	number	14	SENT_60	[p3l1348t2481r1363b2507],
14	6	CD	NUMBER	6	amod	12	SENT_60	[p3l1456t2481r1473b2507],
15	7	CD	NUMBER	7	dep	17	SENT_60	[p3l1565t2481r1581b2506],
16	8	CD	NUMBER	8	num	17	SENT_60	[p3l1652t2481r1669b2507],
17	9	CD	NUMBER	9	_	0	SENT_60	[p3l1760t2481r1777b2507],

1	-354	CD	NUMBER	-354	num	2	SENT_61	[p3l449t2617r613b2644],
2	G	NN	O	g	_	0	SENT_61	[p3l449t2617r613b2644],
3	>	JJR	O	>	amod	4	SENT_61	[p3l449t2617r613b2644],
4	T	NN	O	t	dep	2	SENT_61	[p3l449t2617r613b2644],
5	i	FW	O	i	dep	2	SENT_61	[p3l935t2523r939b2642],

1	+	CC	O	+	cc	2	SENT_62	[p3l919t2674r1196b2723],
2	l6T	NN	O	l6t	_	0	SENT_62	[p3l919t2674r1196b2723],
3	:	:	O	:	_	0	SENT_62	[p3l919t2674r1196b2723],
4	-	:	O	-	_	0	SENT_62	[p3l919t2674r1196b2723],
5	C	NN	O	c	nsubj	7	SENT_62	[p3l919t2674r1196b2723],
6	+452	CD	NUMBER	+452	num	5	SENT_62	[p3l1666t2674r1979b2723],
7	C	NN	O	c	dep	2	SENT_62	[p3l1666t2674r1979b2723],
8	>	JJR	O	>	amod	9	SENT_62	[p3l1666t2674r1979b2723],
9	T	NN	O	t	dobj	7	SENT_62	[p3l1666t2674r1979b2723],

1	—	SYM	O	—	dep	8	SENT_63	[p3l196t2980r243b2996],
2	-	:	O	-	_	0	SENT_63	[p3l284t2972r331b3002],
3	er	NN	O	er	nn	7	SENT_63	[p3l284t2972r331b3002],
4	tr	NN	O	tr	nn	7	SENT_63	[p3l405t2972r452b3002],
5	HO	NNP	O	HO	nn	7	SENT_63	[p3l529t2977r575b3005],
6	Q	NNP	O	Q	nn	7	SENT_63	[p3l616t2944r663b3005],
7	E	NNP	O	E	nsubj	8	SENT_63	[p3l718t2936r767b3021],
8	f	FW	O	f	_	0	SENT_63	[p3l825t2947r1097b3010],
9	!	.	O	!	_	0	SENT_63	[p3l825t2947r1097b3010],
10	"	''	O	"	punct	8	SENT_63	[p3l825t2947r1097b3010],
11	'	''	O	'	_	0	SENT_63	[p3l825t2947r1097b3010],

1	€	NN	O	€	_	0	SENT_64	[p3l825t2947r1097b3010],
2	t	NN	O	t	prep	1	SENT_64	[p3l825t2947r1097b3010],
3	]	CD	NUMBER	]	num	4	SENT_64	[p3l825t2947r1097b3010],
4	h	NN	O	h	dep	2	SENT_64	[p3l825t2947r1097b3010],
5	'	''	O	'	_	0	SENT_64	[p3l825t2947r1097b3010],
6	j	NN	O	j	dep	1	SENT_64	[p3l825t2947r1097b3010],
7	€	CD	NUMBER	€	num	8	SENT_64	[p3l825t2947r1097b3010],
8	l	NN	O	l	dep	6	SENT_64	[p3l825t2947r1097b3010],
9	-	:	O	-	_	0	SENT_64	[p3l825t2947r1097b3010],
10	'	''	DATE	'	_	0	SENT_64	[p3l825t2947r1097b3010],
11	16	CD	DATE	16	number	12	SENT_64	[p3l825t2947r1097b3010],
12	}	CD	NUMBER	}	dep	8	SENT_64	[p3l825t2947r1097b3010],
13	/	:	O	/	punct	12	SENT_64	[p3l825t2947r1097b3010],
14	'	''	O	'	_	0	SENT_64	[p3l825t2947r1097b3010],
15	______________________________________________________	CD	NUMBER	______________________________________________________	dep	1	SENT_64	[p3l1432t3002r2124b3007],
16	+	CC	O	+	_	0	SENT_64	[p3l2130t3002r2144b3010],
17	3	CD	NUMBER	3	dep	1	SENT_64	[p3l196t3005r243b3091],
18	?	.	O	?	_	0	SENT_64	[p3l284t3007r331b3091],

1	+	CC	O	+	cc	2	SENT_65	[p3l284t3007r331b3091],
2	2	CD	NUMBER	2	dep	12	SENT_65	[p3l405t3005r449b3091],
3	:	:	O	:	_	0	SENT_65	[p3l405t3005r449b3091],
4	‘	CD	NUMBER	‘	number	5	SENT_65	[p3l405t3005r449b3091],
5	7	CD	NUMBER	7	dep	2	SENT_65	[p3l528t3016r575b3077],
6	;	:	O	;	_	0	SENT_65	[p3l528t3016r575b3077],
7	it	PRP	O	it	dep	5	SENT_65	[p3l616t3010r663b3077],
8	:	:	O	:	_	0	SENT_65	[p3l718t3038r765b3102],
9	(	CD	NUMBER	(	num	10	SENT_65	[p3l940t3005r1028b3066],
10	W	NN	O	w	dep	7	SENT_65	[p3l940t3005r1028b3066],
11	1.0	CD	NUMBER	1.0	dep	10	SENT_65	[p3l1317t3018r1377b3058],
12	E	NN	O	e	_	0	SENT_65	[p3l2141t3016r2144b3063],

1	AEE	NN	O	aee	_	0	SENT_66	[p3l87t3124r943b3214],
2	;	:	O	;	_	0	SENT_66	[p3l87t3124r943b3214],
3	;	:	O	;	_	0	SENT_66	[p3l87t3124r943b3214],
4	mEﬂ9	NN	O	meﬂ9	dep	5	SENT_66	[p3l87t3124r943b3214],
5	Era	NN	O	era	dep	8	SENT_66	[p3l1748t3166r2007b3263],
6	B	NN	O	b	dep	5	SENT_66	[p3l89t3288r128b3330],
7	39	CD	NUMBER	39	dep	5	SENT_66	[p3l844t3283r957b3330],
8	*	CD	NUMBER	*	dep	1	SENT_66	[p3l844t3283r957b3330],
9	"	``	O	"	punct	10	SENT_66	[p3l844t3283r957b3330],
10	3	CD	NUMBER	3	dep	8	SENT_66	[p3l1226t3283r1270b3360],
11	"	``	O	"	punct	10	SENT_66	[p3l1311t3294r1374b3335],
12	-3	CD	NUMBER	-3	num	13	SENT_66	[p3l1311t3294r1374b3335],
13	12.	CD	NUMBER	12.	dep	10	SENT_66	[p3l1921t3253r2144b3385],
14	;	:	O	;	_	0	SENT_66	[p3l1921t3253r2144b3385],
15	(	CD	NUMBER	(	number	16	SENT_66	[p3l1921t3253r2144b3385],
16	16	CD	NUMBER	16	dep	8	SENT_66	[p3l1921t3253r2144b3385],
17	)	CD	NUMBER	)	num	20	SENT_66	[p3l1921t3253r2144b3385],
18	§	NN	O	§	nn	20	SENT_66	[p3l1921t3253r2144b3385],
19	cmmnmmmmr	NN	O	cmmnmmmmr	nn	20	SENT_66	[p3l87t3420r938b3502],
20	T	NN	O	t	dep	16	SENT_66	[p3l2141t3390r2144b3423],

1	(	NN	O	(	nn	2	SENT_67	[p3l73t3678r153b3736],
2	A	NN	O	a	dep	8	SENT_67	[p3l73t3678r153b3736],
3	)	CD	NUMBER	)	num	5	SENT_67	[p3l73t3678r153b3736],
4	(	NN	O	(	nn	5	SENT_67	[p3l1212t3681r1289b3736],
5	B	NN	O	b	dep	2	SENT_67	[p3l1212t3681r1289b3736],
6	)	CD	NUMBER	)	num	7	SENT_67	[p3l1212t3681r1289b3736],
7	(	NN	O	(	dep	8	SENT_67	[p3l1445t3667r1470b3705],
8	l	NN	O	l	dep	14	SENT_67	[p3l1445t3667r1470b3705],
9	20	CD	NUMBER	20	number	10	SENT_67	[p3l1567t3667r1617b3705],
10	40	CD	NUMBER	40	dep	8	SENT_67	[p3l1685t3667r1738b3705],
11	60	CD	NUMBER	60	num	13	SENT_67	[p3l1820t3667r1872b3705],
12	30	CD	NUMBER	30	num	13	SENT_67	[p3l1954t3667r2004b3706],
13	l	NN	O	l	dep	10	SENT_67	[p3l2078t3667r2089b3703],
14	oo	NN	O	oo	_	0	SENT_67	[p3l2100t3667r2152b3705],

1	time	NN	O	time	_	0	SENT_68	[p3l1696t3755r1806b3799],

1	{	NN	O	{	nn	2	SENT_69	[p4l13t2800r222b2946],
2	C	NN	O	c	_	0	SENT_69	[p4l13t2800r222b2946],
3	)	CD	NUMBER	)	number	4	SENT_69	[p4l13t2800r222b2946],
4	+4	CD	NUMBER	+4	dep	2	SENT_69	[p4l444t2772r958b2911],
5	-521	CD	NUMBER	-521	num	6	SENT_69	[p4l444t2772r958b2911],
6	*	NN	O	*	dep	4	SENT_69	[p4l444t2772r958b2911],
7	+4521	CD	NUMBER	+4521	num	8	SENT_69	[p4l1494t2786r1980b2911],
8	“	NN	O	“	dep	2	SENT_69	[p4l1494t2786r1980b2911],

1	Fig	NN	O	fig	_	0	SENT_70	[p4l33t3021r83b3051],
2	.	.	O	.	_	0	SENT_70	[p4l33t3021r83b3051],

1	1	LS	NUMBER	1	_	0	SENT_71	[p4l99t3021r118b3044],
2	.	.	O	.	_	0	SENT_71	[p4l99t3021r118b3044],

1	(	NN	O	(	nn	2	SENT_72	[p4l136t3021r179b3050],
2	A	NN	O	a	_	0	SENT_72	[p4l136t3021r179b3050],
3	)	CD	NUMBER	)	num	5	SENT_72	[p4l136t3021r179b3050],
4	GGH	NN	O	ggh	nn	5	SENT_72	[p4l191t3021r262b3044],
5	polymorphisms	NNS	O	polymorphism	dep	2	SENT_72	[p4l272t3021r478b3051],
6	and	CC	O	and	_	0	SENT_72	[p4l490t3021r536b3044],
7	derived	VBN	O	derive	partmod	27	SENT_72	[p4l547t3021r645b3044],
8	haplotypes	NNS	O	haplotype	dobj	7	SENT_72	[p4l655t3021r805b3051],
9	,	,	O	,	_	0	SENT_72	[p4l655t3021r805b3051],
10	The	DT	O	the	det	11	SENT_72	[p4l817t3021r868b3044],
11	frequency	NN	O	frequency	nsubjpass	27	SENT_72	[p4l879t3021r1010b3051],
12	of	IN	O	of	_	0	SENT_72	[p4l1021t3021r1050b3044],
13	minor	JJ	O	minor	amod	14	SENT_72	[p4l1058t3021r1138b3044],
14	allele	NN	O	allele	prep_of	11	SENT_72	[p4l1148t3021r1219b3044],
15	for	IN	O	for	dep	14	SENT_72	[p4l1230t3021r1268b3044],
16	each	DT	O	each	det	17	SENT_72	[p4l1278t3021r1338b3044],
17	polymorphism	NN	O	polymorphism	pobj	15	SENT_72	[p4l1348t3021r1542b3051],
18	and	CC	O	and	_	0	SENT_72	[p4l1553t3021r1600b3044],
19	that	IN	O	that	dep	20	SENT_72	[p4l1610t3021r1660b3044],
20	of	IN	O	of	dep	14	SENT_72	[p4l1670t3021r1699b3044],
21	the	DT	O	the	det	22	SENT_72	[p4l1708t3021r1747b3044],
22	haplotypes	NNS	O	haplotype	pobj	20	SENT_72	[p4l1758t3021r1901b3051],
23	in	IN	O	in	_	0	SENT_72	[p4l1912t3021r1937b3044],
24	ALL	NN	O	all	nn	25	SENT_72	[p4l1948t3021r2012b3044],
25	patients	NNS	O	patient	prep_in	11	SENT_72	[p4l2022t3021r2124b3051],
26	are	VBP	O	be	auxpass	27	SENT_72	[p4l34t3069r73b3085],
27	given	VBN	O	give	conj_and	2	SENT_72	[p4l84t3061r156b3092],
28	below	IN	O	below	_	0	SENT_72	[p4l167t3061r246b3085],
29	upper	JJ	O	upper	amod	30	SENT_72	[p4l257t3069r333b3092],
30	panel	NN	O	panel	prep_below	27	SENT_72	[p4l343t3061r415b3092],
31	and	CC	O	and	_	0	SENT_72	[p4l427t3061r474b3085],
32	next	JJ	O	next	advmod	27	SENT_72	[p4l484t3065r541b3085],
33	to	TO	O	to	_	0	SENT_72	[p4l551t3065r576b3085],
34	the	DT	O	the	det	35	SENT_72	[p4l588t3061r627b3085],
35	haplotypes	NNS	O	haplotype	prep_to	27	SENT_72	[p4l638t3061r789b3092],
36	,	,	O	,	_	0	SENT_72	[p4l638t3061r789b3092],
37	respectively	RB	O	respectively	advmod	27	SENT_72	[p4l801t3061r964b3092],
38	.	.	O	.	_	0	SENT_72	[p4l801t3061r964b3092],

1	The	DT	O	the	det	2	SENT_73	[p4l977t3061r1027b3085],
2	probes	NNS	O	probe	nsubj	22	SENT_73	[p4l1038t3061r1126b3092],
3	used	VBN	O	use	partmod	2	SENT_73	[p4l1137t3061r1198b3085],
4	to	TO	O	to	aux	5	SENT_73	[p4l1209t3065r1234b3085],
5	reveal	VB	O	reveal	xcomp	3	SENT_73	[p4l1245t3061r1324b3085],
6	genotypes	NNS	O	genotype	dobj	5	SENT_73	[p4l1335t3065r1468b3092],
7	at	IN	O	at	_	0	SENT_73	[p4l1481t3065r1504b3085],
8	positions	NNS	O	position	amod	20	SENT_73	[p4l1514t3061r1633b3092],
9	-401	CD	NUMBER	-401	tmod	8	SENT_73	[p4l1647t3061r1727b3089],
10	,	,	O	,	_	0	SENT_73	[p4l1647t3061r1727b3089],
11	-354	CD	NUMBER	-354	num	9	SENT_73	[p4l1741t3061r1821b3089],
12	,	,	O	,	_	0	SENT_73	[p4l1741t3061r1821b3089],
13	-124	CD	NUMBER	-124	num	9	SENT_73	[p4l1836t3061r1916b3089],
14	,	,	O	,	_	0	SENT_73	[p4l1836t3061r1916b3089],
15	+16	CD	NUMBER	+16	num	9	SENT_73	[p4l1928t3061r1986b3089],
16	,	,	O	,	_	0	SENT_73	[p4l1928t3061r1986b3089],
17	+452	CD	NUMBER	+452	num	9	SENT_73	[p4l1999t3061r2066b3085],
18	and	CC	O	and	_	0	SENT_73	[p4l2078t3061r2125b3085],
19	+1	CD	NUMBER	+1	tmod	8	SENT_73	[p4l34t3102r65b3125],
20	102	CD	NUMBER	102	prep_at	5	SENT_73	[p4l72t3102r117b3126],
21	are	VBP	O	be	cop	22	SENT_73	[p4l124t3110r163b3126],
22	AACCTCC/TCCTCTCGA	NNP	O	AACCTCC/TCCTCTCGA	_	0	SENT_73	[p4l169t3102r541b3130],
23	,	,	O	,	_	0	SENT_73	[p4l169t3102r541b3130],
24	GGGTGACTG/TAAGTCCA	NNP	O	GGGTGACTG/TAAGTCCA	conj_and	22	SENT_73	[p4l548t3102r952b3130],
25	,	,	O	,	_	0	SENT_73	[p4l548t3102r952b3130],
26	TTCCCAT/GAGGCCCA	NNP	O	TTCCCAT/GAGGCCCA	conj_and	22	SENT_73	[p4l958t3102r1314b3130],
27	,	,	O	,	_	0	SENT_73	[p4l958t3102r1314b3130],
28	GCAGGCA/GGCCCGGAC	NNP	O	GCAGGCA/GGCCCGGAC	conj_and	22	SENT_73	[p4l1321t3102r1708b3130],
29	,	,	O	,	_	0	SENT_73	[p4l1321t3102r1708b3130],
30	GCTTATTAAC/TTGCCA	NNP	O	GCTTATTAAC/TTGCCA	conj_and	22	SENT_73	[p4l1716t3102r2072b3126],
31	and	CC	O	and	_	0	SENT_73	[p4l2078t3102r2125b3126],
32	CTGTATGTGACTA/GTTTAT	NNP	O	CTGTATGTGACTA/GTTTAT	conj_and	22	SENT_73	[p4l34t3143r452b3171],
33	,	,	O	,	_	0	SENT_73	[p4l34t3143r452b3171],
34	respectively	RB	O	respectively	advmod	22	SENT_73	[p4l461t3143r624b3174],
35	.	.	O	.	_	0	SENT_73	[p4l461t3143r624b3174],

1	Minor	JJ	O	minor	amod	3	SENT_74	[p4l634t3143r717b3167],
2	alleles	NNS	O	allele	nn	3	SENT_74	[p4l726t3143r808b3167],
3	speciﬁc	NN	O	speciﬁc	nsubjpass	8	SENT_74	[p4l818t3143r917b3174],
4	for	IN	O	for	_	0	SENT_74	[p4l926t3143r965b3167],
5	each	DT	O	each	det	6	SENT_74	[p4l973t3143r1033b3167],
6	haplotype	NN	O	haplotype	prep_for	3	SENT_74	[p4l1041t3143r1171b3174],
7	are	VBP	O	be	auxpass	8	SENT_74	[p4l1180t3151r1219b3167],
8	indicated	VBN	O	indicate	_	0	SENT_74	[p4l1227t3143r1349b3167],
9	in	IN	O	in	_	0	SENT_74	[p4l1357t3143r1382b3167],
10	bold	JJ	O	bold	amod	11	SENT_74	[p4l1390t3143r1449b3167],
11	character	NN	O	character	prep_in	8	SENT_74	[p4l1457t3143r1582b3167],
12	.	.	O	.	_	0	SENT_74	[p4l1457t3143r1582b3167],

1	Three	CD	NUMBER	three	num	3	SENT_75	[p4l1592t3143r1669b3167],
2	tag	NN	O	tag	nn	3	SENT_75	[p4l1677t3147r1717b3174],
3	SNPs	NNS	O	snp	nsubj	4	SENT_75	[p4l1726t3143r1798b3167],
4	(	VBP	O	(	_	0	SENT_75	[p4l1808t3143r1940b3173],
5	sufﬁcient	NN	O	sufﬁcient	dobj	4	SENT_75	[p4l1808t3143r1940b3173],
6	to	TO	O	to	aux	7	SENT_75	[p4l1948t3147r1973b3167],
7	deﬁne	VB	O	deﬁne	infmod	5	SENT_75	[p4l1982t3143r2062b3167],
8	four	CD	NUMBER	four	num	11	SENT_75	[p4l2070t3143r2125b3167],
9	GGH	NNP	O	GGH	nn	11	SENT_75	[p4l34t3185r105b3208],
10	haplotypes	NNS	O	haplotype	nn	11	SENT_75	[p4l113t3185r267b3215],
11	)	NN	O	)	nsubjpass	14	SENT_75	[p4l113t3185r267b3215],
12	can	MD	O	can	aux	14	SENT_75	[p4l277t3192r322b3208],
13	be	VB	O	be	auxpass	14	SENT_75	[p4l330t3185r361b3208],
14	identiﬁed	VBN	O	identiﬁed	ccomp	7	SENT_75	[p4l370t3185r502b3208],
15	:	:	O	:	_	0	SENT_75	[p4l370t3185r502b3208],
16	one	CD	NUMBER	one	conj_or	5	SENT_75	[p4l514t3192r561b3208],
17	at	IN	O	at	_	0	SENT_75	[p4l570t3188r594b3208],
18	the	DT	O	the	det	19	SENT_75	[p4l602t3185r642b3208],
19	position	NN	O	position	prep_at	16	SENT_75	[p4l650t3185r757b3215],
20	-354	CD	NUMBER	-354	num	19	SENT_75	[p4l768t3185r848b3212],
21	,	,	O	,	_	0	SENT_75	[p4l768t3185r848b3212],
22	one	CD	NUMBER	one	conj_or	5	SENT_75	[p4l859t3192r913b3212],
23	,	,	O	,	_	0	SENT_75	[p4l859t3192r913b3212],
24	whichever	WDT	O	whichever	dep	25	SENT_75	[p4l923t3185r1060b3208],
25	SNP	NN	O	snp	dep	22	SENT_75	[p4l1069t3185r1128b3208],
26	from	IN	O	from	_	0	SENT_75	[p4l1137t3185r1202b3208],
27	positions	NNS	O	position	prep_from	25	SENT_75	[p4l1209t3185r1328b3215],
28	-402	CD	NUMBER	-402	num	27	SENT_75	[p4l1340t3185r1420b3212],
29	,	,	O	,	_	0	SENT_75	[p4l1340t3185r1420b3212],
30	—	CD	NUMBER	—	num	31	SENT_75	[p4l1432t3198r1453b3200],
31	124	CD	NUMBER	124	prep_from	25	SENT_75	[p4l1459t3185r1505b3208],
32	or	CC	O	or	_	0	SENT_75	[p4l1515t3192r1542b3208],
33	+16	CD	NUMBER	+16	conj_or	27	SENT_75	[p4l1551t3185r1601b3208],
34	and	CC	O	and	_	0	SENT_75	[p4l1611t3185r1658b3208],
35	one	CD	NUMBER	one	conj_or	27	SENT_75	[p4l1667t3192r1721b3212],
36	,	,	O	,	_	0	SENT_75	[p4l1667t3192r1721b3212],
37	whichever	WDT	O	whichever	dep	38	SENT_75	[p4l1731t3185r1868b3208],
38	SNP	NN	O	snp	rcmod	22	SENT_75	[p4l1877t3185r1937b3208],
39	from	IN	O	from	_	0	SENT_75	[p4l1946t3185r2010b3208],
40	position	NN	O	position	prep_from	38	SENT_75	[p4l2018t3185r2125b3215],
41	+452	CD	NUMBER	+452	num	40	SENT_75	[p4l34t3225r101b3249],
42	or	CC	O	or	_	0	SENT_75	[p4l111t3233r138b3249],
43	+1102	CD	NUMBER	+1102	dobj	4	SENT_75	[p4l148t3225r238b3249],
44	.	.	O	.	_	0	SENT_75	[p4l148t3225r238b3249],

1	(	NN	O	(	_	0	SENT_76	[p4l251t3226r293b3255],
2	B	NN	O	b	nn	4	SENT_76	[p4l251t3226r293b3255],
3	)	CD	NUMBER	)	num	4	SENT_76	[p4l251t3226r293b3255],
4	Kaplan	NNP	PERSON	Kaplan	dep	1	SENT_76	[p4l304t3225r495b3256],
5	.	.	O	.	_	0	SENT_76	[p4l304t3225r495b3256],

1	—	NN	O	—	_	0	SENT_77	[p4l304t3225r495b3256],
2	.	.	O	.	_	0	SENT_77	[p4l304t3225r495b3256],

1	Meier	JJR	PERSON	meier	amod	2	SENT_78	[p4l304t3225r495b3256],
2	estimates	NNS	O	estimate	_	0	SENT_78	[p4l504t3225r626b3249],
3	of	IN	O	of	_	0	SENT_78	[p4l637t3225r666b3249],
4	overall	JJ	O	overall	amod	5	SENT_78	[p4l674t3225r764b3249],
5	survival	NN	O	survival	prep_of	2	SENT_78	[p4l775t3225r878b3249],
6	(	CD	NUMBER	(	num	8	SENT_78	[p4l889t3225r951b3255],
7	OS	NN	O	os	nn	8	SENT_78	[p4l889t3225r951b3255],
8	)	NN	O	)	nsubj	16	SENT_78	[p4l889t3225r951b3255],
9	for	IN	O	for	_	0	SENT_78	[p4l961t3225r1000b3249],
10	ALL	NN	O	all	nn	11	SENT_78	[p4l1009t3225r1073b3249],
11	patients	NNS	O	patient	prep_for	8	SENT_78	[p4l1082t3225r1185b3256],
12	according	VBG	O	accord	_	0	SENT_78	[p4l1196t3225r1325b3256],
13	to	TO	O	to	prepc_according_to	11	SENT_78	[p4l1335t3229r1360b3249],
14	GGH	NN	O	ggh	pobj	11	SENT_78	[p4l1370t3225r1441b3249],
15	-354	CD	NUMBER	-354	num	14	SENT_78	[p4l1453t3225r1600b3249],
16	G	NN	O	g	rcmod	2	SENT_78	[p4l1453t3225r1600b3249],
17	>	JJR	O	>	amod	19	SENT_78	[p4l1453t3225r1600b3249],
18	T	NN	O	t	nn	19	SENT_78	[p4l1453t3225r1600b3249],
19	genotypes	NNS	O	genotype	dobj	16	SENT_78	[p4l1610t3229r1750b3256],
20	.	.	O	.	_	0	SENT_78	[p4l1610t3229r1750b3256],

1	OS	NNP	O	OS	nn	2	SENT_79	[p4l1762t3225r1802b3249],
2	curves	NNS	O	curve	_	0	SENT_79	[p4l1813t3233r1898b3249],
3	for	IN	O	for	_	0	SENT_79	[p4l1908t3225r1947b3249],
4	patients	NNS	O	patient	prep_for	2	SENT_79	[p4l1955t3225r2058b3256],
5	who	WP	O	who	nsubj	7	SENT_79	[p4l2068t3225r2124b3249],
6	are	VBP	O	be	cop	7	SENT_79	[p4l34t3274r73b3290],
7	positive	JJ	O	positive	rcmod	4	SENT_79	[p4l83t3267r186b3297],
8	(	CD	NUMBER	(	num	11	SENT_79	[p4l198t3267r253b3296],
9	full	JJ	O	full	amod	11	SENT_79	[p4l198t3267r253b3296],
10	line	NN	O	line	nn	11	SENT_79	[p4l263t3267r322b3295],
11	)	NN	O	)	nsubj	15	SENT_79	[p4l263t3267r322b3295],
12	or	CC	O	or	_	0	SENT_79	[p4l334t3274r361b3290],
13	negative	JJ	O	negative	amod	14	SENT_79	[p4l371t3267r480b3297],
14	(	NN	O	(	conj_or	11	SENT_79	[p4l492t3267r584b3295],
15	dotted	VBD	O	dot	ccomp	7	SENT_79	[p4l492t3267r584b3295],
16	line	NN	O	line	nn	17	SENT_79	[p4l594t3267r653b3295],
17	)	NN	O	)	dobj	15	SENT_79	[p4l594t3267r653b3295],
18	for	IN	O	for	_	0	SENT_79	[p4l665t3267r703b3290],
19	GGH	NN	O	ggh	nn	22	SENT_79	[p4l713t3267r784b3290],
20	-354	CD	NUMBER	-354	num	22	SENT_79	[p4l796t3267r889b3290],
21	T	NN	O	t	nn	22	SENT_79	[p4l796t3267r889b3290],
22	genotype	NN	O	genotype	prep_for	15	SENT_79	[p4l900t3270r1027b3297],
23	.	.	O	.	_	0	SENT_79	[p4l900t3270r1027b3297],

1	The	DT	O	the	det	2	SENT_80	[p4l1039t3267r1090b3290],
2	genotype	NN	O	genotype	nsubjpass	42	SENT_80	[p4l1100t3270r1221b3297],
3	and	CC	O	and	_	0	SENT_80	[p4l1232t3267r1279b3290],
4	the	DT	O	the	det	5	SENT_80	[p4l1289t3267r1328b3290],
5	number	NN	O	number	conj_and	2	SENT_80	[p4l1339t3267r1440b3290],
6	of	IN	O	of	_	0	SENT_80	[p4l1450t3267r1479b3290],
7	patients	NNS	O	patient	prep_of	5	SENT_80	[p4l1486t3267r1589b3297],
8	in	IN	O	in	_	0	SENT_80	[p4l1599t3267r1625b3290],
9	each	DT	O	each	det	10	SENT_80	[p4l1635t3267r1695b3290],
10	curve	NN	O	curve	prep_in	7	SENT_80	[p4l1705t3274r1785b3294],
11	,	,	O	,	_	0	SENT_80	[p4l1705t3274r1785b3294],
12	numbers	NNS	O	number	conj_and	10	SENT_80	[p4l1796t3267r1909b3290],
13	of	IN	O	of	_	0	SENT_80	[p4l1920t3267r1949b3290],
14	death	NN	O	death	nn	15	SENT_80	[p4l1957t3267r2028b3290],
15	(	NN	O	(	prep_of	12	SENT_80	[p4l2039t3267r2075b3296],
16	in	IN	O	in	_	0	SENT_80	[p4l2039t3267r2075b3296],
17	the	DT	O	the	det	19	SENT_80	[p4l2085t3267r2125b3290],
18	parenthesis	NN	O	parenthesis	nn	19	SENT_80	[p4l33t3308r192b3338],
19	)	NN	O	)	prep_in	15	SENT_80	[p4l33t3308r192b3338],
20	and	CC	O	and	_	0	SENT_80	[p4l204t3308r251b3331],
21	the	DT	O	the	det	24	SENT_80	[p4l261t3308r301b3331],
22	p	NN	O	p	nn	24	SENT_80	[p4l309t3308r417b3338],
23	—	NN	O	—	nn	24	SENT_80	[p4l309t3308r417b3338],
24	value	NN	O	value	prep_in	7	SENT_80	[p4l309t3308r417b3338],
25	,	,	O	,	_	0	SENT_80	[p4l309t3308r417b3338],
26	estimated	VBN	O	estimate	partmod	2	SENT_80	[p4l429t3308r555b3331],
27	by	IN	O	by	_	0	SENT_80	[p4l565t3308r598b3338],
28	log	NN	O	log	nn	31	SENT_80	[p4l608t3308r721b3338],
29	—	CD	NUMBER	—	num	31	SENT_80	[p4l608t3308r721b3338],
30	rank	NN	O	rank	nn	31	SENT_80	[p4l608t3308r721b3338],
31	test	NN	O	test	agent	26	SENT_80	[p4l731t3311r777b3331],
32	for	IN	O	for	_	0	SENT_80	[p4l787t3308r825b3331],
33	the	DT	O	the	det	35	SENT_80	[p4l835t3308r875b3331],
34	survival	NN	O	survival	nn	35	SENT_80	[p4l886t3308r990b3331],
35	differences	NNS	O	difference	prep_for	26	SENT_80	[p4l1001t3308r1146b3331],
36	between	IN	O	between	_	0	SENT_80	[p4l1157t3308r1267b3331],
37	the	DT	O	the	det	39	SENT_80	[p4l1277t3308r1317b3331],
38	patients	NNS	O	patient	nn	39	SENT_80	[p4l1327t3308r1430b3338],
39	groups	NNS	O	group	prep_between	35	SENT_80	[p4l1441t3315r1538b3338],
40	,	,	O	,	_	0	SENT_80	[p4l1441t3315r1538b3338],
41	are	VBP	O	be	auxpass	42	SENT_80	[p4l1550t3315r1589b3331],
42	indicated	VBN	O	indicate	_	0	SENT_80	[p4l1600t3308r1721b3331],
43	on	IN	O	on	_	0	SENT_80	[p4l1731t3315r1764b3331],
44	the	DT	O	the	det	45	SENT_80	[p4l1774t3308r1814b3331],
45	plot	NN	O	plot	prep_on	42	SENT_80	[p4l1824t3308r1882b3338],
46	.	.	O	.	_	0	SENT_80	[p4l1824t3308r1882b3338],

1	(	NN	O	(	nn	2	SENT_81	[p4l1895t3308r1937b3337],
2	C	NN	O	c	_	0	SENT_81	[p4l1895t3308r1937b3337],
3	)	CD	NUMBER	)	num	4	SENT_81	[p4l1895t3308r1937b3337],
4	Frequency	NN	O	frequency	dep	2	SENT_81	[p4l1948t3308r2087b3338],
5	of	IN	O	of	_	0	SENT_81	[p4l2098t3308r2127b3331],
6	+452	CD	NUMBER	+452	num	7	SENT_81	[p4l34t3348r123b3371],
7	C	NN	O	c	prep_of	4	SENT_81	[p4l34t3348r123b3371],
8	>	JJR	O	>	amod	10	SENT_81	[p4l130t3353r147b3371],
9	T	NN	O	t	nn	10	SENT_81	[p4l154t3348r173b3371],
10	genotypes	NNS	O	genotype	dep	2	SENT_81	[p4l182t3351r315b3378],
11	in	IN	O	in	_	0	SENT_81	[p4l324t3348r349b3371],
12	ALL	NN	O	all	nn	13	SENT_81	[p4l357t3348r422b3371],
13	patients	NNS	O	patient	conj_and	13	SENT_81	[p4l429t3348r532b3378],
14	with	IN	O	with	_	0	SENT_81	[p4l541t3348r599b3371],
15	and	CC	O	and	_	0	SENT_81	[p4l608t3348r655b3371],
16	without	IN	O	without	_	0	SENT_81	[p4l664t3348r765b3371],
17	thrombocytopenia	NN	O	thrombocytopenia	nn	18	SENT_81	[p4l772t3348r1013b3378],
18	grade	NN	O	grade	prep_with	13	SENT_81	[p4l1022t3348r1094b3378],
19	2	CD	NUMBER	2	num	18	SENT_81	[p4l1103t3348r1125b3371],
20	.	.	O	.	_	0	SENT_81	[p4l1103t3348r1125b3371],

1	The	DT	O	the	det	5	SENT_82	[p4l1135t3348r1186b3371],
2	gray	JJ	O	gray	amod	5	SENT_82	[p4l1195t3355r1253b3378],
3	and	CC	O	and	_	0	SENT_82	[p4l1262t3348r1309b3371],
4	white	JJ	O	white	conj_and	2	SENT_82	[p4l1317t3348r1390b3371],
5	bars	NNS	O	bar	nsubj	6	SENT_82	[p4l1398t3348r1453b3371],
6	represent	VBP	O	represent	conj_and	6	SENT_82	[p4l1461t3351r1583b3378],
7	individuals	NNS	O	individual	dobj	6	SENT_82	[p4l1591t3348r1736b3371],
8	with	IN	O	with	_	0	SENT_82	[p4l1746t3348r1804b3371],
9	and	CC	O	and	_	0	SENT_82	[p4l1813t3348r1860b3371],
10	without	IN	O	without	_	0	SENT_82	[p4l1868t3348r1969b3371],
11	at	IN	O	at	advmod	14	SENT_82	[p4l1978t3351r2001b3371],
12	least	JJS	O	least	pobj	11	SENT_82	[p4l2009t3348r2070b3371],
13	one	CD	NUMBER	one	num	14	SENT_82	[p4l2078t3355r2124b3371],
14	episode	NN	O	episode	prep_with	6	SENT_82	[p4l33t3389r134b3419],
15	of	IN	O	of	_	0	SENT_82	[p4l143t3389r172b3412],
16	thrombocytopenia	NN	O	thrombocytopenia	nn	17	SENT_82	[p4l178t3389r419b3419],
17	grade	NN	O	grade	prep_of	14	SENT_82	[p4l427t3389r500b3419],
18	2	CD	NUMBER	2	num	17	SENT_82	[p4l509t3389r532b3416],
19	;	:	O	;	_	0	SENT_82	[p4l509t3389r532b3416],
20	+452	CD	NUMBER	+452	num	21	SENT_82	[p4l542t3387r624b3412],
21	’“	NN	O	’“	dep	14	SENT_82	[p4l542t3387r624b3412],
22	and	CC	O	and	_	0	SENT_82	[p4l635t3389r682b3412],
23	+452	CD	NUMBER	+452	num	24	SENT_82	[p4l690t3389r786b3417],
24	‘	NN	O	‘	conj_and	21	SENT_82	[p4l690t3389r786b3417],
25	,	,	O	,	_	0	SENT_82	[p4l690t3389r786b3417],
26	carriers	NNS	O	carrier	appos	14	SENT_82	[p4l796t3389r894b3412],
27	and	CC	O	and	_	0	SENT_82	[p4l904t3389r951b3412],
28	non-carriers	NNS	O	non-carrier	appos	14	SENT_82	[p4l959t3389r1118b3412],
29	of	IN	O	of	_	0	SENT_82	[p4l1127t3389r1156b3412],
30	+452	CD	NUMBER	+452	num	32	SENT_82	[p4l1163t3389r1251b3412],
31	T	NN	O	t	nn	32	SENT_82	[p4l1163t3389r1251b3412],
32	allele	NN	O	allele	prep_of	26	SENT_82	[p4l1260t3389r1337b3412],
33	.	.	O	.	_	0	SENT_82	[p4l1260t3389r1337b3412],

1	The	DT	O	the	det	2	SENT_83	[p4l1347t3389r1398b3412],
2	number	NN	O	number	nsubj	5	SENT_83	[p4l1406t3389r1508b3412],
3	of	IN	O	of	_	0	SENT_83	[p4l1516t3389r1545b3412],
4	individuals	NNS	O	individual	prep_of	2	SENT_83	[p4l1551t3389r1696b3412],
5	represented	VBN	O	represent	_	0	SENT_83	[p4l1705t3389r1858b3419],
6	by	IN	O	by	_	0	SENT_83	[p4l1866t3389r1898b3419],
7	each	DT	O	each	det	8	SENT_83	[p4l1907t3389r1967b3412],
8	bar	NN	O	bar	prep_by	5	SENT_83	[p4l1975t3389r2023b3417],
9	,	,	O	,	_	0	SENT_83	[p4l1975t3389r2023b3417],
10	as	RB	O	as	_	0	SENT_83	[p4l2033t3396r2059b3412],
11	well	RB	O	well	_	0	SENT_83	[p4l2068t3389r2125b3412],
12	as	IN	O	as	_	0	SENT_83	[p4l34t3437r60b3453],
13	p-value	NN	O	p-value	conj_and	8	SENT_83	[p4l66t3430r167b3460],
14	obtained	VBN	O	obtain	partmod	13	SENT_83	[p4l175t3430r289b3453],
15	by	IN	O	by	_	0	SENT_83	[p4l297t3430r329b3460],
16	Mann	NNP	PERSON	Mann	agent	14	SENT_83	[p4l338t3430r545b3460],
17	.	.	O	.	_	0	SENT_83	[p4l338t3430r545b3460],

1	—	NN	O	—	_	0	SENT_84	[p4l338t3430r545b3460],
2	.	.	O	.	_	0	SENT_84	[p4l338t3430r545b3460],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_85	[p4l338t3430r545b3460],
2	test	NN	O	test	nsubjpass	4	SENT_85	[p4l554t3433r600b3453],
3	is	VBZ	O	be	auxpass	4	SENT_85	[p4l607t3430r628b3453],
4	given	VBN	O	give	_	0	SENT_85	[p4l638t3430r709b3460],
5	on	IN	O	on	_	0	SENT_85	[p4l718t3437r750b3453],
6	the	DT	O	the	det	7	SENT_85	[p4l758t3430r798b3453],
7	plot	NN	O	plot	prep_on	4	SENT_85	[p4l806t3430r864b3460],
8	.	.	O	.	_	0	SENT_85	[p4l806t3430r864b3460],

1	Toxicity	NN	O	toxicity	nsubjpass	3	SENT_86	[p4l874t3430r983b3460],
2	was	VBD	O	be	auxpass	3	SENT_86	[p4l992t3437r1042b3453],
3	graded	VBN	O	grade	_	0	SENT_86	[p4l1051t3430r1141b3460],
4	using	VBG	O	use	xcomp	3	SENT_86	[p4l1149t3430r1220b3460],
5	the	DT	O	the	det	7	SENT_86	[p4l1229t3430r1269b3453],
6	common	JJ	O	common	amod	7	SENT_86	[p4l1277t3437r1393b3453],
7	criteria	NNS	O	criterion	dobj	4	SENT_86	[p4l1401t3430r1495b3453],
8	for	IN	O	for	_	0	SENT_86	[p4l1503t3430r1541b3453],
9	adverse	JJ	O	adverse	amod	10	SENT_86	[p4l1550t3430r1649b3453],
10	events	NNS	O	event	prep_for	4	SENT_86	[p4l1658t3433r1740b3453],
11	of	IN	O	of	_	0	SENT_86	[p4l1749t3430r1778b3453],
12	National	NNP	ORGANIZATION	National	nn	14	SENT_86	[p4l1784t3430r1898b3453],
13	Cancer	NNP	ORGANIZATION	Cancer	nn	14	SENT_86	[p4l1907t3430r2000b3453],
14	Institute	NNP	ORGANIZATION	Institute	prep_of	10	SENT_86	[p4l2008t3430r2123b3453],
15	.	.	O	.	_	0	SENT_86	[p4l2008t3430r2123b3453],

1	on	IN	O	on	_	0	SENT_87	[p4l8t3618r94b3662],
2	linkage	NN	O	linkage	nn	3	SENT_87	[p4l112t3599r372b3680],
3	disequilibrium	NN	O	disequilibrium	prep_on	4	SENT_87	[p4l391t3599r909b3680],
4	between	IN	O	between	_	0	SENT_87	[p4l925t3599r1221b3662],
5	SNPs	NNS	O	snp	pobj	4	SENT_87	[p4l1241t3599r1433b3662],
6	at	IN	O	at	_	0	SENT_87	[p4l1455t3608r1517b3662],
7	positions	NNS	O	position	prep_at	5	SENT_87	[p4l1532t3599r1851b3680],
8	452	CD	NUMBER	452	number	13	SENT_87	[p4l1870t3599r2002b3662],
9	and	CC	O	and	_	0	SENT_87	[p4l2022t3599r2148b3662],
10	1	CD	NUMBER	1	conj_and	13	SENT_87	[p4l15t3707r42b3768],
11	102	CD	NUMBER	102	number	13	SENT_87	[p4l60t3707r182b3770],
12	[	CD	NUMBER	[	number	13	SENT_87	[p4l208t3707r321b3782],
13	1	CD	NUMBER	1	dep	4	SENT_87	[p4l208t3707r321b3782],
14	]	NN	O	]	dep	13	SENT_87	[p4l208t3707r321b3782],
15	.	.	O	.	_	0	SENT_87	[p4l208t3707r321b3782],

1	Variants	NNS	O	variant	dep	2	SENT_88	[p4l344t3706r633b3769],
2	located	JJ	O	located	_	0	SENT_88	[p4l654t3706r910b3769],
3	in	IN	O	in	_	0	SENT_88	[p4l928t3706r995b3768],
4	the	DT	O	the	det	6	SENT_88	[p4l1013t3706r1120b3769],
5	promoter	NN	O	promoter	nn	6	SENT_88	[p4l1138t3716r1466b3788],
6	region	NN	O	region	prep_in	2	SENT_88	[p4l1482t3706r1726b3788],
7	,	,	O	,	_	0	SENT_88	[p4l1482t3706r1726b3788],
8	were	VBD	O	be	partmod	6	SENT_88	[p4l1749t3726r1919b3769],
9	previously	RB	DATE	previously	advmod	8	SENT_88	[p4l1937t3706r2144b3788, p5l8t20r197b101],

1	shown	VBN	O	show	_	0	SENT_89	[p5l223t20r449b83],
2	to	TO	O	to	aux	3	SENT_89	[p5l470t29r537b83],
3	increase	VB	O	increase	xcomp	1	SENT_89	[p5l560t20r849b83],
4	mRNA	NN	O	mrna	nn	5	SENT_89	[p5l872t21r1125b83],
5	expression	NN	O	expression	dobj	3	SENT_89	[p5l1148t20r1525b101],
6	in	FW	O	in	prep	3	SENT_89	[p5l1550t22r1613b83],
7	vitro	FW	O	vitro	nn	8	SENT_89	[p5l1637t22r1797b83],
8	[	FW	O	[	pobj	6	SENT_89	[p5l1827t21r1940b96],
9	2	CD	NUMBER	2	number	10	SENT_89	[p5l1827t21r1940b96],
10	]	CD	NUMBER	]	dep	8	SENT_89	[p5l1827t21r1940b96],
11	.	.	O	.	_	0	SENT_89	[p5l1827t21r1940b96],

1	They	PRP	O	they	nsubj	4	SENT_90	[p5l1967t20r2146b101],
2	could	MD	O	could	aux	4	SENT_90	[p5l8t126r204b188],
3	thus	RB	O	thus	advmod	4	SENT_90	[p5l232t126r376b188],
4	affect	VB	O	affect	_	0	SENT_90	[p5l410t126r608b188],
5	MTX	NNP	O	MTX	dobj	4	SENT_90	[p5l636t126r976b189],
6	.	.	O	.	_	0	SENT_90	[p5l636t126r976b189],

1	—	NN	O	—	_	0	SENT_91	[p5l636t126r976b189],
2	.	.	O	.	_	0	SENT_91	[p5l636t126r976b189],

1	PG	NN	O	pg	nn	2	SENT_92	[p5l636t126r976b189],
2	formation	NN	O	formation	_	0	SENT_92	[p5l1006t126r1355b188],
3	increasing	VBG	O	increase	partmod	2	SENT_92	[p5l1384t125r1748b207],
4	the	DT	O	the	det	5	SENT_92	[p5l1778t126r1884b188],
5	rate	NN	O	rate	dobj	3	SENT_92	[p5l1913t135r2045b188],
6	of	IN	O	of	_	0	SENT_92	[p5l2076t126r2153b188],
7	MTX	NNP	O	MTX	prep_of	5	SENT_92	[p5l7t234r347b296],
8	.	.	O	.	_	0	SENT_92	[p5l7t234r347b296],

1	—	NN	O	—	_	0	SENT_93	[p5l7t234r347b296],
2	.	.	O	.	_	0	SENT_93	[p5l7t234r347b296],

1	PG	NN	O	pg	_	0	SENT_94	[p5l7t234r347b296],
2	breakdown	NN	O	breakdown	dep	1	SENT_94	[p5l373t233r784b295],
3	.	.	O	.	_	0	SENT_94	[p5l373t233r784b295],

1	Indeed	RB	O	indeed	advmod	6	SENT_95	[p5l816t233r1076b307],
2	,	,	O	,	_	0	SENT_95	[p5l816t233r1076b307],
3	—	NN	O	—	nn	5	SENT_95	[p5l1112t234r1362b295],
4	40lT	NN	O	40lt	nn	5	SENT_95	[p5l1112t234r1362b295],
5	allele	NN	O	allele	nsubj	6	SENT_95	[p5l1392t233r1580b295],
6	correlated	VBD	O	correlate	_	0	SENT_95	[p5l1609t233r1964b295],
7	with	IN	O	with	_	0	SENT_95	[p5l1991t233r2147b295],
8	decreased	VBN	O	decrease	amod	10	SENT_95	[p5l8t340r357b403],
9	MT	NN	O	mt	nn	10	SENT_95	[p5l374t342r506b402],
10	X	NN	O	x	prep_with	6	SENT_95	[p5l508t340r715b403],
11	.	.	O	.	_	0	SENT_95	[p5l508t340r715b403],

1	—	NN	O	—	_	0	SENT_96	[p5l508t340r715b403],
2	.	.	O	.	_	0	SENT_96	[p5l508t340r715b403],

1	PG	NN	O	pg	nn	2	SENT_97	[p5l508t340r715b403],
2	levels	NNS	O	level	_	0	SENT_97	[p5l732t340r932b403],
3	in	IN	O	in	_	0	SENT_97	[p5l952t340r1019b402],
4	patients	NNS	O	patient	prep_in	2	SENT_97	[p5l1036t340r1310b421],
5	with	IN	O	with	_	0	SENT_97	[p5l1330t340r1486b403],
6	rheumatoid	JJ	O	rheumatoid	amod	10	SENT_97	[p5l1503t340r1909b403],
7	arthritis	NN	O	arthritis	nn	10	SENT_97	[p5l1928t340r2144b403, p5l7t446r87b507],
8	[	NN	O	[	nn	10	SENT_97	[p5l115t445r228b521],
9	6	CD	NUMBER	6	num	10	SENT_97	[p5l115t445r228b521],
10	]	NN	O	]	prep_with	2	SENT_97	[p5l115t445r228b521],
11	.	.	O	.	_	0	SENT_97	[p5l115t445r228b521],

1	Possible	JJ	O	possible	amod	2	SENT_98	[p5l252t446r547b507],
2	association	NN	O	association	nsubjpass	12	SENT_98	[p5l569t446r961b507],
3	of	IN	O	of	_	0	SENT_98	[p5l982t446r1059b507],
4	these	DT	O	these	det	5	SENT_98	[p5l1072t446r1253b507],
5	variants	NNS	O	variant	prep_of	2	SENT_98	[p5l1273t445r1549b508],
6	with	IN	O	with	_	0	SENT_98	[p5l1571t446r1727b508],
7	worse	JJR	O	worse	amod	9	SENT_98	[p5l1747t465r1955b508],
8	ALL	NN	O	all	nn	9	SENT_98	[p5l1975t446r2147b507],
9	outcome	NN	O	outcome	prep_with	5	SENT_98	[p5l8t563r311b616],
10	could	MD	O	could	aux	12	SENT_98	[p5l335t553r531b616],
11	be	VB	O	be	auxpass	12	SENT_98	[p5l552t553r634b616],
12	anticipated	VBN	O	anticipate	_	0	SENT_98	[p5l659t553r1047b634],
13	as	RB	O	as	advmod	14	SENT_98	[p5l1071t573r1139b616],
14	well	RB	O	well	advmod	12	SENT_98	[p5l1164t553r1333b616],
15	.	.	O	.	_	0	SENT_98	[p5l1164t553r1333b616],

1	Our	PRP$	O	we	poss	2	SENT_99	[p5l1362t554r1498b616],
2	analyses	NNS	O	analysis	nsubj	3	SENT_99	[p5l1521t553r1817b634],
3	were	VBD	O	be	_	0	SENT_99	[p5l1842t573r2012b616],
4	not	RB	O	not	neg	3	SENT_99	[p5l2035t563r2148b616],
5	in	IN	O	in	_	0	SENT_99	[p5l7t660r74b722],
6	favor	NN	O	favor	prep_in	3	SENT_99	[p5l100t660r283b723],
7	of	IN	O	of	_	0	SENT_99	[p5l309t660r386b722],
8	this	DT	O	this	det	9	SENT_99	[p5l406t660r530b722],
9	expectation	NN	O	expectation	prep_of	6	SENT_99	[p5l559t660r983b741],
10	.	.	O	.	_	0	SENT_99	[p5l559t660r983b741],

1	The	DT	O	the	det	2	SENT_100	[p5l1014t660r1150b722],
2	association	NN	O	association	nsubjpass	5	SENT_100	[p5l1179t660r1571b722],
3	was	VBD	O	be	auxpass	5	SENT_100	[p5l1597t679r1731b723],
4	only	RB	O	only	advmod	5	SENT_100	[p5l1759t660r1914b741],
5	found	VBN	O	find	_	0	SENT_100	[p5l1941t660r2148b722],
6	between	IN	O	between	_	0	SENT_100	[p5l6t767r302b830],
7	—	CD	NUMBER	—	num	10	SENT_100	[p5l328t767r577b830],
8	354T	NN	O	354t	nn	10	SENT_100	[p5l328t767r577b830],
9	variant	JJ	O	variant	amod	10	SENT_100	[p5l597t767r842b830],
10	(	NN	O	(	nsubj	12	SENT_100	[p5l864t767r1200b848],
11	uniquely	RB	O	uniquely	advmod	12	SENT_100	[p5l864t767r1200b848],
12	tagging	VBG	O	tag	prepc_between	5	SENT_100	[p5l1220t767r1484b848],
13	haplotype	NN	O	haplotype	nn	16	SENT_100	[p5l1505t768r1854b848],
14	*	NN	O	*	nn	16	SENT_100	[p5l1879t750r1998b845],
15	B	NN	O	b	nn	16	SENT_100	[p5l1879t750r1998b845],
16	)	NN	O	)	dobj	12	SENT_100	[p5l1879t750r1998b845],
17	and	CC	O	and	_	0	SENT_100	[p5l2022t767r2148b830],
18	an	DT	O	a	det	20	SENT_100	[p5l9t893r89b935],
19	increased	VBN	O	increase	amod	20	SENT_100	[p5l113t873r449b935],
20	OS	NN	O	os	dobj	12	SENT_100	[p5l475t873r602b935],
21	.	.	O	.	_	0	SENT_100	[p5l475t873r602b935],

1	However	RB	O	however	advmod	7	SENT_101	[p5l632t875r966b946],
2	,	,	O	,	_	0	SENT_101	[p5l632t875r966b946],
3	this	DT	O	this	det	4	SENT_101	[p5l994t873r1119b935],
4	association	NN	O	association	nsubjpass	7	SENT_101	[p5l1148t873r1540b935],
5	was	VBD	O	be	auxpass	7	SENT_101	[p5l1565t893r1698b935],
6	not	RB	O	not	neg	7	SENT_101	[p5l1725t882r1838b935],
7	retained	VBN	O	retain	_	0	SENT_101	[p5l1861t873r2148b935],
8	in	IN	O	in	_	0	SENT_101	[p5l7t979r74b1040],
9	multivariate	JJ	O	multivariate	amod	10	SENT_101	[p5l93t979r517b1041],
10	analysis	NN	O	analysis	prep_in	7	SENT_101	[p5l538t979r819b1060],
11	suggesting	VBG	O	suggest	partmod	10	SENT_101	[p5l843t979r1218b1060],
12	minor	JJ	O	minor	amod	14	SENT_101	[p5l1238t979r1450b1041],
13	independent	JJ	O	independent	amod	14	SENT_101	[p5l1467t979r1903b1060],
14	role	NN	O	role	dobj	11	SENT_101	[p5l1919t979r2055b1041],
15	of	IN	O	of	_	0	SENT_101	[p5l2076t978r2153b1041],
16	this	DT	O	this	det	17	SENT_101	[p5l7t1087r132b1150],
17	polymorphism	NN	O	polymorphism	prep_of	14	SENT_101	[p5l157t1087r694b1168],
18	.	.	O	.	_	0	SENT_101	[p5l157t1087r694b1168],

1	The	DT	O	the	det	3	SENT_102	[p5l114t1194r250b1257],
2	+452	CD	NUMBER	+452	num	3	SENT_102	[p5l291t1194r666b1257],
3	C	NN	O	c	nsubj	15	SENT_102	[p5l291t1194r666b1257],
4	>	JJR	O	>	amod	6	SENT_102	[p5l291t1194r666b1257],
5	T	NN	O	t	nn	6	SENT_102	[p5l291t1194r666b1257],
6	changes	NNS	O	change	dep	3	SENT_102	[p5l706t1194r988b1275],
7	the	DT	O	the	det	8	SENT_102	[p5l1029t1194r1136b1257],
8	codon	NN	O	codon	dep	3	SENT_102	[p5l1177t1194r1392b1257],
9	127	CD	NUMBER	127	num	8	SENT_102	[p5l1439t1194r1559b1257],
10	from	IN	O	from	_	0	SENT_102	[p5l1602t1194r1774b1257],
11	threonine	NN	O	threonine	prep_from	8	SENT_102	[p5l1812t1194r2146b1257],
12	to	TO	O	to	_	0	SENT_102	[p5l7t1309r73b1362],
13	isoleucine	NN	O	isoleucine	prep_to	11	SENT_102	[p5l111t1299r489b1374],
14	,	,	O	,	_	0	SENT_102	[p5l111t1299r489b1374],
15	reducing	VBG	O	reduce	_	0	SENT_102	[p5l528t1300r838b1381],
16	the	DT	O	the	det	17	SENT_102	[p5l876t1300r982b1362],
17	activity	NN	O	activity	dobj	15	SENT_102	[p5l1021t1300r1281b1381],
18	of	IN	O	of	_	0	SENT_102	[p5l1320t1300r1396b1362],
19	the	DT	O	the	det	20	SENT_102	[p5l1427t1300r1533b1362],
20	protein	NN	O	protein	prep_of	17	SENT_102	[p5l1569t1300r1821b1381],
21	in	IN	O	in	_	0	SENT_102	[p5l1858t1300r1925b1361],
22	an	DT	O	a	prep_in	20	SENT_102	[p5l1963t1319r2043b1362],
23	in	FW	O	in	nn	24	SENT_102	[p5l2083t1302r2146b1362],
24	vitro	FW	O	vitro	advmod	25	SENT_102	[p5l7t1411r168b1471],
25	setting	VBG	O	set	partmod	22	SENT_102	[p5l208t1408r439b1489],
26	[	CD	NUMBER	[	num	27	SENT_102	[p5l483t1408r730b1484],
27	l	NN	O	l	dobj	25	SENT_102	[p5l483t1408r730b1484],
28	,2,6	CD	NUMBER	,2,6	num	29	SENT_102	[p5l483t1408r730b1484],
29	]	NN	O	]	dep	27	SENT_102	[p5l483t1408r730b1484],
30	.	.	O	.	_	0	SENT_102	[p5l483t1408r730b1484],

1	Additionally	RB	O	additionally	advmod	7	SENT_103	[p5l770t1408r1232b1489],
2	,	,	O	,	_	0	SENT_103	[p5l770t1408r1232b1489],
3	GGH	NN	O	ggh	nsubjpass	7	SENT_103	[p5l1272t1409r1462b1471],
4	+452	CD	NUMBER	+452	num	5	SENT_103	[p5l1499t1408r1734b1471],
5	T	NN	O	t	dep	3	SENT_103	[p5l1499t1408r1734b1471],
6	was	VBD	O	be	auxpass	7	SENT_103	[p5l1770t1428r1903b1471],
7	found	VBN	O	find	_	0	SENT_103	[p5l1941t1408r2148b1471],
8	overrepresented	VBN	O	overrepresent	dep	7	SENT_103	[p5l8t1515r573b1596],
9	in	IN	O	in	_	0	SENT_103	[p5l614t1515r681b1577],
10	a	DT	O	a	det	11	SENT_103	[p5l725t1534r762b1577],
11	subgroup	NN	O	subgroup	prep_in	8	SENT_103	[p5l806t1515r1131b1596],
12	of	IN	O	of	_	0	SENT_103	[p5l1176t1515r1252b1577],
13	ALL	NN	O	all	nn	14	SENT_103	[p5l1288t1515r1460b1577],
14	patients	NNS	O	patient	prep_of	11	SENT_103	[p5l1501t1515r1775b1596],
15	with	IN	O	with	_	0	SENT_103	[p5l1820t1515r1976b1578],
16	low	JJ	O	low	amod	18	SENT_103	[p5l2018t1515r2146b1578],
17	GGH	NN	O	ggh	nn	18	SENT_103	[p5l8t1623r198b1685],
18	activity	NN	O	activity	prep_with	8	SENT_103	[p5l215t1622r476b1703],
19	leading	VBG	O	lead	partmod	18	SENT_103	[p5l493t1622r752b1703],
20	to	TO	O	to	_	0	SENT_103	[p5l768t1632r835b1685],
21	increased	VBN	O	increase	amod	22	SENT_103	[p5l851t1622r1187b1685],
22	accumulation	NN	O	accumulation	prep_to	19	SENT_103	[p5l1204t1622r1680b1685],
23	of	IN	O	of	_	0	SENT_103	[p5l1697t1622r1774b1685],
24	long	JJ	O	long	amod	26	SENT_103	[p5l1784t1622r1939b1703],
25	chain	NN	O	chain	nn	26	SENT_103	[p5l1957t1622r2147b1685],
26	MTX	NN	O	mtx	prep_of	22	SENT_103	[p5l7t1729r347b1792],
27	.	.	O	.	_	0	SENT_103	[p5l7t1729r347b1792],

1	—	NN	O	—	_	0	SENT_104	[p5l7t1729r347b1792],
2	.	.	O	.	_	0	SENT_104	[p5l7t1729r347b1792],

1	PG	NN	O	pg	_	0	SENT_105	[p5l7t1729r347b1792],
2	[	CD	NUMBER	[	number	3	SENT_105	[p5l381t1730r494b1805],
3	1	CD	NUMBER	1	dep	1	SENT_105	[p5l381t1730r494b1805],
4	]	NN	O	]	dep	3	SENT_105	[p5l381t1730r494b1805],
5	.	.	O	.	_	0	SENT_105	[p5l381t1730r494b1805],

1	Our	PRP$	O	we	poss	2	SENT_106	[p5l528t1730r665b1792],
2	ﬁnding	NN	O	ﬁnding	nsubj	18	SENT_106	[p5l692t1729r940b1810],
3	of	IN	O	of	_	0	SENT_106	[p5l970t1729r1047b1792],
4	the	DT	O	the	det	5	SENT_106	[p5l1069t1729r1176b1792],
5	association	NN	O	association	prep_of	2	SENT_106	[p5l1206t1729r1598b1792],
6	of	IN	O	of	_	0	SENT_106	[p5l1627t1729r1704b1792],
7	+452	CD	NUMBER	+452	num	8	SENT_106	[p5l1727t1729r1963b1792],
8	T	NN	O	t	prep_of	5	SENT_106	[p5l1727t1729r1963b1792],
9	with	IN	O	with	_	0	SENT_106	[p5l1991t1729r2147b1792],
10	increased	VBN	O	increase	amod	11	SENT_106	[p5l7t1834r343b1897],
11	rate	NN	O	rate	prep_with	8	SENT_106	[p5l366t1844r498b1897],
12	of	IN	O	of	_	0	SENT_106	[p5l525t1835r602b1897],
13	thrombocytopenia	NN	O	thrombocytopenia	nn	14	SENT_106	[p5l622t1835r1269b1916],
14	grade	NN	O	grade	prep_of	11	SENT_106	[p5l1295t1835r1489b1916],
15	2	CD	NUMBER	2	num	14	SENT_106	[p5l1516t1835r1556b1896],
16	would	MD	O	would	aux	18	SENT_106	[p5l1583t1835r1804b1897],
17	also	RB	O	also	advmod	18	SENT_106	[p5l1830t1835r1968b1897],
18	suggest	VB	O	suggest	_	0	SENT_106	[p5l1999t1854r2144b1916, p5l8t1953r150b2024],
19	higher	JJR	O	higher	amod	20	SENT_106	[p5l173t1943r401b2024],
20	accumulation	NN	O	accumulation	dobj	18	SENT_106	[p5l426t1943r903b2006],
21	of	IN	O	of	_	0	SENT_106	[p5l929t1943r1006b2006],
22	MTX	NNP	O	MTX	prep_of	20	SENT_106	[p5l1024t1944r1382b2006],
23	.	.	O	.	_	0	SENT_106	[p5l1024t1944r1382b2006],

1	—	NN	O	—	_	0	SENT_107	[p5l1024t1944r1382b2006],
2	.	.	O	.	_	0	SENT_107	[p5l1024t1944r1382b2006],

1	PG	NN	O	pg	_	0	SENT_108	[p5l1024t1944r1382b2006],
2	.	.	O	.	_	0	SENT_108	[p5l1024t1944r1382b2006],

1	However	RB	O	however	advmod	29	SENT_109	[p5l1412t1945r1746b2017],
2	,	,	O	,	_	0	SENT_109	[p5l1412t1945r1746b2017],
3	in	IN	O	in	_	0	SENT_109	[p5l1774t1943r1842b2005],
4	contrast	NN	O	contrast	prep_in	29	SENT_109	[p5l1867t1953r2148b2006],
5	with	IN	O	with	_	0	SENT_109	[p5l7t2050r164b2113],
6	the	DT	O	the	det	7	SENT_109	[p5l190t2050r296b2113],
7	variants	NNS	O	variant	prep_with	4	SENT_109	[p5l324t2050r599b2113],
8	of	IN	O	of	_	0	SENT_109	[p5l629t2050r706b2113],
9	other	JJ	O	other	amod	10	SENT_109	[p5l728t2050r909b2113],
10	genes	NNS	O	gene	prep_of	7	SENT_109	[p5l936t2070r1133b2131],
11	that	WDT	O	that	rel	14	SENT_109	[p5l1162t2050r1295b2113],
12	we	PRP	O	we	nsubj	14	SENT_109	[p5l1321t2070r1421b2113],
13	previously	RB	DATE	previously	advmod	14	SENT_109	[p5l1447t2050r1820b2131],
14	found	VBD	O	find	rcmod	4	SENT_109	[p5l1847t2050r2054b2113],
15	to	TO	O	to	aux	16	SENT_109	[p5l2080t2060r2146b2113],
16	correlate	VB	O	correlate	xcomp	14	SENT_109	[p5l8t2156r316b2218],
17	with	IN	O	with	_	0	SENT_109	[p5l348t2156r504b2218],
18	chemotherapy	NN	O	chemotherapy	nn	19	SENT_109	[p5l535t2156r1036b2237],
19	toxicity	NN	O	toxicity	prep_with	16	SENT_109	[p5l1067t2156r1337b2237],
20	[	CD	NUMBER	[	number	21	SENT_109	[p5l1375t2155r1489b2231],
21	5	CD	NUMBER	5	num	22	SENT_109	[p5l1375t2155r1489b2231],
22	]	NN	O	]	dep	16	SENT_109	[p5l1375t2155r1489b2231],
23	,	,	O	,	_	0	SENT_109	[p5l1375t2155r1489b2231],
24	+452	CD	NUMBER	+452	num	26	SENT_109	[p5l1524t2155r1759b2219],
25	T	NN	O	t	nn	26	SENT_109	[p5l1524t2155r1759b2219],
26	allele	NN	O	allele	nsubjpass	29	SENT_109	[p5l1792t2156r1980b2218],
27	was	VBD	O	be	auxpass	29	SENT_109	[p5l2012t2175r2145b2219],
28	not	RB	O	not	neg	29	SENT_109	[p5l7t2274r120b2327],
29	associated	VBN	O	associate	_	0	SENT_109	[p5l158t2264r522b2327],
30	with	IN	O	with	_	0	SENT_109	[p5l559t2264r715b2327],
31	better	JJR	O	better	amod	33	SENT_109	[p5l751t2264r955b2327],
32	disease	NN	O	disease	nn	33	SENT_109	[p5l992t2264r1246b2327],
33	outcome	NN	O	outcome	prep_with	29	SENT_109	[p5l1285t2274r1607b2327],
34	.	.	O	.	_	0	SENT_109	[p5l1285t2274r1607b2327],

1	Finally	RB	O	finally	advmod	13	SENT_110	[p5l1649t2264r1913b2345],
2	,	,	O	,	_	0	SENT_110	[p5l1649t2264r1913b2345],
3	given	VBN	O	give	prep	13	SENT_110	[p5l1955t2264r2147b2345],
4	several	JJ	O	several	amod	5	SENT_110	[p5l10t2371r253b2434],
5	mutations	NNS	O	mutation	dep	3	SENT_110	[p5l287t2371r635b2433],
6	and	CC	O	and	_	0	SENT_110	[p5l672t2371r798b2433],
7	haplotypes	NNS	O	haplotype	dep	3	SENT_110	[p5l830t2371r1213b2452],
8	tested	VBN	O	test	partmod	5	SENT_110	[p5l1249t2371r1473b2445],
9	,	,	O	,	_	0	SENT_110	[p5l1249t2371r1473b2445],
10	it	PRP	O	it	nsubj	13	SENT_110	[p5l1510t2371r1559b2433],
11	is	VBZ	O	be	cop	13	SENT_110	[p5l1591t2371r1646b2433],
12	also	RB	O	also	advmod	13	SENT_110	[p5l1684t2371r1822b2433],
13	possible	JJ	O	possible	_	0	SENT_110	[p5l1855t2371r2146b2452],
14	that	IN	O	that	complm	19	SENT_110	[p5l7t2477r140b2539],
15	the	DT	O	the	det	17	SENT_110	[p5l163t2477r270b2539],
16	observed	VBN	O	observe	amod	17	SENT_110	[p5l296t2477r614b2539],
17	correlation	NN	O	correlation	nsubj	19	SENT_110	[p5l639t2477r1022b2539],
18	was	VBD	O	be	cop	19	SENT_110	[p5l1047t2497r1180b2539],
19	due	JJ	O	due	ccomp	13	SENT_110	[p5l1208t2477r1333b2539],
20	to	TO	O	to	_	0	SENT_110	[p5l1358t2487r1424b2539],
21	chance	NN	O	chance	prep_to	19	SENT_110	[p5l1451t2477r1713b2539],
22	.	.	O	.	_	0	SENT_110	[p5l1451t2477r1713b2539],

1	Our	PRP$	O	we	poss	2	SENT_111	[p5l116t2584r252b2647],
2	results	NNS	O	result	nsubj	5	SENT_111	[p5l279t2584r509b2647],
3	do	VBP	O	do	aux	5	SENT_111	[p5l542t2584r626b2647],
4	not	RB	O	not	neg	5	SENT_111	[p5l657t2594r771b2647],
5	support	VB	O	support	_	0	SENT_111	[p5l802t2594r1066b2665],
6	major	JJ	O	major	amod	7	SENT_111	[p5l1094t2584r1302b2665],
7	role	NN	O	role	dobj	5	SENT_111	[p5l1329t2584r1466b2647],
8	of	IN	O	of	_	0	SENT_111	[p5l1497t2584r1574b2647],
9	GGH	NN	O	ggh	nn	10	SENT_111	[p5l1599t2584r1789b2647],
10	polymorphisms/haplotypes	NNS	O	polymorphisms/haplotypes	prep_of	7	SENT_111	[p5l1818t2584r2144b2665, p5l6t2689r687b2771],
11	.	.	O	.	_	0	SENT_111	[p5l1818t2584r2144b2665, p5l6t2689r687b2771],

1	The	DT	O	the	det	2	SENT_112	[p5l727t2690r862b2752],
2	results	NNS	O	result	nsubjpass	6	SENT_112	[p5l897t2690r1127b2752],
3	should	MD	O	should	aux	6	SENT_112	[p5l1167t2690r1401b2752],
4	be	VB	O	be	auxpass	6	SENT_112	[p5l1434t2690r1516b2752],
5	however	RB	O	however	advmod	6	SENT_112	[p5l1552t2690r1853b2753],
6	considered	VBN	O	consider	_	0	SENT_112	[p5l1887t2690r2144b2752, p5l9t2797r160b2859],
7	as	IN	O	as	_	0	SENT_112	[p5l203t2816r271b2859],
8	preliminary	JJ	O	preliminary	prep_as	6	SENT_112	[p5l314t2797r729b2878],
9	given	VBN	O	give	partmod	8	SENT_112	[p5l773t2797r965b2878],
10	the	DT	O	the	det	12	SENT_112	[p5l1006t2797r1113b2859],
11	limited	JJ	O	limited	amod	12	SENT_112	[p5l1156t2797r1407b2859],
12	number	NN	O	number	dobj	9	SENT_112	[p5l1449t2797r1721b2859],
13	of	IN	O	of	_	0	SENT_112	[p5l1762t2797r1839b2859],
14	patients	NNS	O	patient	prep_of	12	SENT_112	[p5l1874t2797r2149b2878],
15	studied	VBN	O	study	partmod	14	SENT_112	[p5l11t2902r281b2964],
16	.	.	O	.	_	0	SENT_112	[p5l11t2902r281b2964],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_113	[p5l7t3126r743b3206],

1	We	PRP	O	we	nsubj	3	SENT_114	[p5l114t3342r229b3403],
2	are	VBP	O	be	cop	3	SENT_114	[p5l255t3360r359b3403],
3	thankful	JJ	O	thankful	_	0	SENT_114	[p5l384t3341r679b3403],
4	to	TO	O	to	_	0	SENT_114	[p5l703t3350r769b3403],
5	all	DT	O	all	det	6	SENT_114	[p5l796t3341r880b3403],
6	patients	NNS	O	patient	prep_to	3	SENT_114	[p5l904t3341r1178b3422],
7	and	CC	O	and	_	0	SENT_114	[p5l1206t3341r1332b3403],
8	their	PRP$	O	they	poss	9	SENT_114	[p5l1354t3341r1518b3403],
9	parents	NNS	O	parent	prep_to	3	SENT_114	[p5l1538t3350r1793b3422],
10	who	WP	O	who	nsubj	11	SENT_114	[p5l1819t3341r1969b3403],
11	consented	VBD	O	consent	rcmod	9	SENT_114	[p5l1995t3360r2148b3403, p5l11t3448r234b3511],
12	to	TO	O	to	aux	13	SENT_114	[p5l267t3458r333b3511],
13	participate	VB	O	participate	xcomp	11	SENT_114	[p5l367t3448r743b3529],
14	in	IN	O	in	_	0	SENT_114	[p5l778t3448r845b3510],
15	genetics	NNS	O	genetics	nn	16	SENT_114	[p5l880t3448r1167b3529],
16	study	NN	O	study	prep_in	13	SENT_114	[p5l1206t3448r1394b3529],
17	related	JJ	O	related	amod	16	SENT_114	[p5l1427t3448r1670b3511],
18	to	TO	O	to	_	0	SENT_114	[p5l1703t3458r1769b3511],
19	leukemia	NN	O	leukemia	prep_to	17	SENT_114	[p5l1804t3448r2146b3511],
20	.	.	O	.	_	0	SENT_114	[p5l1804t3448r2146b3511],

1	The	DT	O	the	det	3	SENT_115	[p5l8t3554r144b3616],
2	Canadian	JJ	MISC	canadian	amod	3	SENT_115	[p5l164t3554r498b3616],
3	Institutes	NNPS	ORGANIZATION	Institutes	_	0	SENT_115	[p5l516t3554r840b3616],
4	of	IN	ORGANIZATION	of	_	0	SENT_115	[p5l862t3554r939b3616],
5	Health	NNP	ORGANIZATION	Health	nn	6	SENT_115	[p5l951t3554r1187b3616],
6	Research	NNP	ORGANIZATION	Research	prep_of	3	SENT_115	[p5l1205t3554r1549b3627],
7	,	,	ORGANIZATION	,	_	0	SENT_115	[p5l1205t3554r1549b3627],
8	Research	NNP	ORGANIZATION	Research	nn	9	SENT_115	[p5l1571t3554r1897b3616],
9	Center	NNP	ORGANIZATION	Center	appos	6	SENT_115	[p5l1916t3554r2152b3616],
10	of	IN	O	of	_	0	SENT_115	[p5l9t3661r86b3724],
11	Sainte	NNP	LOCATION	Sainte	prep_of	3	SENT_115	[p5l110t3661r606b3724],
12	.	.	O	.	_	0	SENT_115	[p5l110t3661r606b3724],

1	—	NN	O	—	_	0	SENT_116	[p5l110t3661r606b3724],
2	.	.	O	.	_	0	SENT_116	[p5l110t3661r606b3724],

1	Justine	NNP	PERSON	Justine	nn	2	SENT_117	[p5l110t3661r606b3724],
2	Hospital	NNP	PERSON	Hospital	_	0	SENT_117	[p5l634t3661r934b3742],
3	and	CC	O	and	_	0	SENT_117	[p5l964t3661r1090b3724],
4	Foundation	NNP	O	Foundation	nn	5	SENT_117	[p5l1116t3661r1520b3724],
5	Charles	NNP	PERSON	Charles	conj_and	2	SENT_117	[p5l1549t3661r2151b3724],
6	.	.	O	.	_	0	SENT_117	[p5l1549t3661r2151b3724],

1	—	NN	O	—	_	0	SENT_118	[p5l1549t3661r2151b3724],
2	.	.	O	.	_	0	SENT_118	[p5l1549t3661r2151b3724],

1	Bruneau	NNP	PERSON	Bruneau	nsubj	2	SENT_119	[p5l1549t3661r2151b3724],
2	supported	VBD	O	support	_	0	SENT_119	[p6l11t20r359b101],
3	this	DT	O	this	det	4	SENT_119	[p6l405t20r529b83],
4	work	NN	O	work	dobj	2	SENT_119	[p6l580t20r777b83],
5	.	.	O	.	_	0	SENT_119	[p6l580t20r777b83],

1	MK	NN	O	mk	nsubj	3	SENT_120	[p6l828t22r972b82],
2	is	VBZ	O	be	cop	3	SENT_120	[p6l1017t20r1072b83],
3	scholar	NN	O	scholar	_	0	SENT_120	[p6l1125t20r1379b83],
4	of	IN	O	of	_	0	SENT_120	[p6l1426t20r1503b83],
5	the	DT	O	the	det	13	SENT_120	[p6l1543t20r1650b83],
6	Fonds	NNP	O	Fonds	nn	13	SENT_120	[p6l1697t20r1910b83],
7	de	FW	O	de	nn	13	SENT_120	[p6l1960t20r2041b83],
8	la	FW	O	la	nn	13	SENT_120	[p6l2089t20r2152b83],
9	Recherche	FW	O	recherche	nn	13	SENT_120	[p6l8t126r382b189],
10	en	FW	O	en	nn	13	SENT_120	[p6l408t146r490b189],
11	Santé	FW	O	santé	nn	13	SENT_120	[p6l516t125r710b189],
12	du	NNP	O	du	nn	13	SENT_120	[p6l736t126r822b189],
13	Quebec	NNP	O	Quebec	prep_of	3	SENT_120	[p6l848t125r1135b204],
14	.	.	O	.	_	0	SENT_120	[p6l848t125r1135b204],

1	Contributions	NNS	O	contribution	_	0	SENT_121	[p6l119t233r625b297],
2	.	.	O	.	_	0	SENT_121	[p6l119t233r625b297],

1	All	DT	O	all	det	2	SENT_122	[p6l685t233r797b295],
2	authors	NNS	O	author	nsubj	3	SENT_122	[p6l854t233r1111b296],
3	contributed	VBD	O	contribute	dep	55	SENT_122	[p6l1169t233r1572b296],
4	to	TO	O	to	_	0	SENT_122	[p6l1626t243r1692b296],
5	this	DT	O	this	det	6	SENT_122	[p6l1748t233r1872b296],
6	article	NN	O	article	prep_to	3	SENT_122	[p6l1932t233r2150b296],
7	including	VBG	O	include	_	0	SENT_122	[p6l8t341r342b422],
8	conception	NN	O	conception	prep_including	6	SENT_122	[p6l389t341r778b422],
9	and	CC	O	and	_	0	SENT_122	[p6l826t341r952b404],
10	design	NN	O	design	nn	12	SENT_122	[p6l997t341r1227b422],
11	(	CD	NUMBER	(	num	12	SENT_122	[p6l1275t342r1463b418],
12	MK	NN	O	mk	prep_including	6	SENT_122	[p6l1275t342r1463b418],
13	,	,	O	,	_	0	SENT_122	[p6l1275t342r1463b418],
14	AM	VBP	O	be	dep	15	SENT_122	[p6l1512t342r1702b418],
15	)	JJ	O	)	dobj	3	SENT_122	[p6l1512t342r1702b418],
16	,	,	O	,	_	0	SENT_122	[p6l1512t342r1702b418],
17	genotyping	NN	O	genotyping	nsubj	21	SENT_122	[p6l1752t341r2150b422],
18	of	IN	O	of	_	0	SENT_122	[p6l9t446r86b509],
19	the	DT	O	the	det	20	SENT_122	[p6l109t447r215b509],
20	polymorphisms	NNS	O	polymorphism	prep_of	17	SENT_122	[p6l245t447r797b528],
21	(	VBP	O	(	dep	3	SENT_122	[p6l832t447r1079b524],
22	FGB	NN	ORGANIZATION	fgb	nn	23	SENT_122	[p6l832t447r1079b524],
23	)	NN	O	)	dobj	21	SENT_122	[p6l832t447r1079b524],
24	,	,	O	,	_	0	SENT_122	[p6l832t447r1079b524],
25	clinical	JJ	O	clinical	amod	26	SENT_122	[p6l1112t446r1372b509],
26	data	NNS	O	datum	appos	23	SENT_122	[p6l1403t447r1550b509],
27	collection	NN	O	collection	nn	29	SENT_122	[p6l1578t447r1928b509],
28	(	CD	NUMBER	(	num	29	SENT_122	[p6l1960t447r2148b524],
29	AM	NNP	O	AM	dep	26	SENT_122	[p6l1960t447r2148b524],
30	,	,	O	,	_	0	SENT_122	[p6l1960t447r2148b524],
31	MK	NNP	O	MK	nn	32	SENT_122	[p6l7t556r198b632],
32	)	NNP	O	)	appos	23	SENT_122	[p6l7t556r198b632],
33	,	,	O	,	_	0	SENT_122	[p6l7t556r198b632],
34	analysis	NN	O	analysis	nsubj	39	SENT_122	[p6l232t555r513b636],
35	and	CC	O	and	_	0	SENT_122	[p6l545t555r671b618],
36	interpretation	NN	O	interpretation	conj_and	34	SENT_122	[p6l698t555r1178b636],
37	of	IN	O	of	_	0	SENT_122	[p6l1207t555r1284b618],
38	data	NNS	O	datum	prep_of	34	SENT_122	[p6l1307t555r1454b618],
39	(	VBP	O	(	rcmod	23	SENT_122	[p6l1484t556r1701b632],
40	FGB	NN	ORGANIZATION	fgb	nsubj	52	SENT_122	[p6l1484t556r1701b632],
41	,	,	O	,	_	0	SENT_122	[p6l1484t556r1701b632],
42	MK	NN	O	mk	nn	43	SENT_122	[p6l1732t556r1923b632],
43	)	NN	O	)	appos	40	SENT_122	[p6l1732t556r1923b632],
44	,	,	O	,	_	0	SENT_122	[p6l1732t556r1923b632],
45	drafting	VBG	O	draft	ccomp	39	SENT_122	[p6l1956t555r2148b618, p6l8t662r118b743],
46	the	DT	O	the	det	50	SENT_122	[p6l158t662r264b724],
47	article	NN	O	article	nn	50	SENT_122	[p6l304t662r523b724],
48	(	CD	NUMBER	(	num	50	SENT_122	[p6l564t662r760b739],
49	MK	NN	O	mk	nn	50	SENT_122	[p6l564t662r760b739],
50	)	NN	O	)	dobj	45	SENT_122	[p6l564t662r760b739],
51	and	CC	O	and	_	0	SENT_122	[p6l803t662r928b724],
52	revising	VBG	O	revise	ccomp	39	SENT_122	[p6l964t662r1248b743],
53	it	PRP	O	it	dobj	52	SENT_122	[p6l1287t662r1335b724],
54	critically	RB	O	critically	advmod	52	SENT_122	[p6l1372t662r1687b743],
55	(	VBD	O	(	_	0	SENT_122	[p6l1728t662r1945b739],
56	FGB	NNP	ORGANIZATION	FGB	nsubj	55	SENT_122	[p6l1728t662r1945b739],
57	,	,	O	,	_	0	SENT_122	[p6l1728t662r1945b739],
58	MK	NNP	O	MK	appos	56	SENT_122	[p6l1986t663r2148b736],
59	,	,	O	,	_	0	SENT_122	[p6l1986t663r2148b736],
60	AM	NNP	O	AM	nn	61	SENT_122	[p6l8t769r197b845],
61	)	NNP	O	)	appos	58	SENT_122	[p6l8t769r197b845],
62	.	.	O	.	_	0	SENT_122	[p6l8t769r197b845],

1	References	NNS	O	reference	_	0	SENT_123	[p6l9t1007r420b1071],

1	[	NN	O	[	nn	5	SENT_124	[p6l8t1217r80b1277],
2	1	CD	NUMBER	1	num	5	SENT_124	[p6l8t1217r80b1277],
3	]	CD	NUMBER	]	num	5	SENT_124	[p6l8t1217r80b1277],
4	Cheng	NNP	O	Cheng	nn	5	SENT_124	[p6l117t1216r300b1281],
5	Q	NNP	O	Q	_	0	SENT_124	[p6l337t1217r401b1279],
6	,	,	O	,	_	0	SENT_124	[p6l337t1217r401b1279],
7	Wu	NNP	PERSON	Wu	nn	8	SENT_124	[p6l437t1218r536b1267],
8	B	NNP	PERSON	B	appos	5	SENT_124	[p6l571t1218r632b1276],
9	,	,	O	,	_	0	SENT_124	[p6l571t1218r632b1276],
10	Kager	NNP	ORGANIZATION	Kager	nn	11	SENT_124	[p6l671t1218r844b1281],
11	L	NNP	ORGANIZATION	L	appos	8	SENT_124	[p6l877t1218r934b1276],
12	,	,	O	,	_	0	SENT_124	[p6l877t1218r934b1276],
13	Panetta	NNP	PERSON	Panetta	nn	14	SENT_124	[p6l972t1218r1181b1267],
14	JC	NNP	O	JC	appos	8	SENT_124	[p6l1214t1217r1304b1276],
15	,	,	O	,	_	0	SENT_124	[p6l1214t1217r1304b1276],
16	Zheng	NNP	PERSON	Zheng	nn	17	SENT_124	[p6l1340t1216r1521b1281],
17	J	NNP	PERSON	J	appos	8	SENT_124	[p6l1556t1218r1598b1276],
18	,	,	O	,	_	0	SENT_124	[p6l1556t1218r1598b1276],
19	Pui	NNP	PERSON	Pui	nn	20	SENT_124	[p6l1635t1216r1728b1267],
20	CH	NN	O	ch	appos	8	SENT_124	[p6l1765t1217r1877b1276],
21	,	,	O	,	_	0	SENT_124	[p6l1765t1217r1877b1276],
22	et	FW	O	et	nn	23	SENT_124	[p6l1915t1224r1965b1267],
23	al.	FW	O	al.	appos	8	SENT_124	[p6l2000t1216r2063b1267],
24	.	.	O	.	_	0	SENT_124	[p6l2000t1216r2063b1267],

1	A	DT	O	a	det	3	SENT_125	[p6l2101t1217r2151b1266],
2	substrate	NN	O	substrate	nn	3	SENT_125	[p6l119t1305r368b1356],
3	speciﬁc	NN	O	speciﬁc	npadvmod	4	SENT_125	[p6l392t1305r605b1370],
4	functional	JJ	O	functional	amod	5	SENT_125	[p6l627t1305r915b1356],
5	polymorphism	NN	O	polymorphism	nsubj	12	SENT_125	[p6l935t1305r1352b1370],
6	of	IN	O	of	_	0	SENT_125	[p6l1373t1305r1435b1356],
7	human	JJ	O	human	amod	11	SENT_125	[p6l1450t1305r1644b1356],
8	gamma	NN	O	gamma	nn	11	SENT_125	[p6l1665t1305r2151b1370],
9	—	NN	O	—	nn	11	SENT_125	[p6l1665t1305r2151b1370],
10	glutamyl	NN	O	glutamyl	nn	11	SENT_125	[p6l1665t1305r2151b1370],
11	hydrolase	NN	O	hydrolase	prep_of	5	SENT_125	[p6l116t1395r392b1460],
12	alters	VBZ	O	alter	_	0	SENT_125	[p6l411t1394r561b1445],
13	catalytic	JJ	O	catalytic	amod	14	SENT_125	[p6l581t1394r819b1460],
14	activity	NN	O	activity	dobj	12	SENT_125	[p6l840t1395r1048b1460],
15	and	CC	O	and	_	0	SENT_125	[p6l1068t1395r1168b1445],
16	methotrexate	NN	O	methotrexate	nn	18	SENT_125	[p6l1185t1395r1556b1445],
17	polyglutamate	NN	O	polyglutamate	nn	18	SENT_125	[p6l1573t1395r1980b1460],
18	accumulation	NN	O	accumulation	dobj	12	SENT_125	[p6l2000t1410r2149b1445, p6l116t1483r369b1534],
19	in	IN	O	in	_	0	SENT_125	[p6l405t1483r459b1533],
20	acute	JJ	O	acute	amod	21	SENT_125	[p6l497t1491r644b1534],
21	lymphoblastic	JJ	O	lymphoblastic	amod	23	SENT_125	[p6l681t1483r1083b1549],
22	leukaemia	NN	O	leukaemia	nn	23	SENT_125	[p6l1121t1484r1414b1534],
23	cells	NNS	O	cell	prep_in	14	SENT_125	[p6l1450t1484r1592b1534],
24	.	.	O	.	_	0	SENT_125	[p6l1450t1484r1592b1534],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_126	[p6l1633t1484r2149b1549],
2	2004	CD	DATE	2004	num	1	SENT_126	[p6l117t1572r597b1631],
3	;	:	O	;	_	0	SENT_126	[p6l117t1572r597b1631],
4	14:557	CD	NUMBER	14:557	number	5	SENT_126	[p6l117t1572r597b1631],
5	—	CD	NUMBER	—	dep	1	SENT_126	[p6l117t1572r597b1631],
6	67	CD	NUMBER	67	dep	5	SENT_126	[p6l117t1572r597b1631],
7	.	.	O	.	_	0	SENT_126	[p6l117t1572r597b1631],

1	[	NN	O	[	nn	5	SENT_127	[p6l8t1661r80b1721],
2	2	CD	NUMBER	2	num	5	SENT_127	[p6l8t1661r80b1721],
3	]	CD	NUMBER	]	num	5	SENT_127	[p6l8t1661r80b1721],
4	Chave	NNP	ORGANIZATION	Chave	nn	5	SENT_127	[p6l117t1661r294b1711],
5	KJ	NNP	ORGANIZATION	KJ	_	0	SENT_127	[p6l335t1662r426b1720],
6	,	,	O	,	_	0	SENT_127	[p6l335t1662r426b1720],
7	Ryan	NNP	PERSON	Ryan	nn	8	SENT_127	[p6l468t1662r617b1726],
8	TJ	NNP	PERSON	TJ	appos	5	SENT_127	[p6l656t1662r741b1720],
9	,	,	O	,	_	0	SENT_127	[p6l656t1662r741b1720],
10	Chmura	NNP	PERSON	Chmura	nn	11	SENT_127	[p6l783t1661r1012b1711],
11	SE	NN	O	se	appos	5	SENT_127	[p6l1051t1661r1146b1720],
12	,	,	O	,	_	0	SENT_127	[p6l1051t1661r1146b1720],
13	Galivan	NNP	O	Galivan	nn	14	SENT_127	[p6l1189t1660r1409b1711],
14	J	NNP	O	J	appos	5	SENT_127	[p6l1448t1662r1474b1711],
15	.	.	O	.	_	0	SENT_127	[p6l1480t1702r1488b1711],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_128	[p6l1531t1660r1911b1711],
2	of	IN	O	of	_	0	SENT_128	[p6l1950t1660r2012b1711],
3	single	JJ	O	single	amod	5	SENT_128	[p6l2048t1661r2149b1711, p6l117t1750r201b1815],
4	nucleotide	NN	O	nucleotide	nn	5	SENT_128	[p6l231t1750r526b1800],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_128	[p6l555t1749r997b1815],
6	in	IN	O	in	_	0	SENT_128	[p6l1028t1750r1082b1799],
7	the	DT	O	the	det	10	SENT_128	[p6l1111t1750r1196b1800],
8	human	JJ	O	human	amod	10	SENT_128	[p6l1225t1750r1418b1800],
9	gamma	NN	O	gamma	nn	10	SENT_128	[p6l1448t1750r1933b1815],
10	—	NN	O	—	prep_in	5	SENT_128	[p6l1448t1750r1933b1815],
11	glutamyl	NN	O	glutamyl	nn	12	SENT_128	[p6l1448t1750r1933b1815],
12	hydroLetters	NNS	O	hydroletter	dep	1	SENT_128	[p6l1962t1750r2149b1815, p6l344t1891r436b1914],

1	to	TO	O	to	dep	3	SENT_129	[p6l446t1895r469b1914],
2	the	DT	O	the	det	3	SENT_129	[p6l480t1890r518b1914],
3	Editor	NNP	O	Editor	_	0	SENT_129	[p6l527t1890r633b1914],
4	/	:	O	/	punct	3	SENT_129	[p6l527t1890r633b1914],
5	Leukemia	NNP	ORGANIZATION	Leukemia	dep	8	SENT_129	[p6l638t1890r766b1914],
6	Research	NNP	ORGANIZATION	Research	dep	5	SENT_129	[p6l775t1890r896b1914],
7	31	CD	NUMBER	31	dep	8	SENT_129	[p6l906t1890r936b1913],
8	(	CD	NUMBER	(	dep	11	SENT_129	[p6l948t1890r1034b1919],
9	2007	CD	DATE	2007	dep	8	SENT_129	[p6l948t1890r1034b1919],
10	)	CD	NUMBER	)	num	11	SENT_129	[p6l948t1890r1034b1919],
11	1023-1028 1025	CD	DURATION	1023-1028 1025	dep	3	SENT_129	[p6l1754t1890r1815b1914],[p6l1045t1890r1193b1913],

1	lase	NN	O	lase	nn	2	SENT_130	[p6l117t2070r226b2120],
2	gene	NN	O	gene	_	0	SENT_130	[p6l271t2086r403b2135],
3	and	CC	O	and	_	0	SENT_130	[p6l449t2070r549b2120],
4	characterization	NN	O	characterization	conj_and	2	SENT_130	[p6l594t2070r1047b2120],
5	of	IN	O	of	_	0	SENT_130	[p6l1092t2070r1154b2120],
6	promoter	NN	O	promoter	nn	7	SENT_130	[p6l1192t2078r1455b2135],
7	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_130	[p6l1496t2070r1955b2135],
8	.	.	O	.	_	0	SENT_130	[p6l1496t2070r1955b2135],

1	Gene	NNP	O	Gene	_	0	SENT_131	[p6l2004t2071r2151b2121],
2	2003	CD	DATE	2003	num	1	SENT_131	[p6l118t2159r634b2218],
3	;	:	O	;	_	0	SENT_131	[p6l118t2159r634b2218],
4	319:167	CD	NUMBER	319:167	number	5	SENT_131	[p6l118t2159r634b2218],
5	—	CD	NUMBER	—	dep	1	SENT_131	[p6l118t2159r634b2218],
6	75	CD	NUMBER	75	dep	5	SENT_131	[p6l118t2159r634b2218],
7	.	.	O	.	_	0	SENT_131	[p6l118t2159r634b2218],

1	[	NN	O	[	nn	3	SENT_132	[p6l9t2248r80b2308],
2	3	CD	NUMBER	3	num	3	SENT_132	[p6l9t2248r80b2308],
3	]	NN	O	]	_	0	SENT_132	[p6l9t2248r80b2308],
4	Krajinovic	JJ	O	krajinovic	amod	5	SENT_132	[p6l118t2247r418b2312],
5	M	NN	O	m	dep	3	SENT_132	[p6l437t2248r514b2307],
6	,	,	O	,	_	0	SENT_132	[p6l437t2248r514b2307],
7	Costea	NNP	O	Costea	nn	11	SENT_132	[p6l534t2248r728b2298],
8	I	PRP	O	I	dep	11	SENT_132	[p6l743t2248r780b2307],
9	,	,	O	,	_	0	SENT_132	[p6l743t2248r780b2307],
10	Primeau	NNP	PERSON	Primeau	dep	11	SENT_132	[p6l800t2247r1037b2297],
11	M	NNP	O	M	appos	5	SENT_132	[p6l1054t2248r1131b2307],
12	,	,	O	,	_	0	SENT_132	[p6l1054t2248r1131b2307],
13	Dulucq	NNP	PERSON	Dulucq	nn	14	SENT_132	[p6l1150t2247r1360b2312],
14	S	NNP	PERSON	S	appos	5	SENT_132	[p6l1379t2248r1430b2307],
15	,	,	O	,	_	0	SENT_132	[p6l1379t2248r1430b2307],
16	Moghrabi	NNP	PERSON	Moghrabi	nn	18	SENT_132	[p6l1449t2247r1729b2312],
17	A.	NNP	O	A.	nn	18	SENT_132	[p6l1747t2248r1811b2297],
18	Combining	NNP	O	Combining	appos	5	SENT_132	[p6l1833t2247r2151b2312],
19	several	JJ	O	several	amod	20	SENT_132	[p6l119t2336r314b2387],
20	polymorphisms	NNS	O	polymorphism	dep	3	SENT_132	[p6l337t2336r779b2401],
21	of	IN	O	of	_	0	SENT_132	[p6l806t2336r868b2386],
22	thymidylate	NN	O	thymidylate	nn	24	SENT_132	[p6l887t2336r1226b2401],
23	synthase	NN	O	synthase	nn	24	SENT_132	[p6l1253t2336r1494b2401],
24	gene	NN	O	gene	prep_of	20	SENT_132	[p6l1519t2352r1651b2401],
25	for	IN	O	for	_	0	SENT_132	[p6l1675t2336r1758b2386],
26	pharmacogenetic	JJ	O	pharmacogenetic	amod	27	SENT_132	[p6l1779t2336r2150b2401, p6l117t2425r253b2475],
27	analysis	NN	O	analysis	prep_for	24	SENT_132	[p6l275t2425r516b2490],
28	.	.	O	.	_	0	SENT_132	[p6l275t2425r516b2490],

1	Pharmacogenomics	NNS	MISC	pharmacogenomic	_	0	SENT_133	[p6l540t2425r1097b2490],
2	J	NNP	O	J	dep	1	SENT_133	[p6l1117t2426r1144b2476],
3	2005	CD	DATE	2005	num	2	SENT_133	[p6l1164t2425r1302b2476],
4	;	:	O	;	_	0	SENT_133	[p6l1311t2425r1609b2485],
5	5:374	CD	NUMBER	5:374	number	6	SENT_133	[p6l1311t2425r1609b2485],
6	—	CD	NUMBER	—	dep	1	SENT_133	[p6l1311t2425r1609b2485],
7	80	CD	NUMBER	80	dep	6	SENT_133	[p6l1311t2425r1609b2485],
8	.	.	O	.	_	0	SENT_133	[p6l1311t2425r1609b2485],

1	[	NN	O	[	_	0	SENT_134	[p6l9t2514r80b2575],
2	4	CD	NUMBER	4	num	1	SENT_134	[p6l9t2514r80b2575],
3	]	CD	NUMBER	]	num	5	SENT_134	[p6l9t2514r80b2575],
4	Stephens	NNP	PERSON	Stephens	nn	5	SENT_134	[p6l119t2514r371b2579],
5	M	NN	PERSON	m	dep	1	SENT_134	[p6l412t2515r490b2574],
6	,	,	O	,	_	0	SENT_134	[p6l412t2515r490b2574],
7	Smith	NNP	ORGANIZATION	Smith	nn	8	SENT_134	[p6l533t2514r701b2565],
8	NJ	NNP	ORGANIZATION	NJ	appos	5	SENT_134	[p6l740t2515r833b2574],
9	,	,	O	,	_	0	SENT_134	[p6l740t2515r833b2574],
10	Donnelly	NNP	PERSON	Donnelly	nn	12	SENT_134	[p6l875t2514r1139b2579],
11	P.	NNP	O	P.	nn	12	SENT_134	[p6l1179t2515r1223b2564],
12	A	NNP	O	A	appos	5	SENT_134	[p6l1266t2515r1316b2564],
13	new	JJ	O	new	amod	15	SENT_134	[p6l1355t2530r1470b2565],
14	statistical	JJ	O	statistical	amod	15	SENT_134	[p6l1513t2514r1778b2564],
15	method	NN	O	method	dep	1	SENT_134	[p6l1818t2514r2031b2564],
16	for	IN	O	for	_	0	SENT_134	[p6l2070t2514r2153b2564],
17	haplotype	NN	O	haplotype	nn	18	SENT_134	[p6l117t2603r397b2668],
18	reconstruction	NN	O	reconstruction	prep_for	15	SENT_134	[p6l429t2603r837b2653],
19	from	IN	O	from	_	0	SENT_134	[p6l870t2603r1008b2653],
20	population	NN	O	population	nn	21	SENT_134	[p6l1038t2603r1344b2668],
21	data	NNS	O	datum	prep_from	18	SENT_134	[p6l1377t2603r1508b2653],
22	.	.	O	.	_	0	SENT_134	[p6l1377t2603r1508b2653],

1	Am	VBP	O	be	dep	2	SENT_135	[p6l1544t2604r1651b2653],
2	J	NN	O	j	_	0	SENT_135	[p6l1682t2604r1709b2654],
3	Human	JJ	O	human	amod	4	SENT_135	[p6l1741t2604r1950b2653],
4	Genet	NNP	O	Genet	dep	2	SENT_135	[p6l1984t2603r2153b2654],
5	2001	CD	DATE	2001	dep	4	SENT_135	[p6l118t2692r598b2751],
6	;	:	O	;	_	0	SENT_135	[p6l118t2692r598b2751],
7	68:978	CD	NUMBER	68:978	dep	5	SENT_135	[p6l118t2692r598b2751],
8	—	CD	NUMBER	—	num	9	SENT_135	[p6l118t2692r598b2751],
9	89	CD	NUMBER	89	dep	7	SENT_135	[p6l118t2692r598b2751],
10	.	.	O	.	_	0	SENT_135	[p6l118t2692r598b2751],

1	[	NN	O	[	nsubj	3	SENT_136	[p6l9t2780r80b2841],
2	5	CD	NUMBER	5	num	3	SENT_136	[p6l9t2780r80b2841],
3	]	CD	NUMBER	]	_	0	SENT_136	[p6l9t2780r80b2841],
4	Costea	NNP	O	Costea	nn	5	SENT_136	[p6l118t2781r311b2831],
5	l	NN	O	l	dobj	3	SENT_136	[p6l354t2780r387b2840],
6	,	,	O	,	_	0	SENT_136	[p6l354t2780r387b2840],
7	Moghrabi	NNP	PERSON	Moghrabi	nn	8	SENT_136	[p6l433t2780r713b2845],
8	A	NNP	O	A	dobj	3	SENT_136	[p6l757t2781r822b2840],
9	,	,	O	,	_	0	SENT_136	[p6l757t2781r822b2840],
10	Laverdiere	NNP	PERSON	Laverdiere	nn	11	SENT_136	[p6l868t2780r1174b2831],
11	C	NNP	O	C	dobj	3	SENT_136	[p6l1219t2781r1279b2840],
12	,	,	O	,	_	0	SENT_136	[p6l1219t2781r1279b2840],
13	Graziani	NNP	PERSON	Graziani	nn	14	SENT_136	[p6l1327t2780r1569b2831],
14	A	NNP	O	A	dobj	3	SENT_136	[p6l1614t2781r1679b2840],
15	,	,	O	,	_	0	SENT_136	[p6l1614t2781r1679b2840],
16	Krajinovic	NNP	O	Krajinovic	nn	21	SENT_136	[p6l1726t2780r2027b2845],
17	M.	NNP	O	M.	nn	21	SENT_136	[p6l2072t2782r2148b2831],
18	Folate	NNP	O	Folate	nn	21	SENT_136	[p6l117t2869r292b2920],
19	cycle	NN	O	cycle	nn	21	SENT_136	[p6l335t2869r482b2934],
20	gene	NN	O	gene	nn	21	SENT_136	[p6l525t2885r657b2934],
21	Variants	NNS	O	variant	dobj	3	SENT_136	[p6l698t2869r919b2920],
22	and	CC	O	and	_	0	SENT_136	[p6l964t2869r1065b2920],
23	chemotherapy	NN	O	chemotherapy	nn	24	SENT_136	[p6l1106t2869r1508b2934],
24	toxicity	NN	O	toxicity	dobj	3	SENT_136	[p6l1550t2869r1766b2934],
25	in	IN	O	in	_	0	SENT_136	[p6l1808t2869r1862b2919],
26	pediatric	JJ	O	pediatric	amod	27	SENT_136	[p6l1902t2869r2151b2934],
27	patients	NNS	O	patient	prep_in	3	SENT_136	[p6l116t2958r336b3023],
28	with	IN	O	with	_	0	SENT_136	[p6l367t2958r492b3009],
29	acute	JJ	O	acute	amod	31	SENT_136	[p6l523t2966r670b3009],
30	lymphoblastic	JJ	O	lymphoblastic	amod	31	SENT_136	[p6l700t2958r1102b3023],
31	leukemia	NN	O	leukemia	prep_with	27	SENT_136	[p6l1132t2958r1406b3009],
32	.	.	O	.	_	0	SENT_136	[p6l1132t2958r1406b3009],

1	Haematologica	NNP	O	Haematologica	_	0	SENT_137	[p6l1439t2958r1871b3023],
2	2006	CD	DATE	2006	num	1	SENT_137	[p6l1900t2958r2147b3018],
3	;	:	O	;	_	0	SENT_137	[p6l1900t2958r2147b3018],
4	9l	NN	O	9l	dep	1	SENT_137	[p6l1900t2958r2147b3018],
5	:	:	O	:	_	0	SENT_137	[p6l1900t2958r2147b3018],
6	1113-6	CD	NUMBER	1113-6	dep	4	SENT_137	[p6l124t3047r344b3098],
7	.	.	O	.	_	0	SENT_137	[p6l124t3047r344b3098],

1	[	NN	O	[	nn	4	SENT_138	[p6l9t3136r80b3197],
2	6	CD	NUMBER	6	num	4	SENT_138	[p6l9t3136r80b3197],
3	]	NN	O	]	nn	4	SENT_138	[p6l9t3136r80b3197],
4	Dervieux	NN	ORGANIZATION	dervieux	_	0	SENT_138	[p6l117t3136r381b3187],
5	T	NN	ORGANIZATION	t	dep	4	SENT_138	[p6l420t3138r471b3196],
6	,	,	O	,	_	0	SENT_138	[p6l420t3138r471b3196],
7	Kremer	NNP	PERSON	Kremer	nn	8	SENT_138	[p6l514t3138r731b3187],
8	J	NNP	PERSON	J	appos	5	SENT_138	[p6l768t3138r809b3196],
9	,	,	O	,	_	0	SENT_138	[p6l768t3138r809b3196],
10	Lein	NNP	PERSON	Lein	nn	11	SENT_138	[p6l851t3136r981b3187],
11	DO	NNP	O	DO	appos	5	SENT_138	[p6l1019t3137r1136b3196],
12	,	,	O	,	_	0	SENT_138	[p6l1019t3137r1136b3196],
13	Capps	NNP	PERSON	Capps	nn	14	SENT_138	[p6l1178t3137r1352b3201],
14	R	NNP	PERSON	R	appos	5	SENT_138	[p6l1393t3138r1454b3196],
15	,	,	O	,	_	0	SENT_138	[p6l1393t3138r1454b3196],
16	Barham	NNP	PERSON	Barham	nn	17	SENT_138	[p6l1495t3136r1721b3187],
17	R	NNP	PERSON	R	appos	5	SENT_138	[p6l1759t3138r1820b3196],
18	,	,	O	,	_	0	SENT_138	[p6l1759t3138r1820b3196],
19	Meyer	NNP	PERSON	Meyer	nn	20	SENT_138	[p6l1861t3138r2047b3201],
20	G	NNP	O	G	appos	5	SENT_138	[p6l2085t3137r2149b3196],
21	,	,	O	,	_	0	SENT_138	[p6l2085t3137r2149b3196],
22	et	FW	O	et	nn	23	SENT_138	[p6l118t3233r168b3276],
23	al.	FW	O	al.	appos	5	SENT_138	[p6l197t3225r259b3276],
24	.	.	O	.	_	0	SENT_138	[p6l197t3225r259b3276],

1	Contribution	NN	O	contribution	_	0	SENT_139	[p6l292t3225r654b3276],
2	of	IN	O	of	_	0	SENT_139	[p6l684t3225r745b3276],
3	common	JJ	O	common	amod	4	SENT_139	[p6l770t3241r1018b3276],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_139	[p6l1045t3225r1488b3290],
5	in	IN	O	in	_	0	SENT_139	[p6l1519t3225r1572b3275],
6	reduced	VBN	O	reduce	amod	8	SENT_139	[p6l1600t3225r1826b3276],
7	folate	NN	O	folate	nn	8	SENT_139	[p6l1854t3225r2015b3276],
8	carrier	NN	O	carrier	prep_in	4	SENT_139	[p6l2044t3241r2150b3276, p6l116t3314r216b3365],
9	and	CC	O	and	_	0	SENT_139	[p6l237t3314r338b3365],
10	gamma	NN	O	gamma	nn	12	SENT_139	[p6l361t3314r1124b3379],
11	—	NN	O	—	nn	12	SENT_139	[p6l361t3314r1124b3379],
12	glutamylhydrolase	NN	O	glutamylhydrolase	prep_in	4	SENT_139	[p6l361t3314r1124b3379],
13	to	TO	O	to	_	0	SENT_139	[p6l1146t3322r1199b3365],
14	methotrexate	NN	O	methotrexate	nn	16	SENT_139	[p6l1222t3314r1592b3365],
15	polyglutamate	NN	O	polyglutamate	nn	16	SENT_139	[p6l1614t3314r2022b3379],
16	levels	NNS	O	level	prep_to	1	SENT_139	[p6l2044t3314r2150b3365, p6l118t3403r192b3454],
17	in	IN	O	in	_	0	SENT_139	[p6l227t3403r280b3453],
18	patients	NNS	O	patient	prep_in	1	SENT_139	[p6l311t3403r531b3468],
19	with	IN	O	with	_	0	SENT_139	[p6l565t3403r691b3454],
20	rheumatoid	JJ	O	rheumatoid	amod	21	SENT_139	[p6l722t3403r1047b3454],
21	arthritis	NN	O	arthritis	prep_with	1	SENT_139	[p6l1080t3403r1313b3454],
22	.	.	O	.	_	0	SENT_139	[p6l1080t3403r1313b3454],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_140	[p6l1348t3403r1866b3468],
2	2004	CD	DATE	2004	num	1	SENT_140	[p6l1900t3404r2147b3463],
3	;	:	O	;	_	0	SENT_140	[p6l1900t3404r2147b3463],
4	14	CD	NUMBER	14	num	6	SENT_140	[p6l1900t3404r2147b3463],
5	:	:	O	:	_	0	SENT_140	[p6l1900t3404r2147b3463],
6	733-9	CD	NUMBER	733-9	dep	1	SENT_140	[p6l117t3493r308b3543],
7	.	.	O	.	_	0	SENT_140	[p6l117t3493r308b3543],

1	Facundo	NNP	PERSON	Facundo	nn	2	SENT_141	[p6l1154t3705r1458b3767],
2	Garcia	NNP	PERSON	Garcia	_	0	SENT_141	[p6l1485t3705r2152b3767],
3	.	.	O	.	_	0	SENT_141	[p6l1485t3705r2152b3767],

1	—	NN	O	—	_	0	SENT_142	[p6l1485t3705r2152b3767],
2	.	.	O	.	_	0	SENT_142	[p6l1485t3705r2152b3767],

1	Bournissen	NNP	PERSON	Bournissen	_	0	SENT_143	[p6l1485t3705r2152b3767],

1	Research	NNP	O	Research	dep	101	SENT_144	[p7l358t29r686b92],
2	Center	NNP	O	Center	dep	101	SENT_144	[p7l715t30r956b102],
3	,	,	O	,	_	0	SENT_144	[p7l715t30r956b102],
4	Centre	NNP	ORGANIZATION	Centre	dep	101	SENT_144	[p7l994t30r1226b92],
5	Hospitalier	NNP	ORGANIZATION	Hospitalier	dep	101	SENT_144	[p7l1249t29r1660b109],
6	Universitaire	NNP	ORGANIZATION	Universitaire	dep	101	SENT_144	[p7l1689t31r2150b92],
7	Sainte-Justine	NNP	ORGANIZATION	Sainte-Justine	dep	101	SENT_144	[p7l653t137r1167b209],
8	,	,	O	,	_	0	SENT_144	[p7l653t137r1167b209],
9	Quebec	NNP	LOCATION	Quebec	dep	101	SENT_144	[p7l1204t135r1471b213],
10	H3	NN	O	h3	dep	101	SENT_144	[p7l1494t136r1601b198],
11	T	NN	O	t	dep	101	SENT_144	[p7l1609t138r1661b197],
12	1	CD	NUMBER	1	dep	101	SENT_144	[p7l1680t136r1713b197],
13	C5	NN	O	c5	dep	101	SENT_144	[p7l1726t137r1837b209],
14	,	,	O	,	_	0	SENT_144	[p7l1726t137r1837b209],
15	Canada	NNP	LOCATION	Canada	dep	101	SENT_144	[p7l1875t135r2151b199],
16	Albert	NNP	PERSON	Albert	dep	101	SENT_144	[p7l1448t246r1675b309],
17	Moghrabi	NNP	PERSON	Moghrabi	dep	101	SENT_144	[p7l1698t246r2048b327],
18	arb	NN	O	arb	dep	101	SENT_144	[p7l2064t228r2146b285],
19	a	DT	O	a	dep	101	SENT_144	[p7l310t350r339b382],
20	Research	NNP	O	Research	dep	101	SENT_144	[p7l358t353r686b416],
21	Center	NNP	O	Center	dep	101	SENT_144	[p7l715t354r956b426],
22	;	:	O	;	_	0	SENT_144	[p7l715t354r956b426],
23	Centre	NNP	ORGANIZATION	Centre	dep	101	SENT_144	[p7l994t354r1226b416],
24	Hospitalier	NNP	ORGANIZATION	Hospitalier	dep	101	SENT_144	[p7l1249t353r1660b433],
25	Universitaire	NNP	ORGANIZATION	Universitaire	dep	101	SENT_144	[p7l1689t355r2150b416],
26	Sainte-Justine	NNP	ORGANIZATION	Sainte-Justine	dep	101	SENT_144	[p7l653t460r1167b533],
27	,	,	O	,	_	0	SENT_144	[p7l653t460r1167b533],
28	Quebec	NNP	LOCATION	Quebec	dep	101	SENT_144	[p7l1204t459r1471b537],
29	H3	NN	O	h3	dep	101	SENT_144	[p7l1494t460r1601b522],
30	T	NN	O	t	dep	101	SENT_144	[p7l1609t462r1661b521],
31	1	CD	NUMBER	1	dep	101	SENT_144	[p7l1680t460r1713b521],
32	C5	NN	O	c5	dep	101	SENT_144	[p7l1726t461r1837b532],
33	,	,	O	,	_	0	SENT_144	[p7l1726t461r1837b532],
34	Canada	NNP	ORGANIZATION	Canada	dep	101	SENT_144	[p7l1875t459r2151b523],
35	b	NN	ORGANIZATION	b	dep	101	SENT_144	[p7l1175t548r1208b596],
36	Department	NNP	ORGANIZATION	Department	dep	101	SENT_144	[p7l1228t568r1658b646],
37	of	IN	ORGANIZATION	of	dep	101	SENT_144	[p7l1680t566r1761b646],
38	Pediatrics	NNPS	ORGANIZATION	Pediatrics	dep	101	SENT_144	[p7l1770t566r2143b639],
39	,	,	O	,	_	0	SENT_144	[p7l1770t566r2143b639],
40	University	NNP	ORGANIZATION	University	dep	101	SENT_144	[p7l1019t676r1380b753],
41	of	IN	ORGANIZATION	of	dep	101	SENT_144	[p7l1406t674r1486b754],
42	Montreal	NNP	ORGANIZATION	Montreal	dep	101	SENT_144	[p7l1494t673r1837b746],
43	,	,	O	,	_	0	SENT_144	[p7l1494t673r1837b746],
44	Canada	NNP	PERSON	Canada	dep	101	SENT_144	[p7l1875t673r2151b737],
45	Maja	NNP	PERSON	Maja	dep	101	SENT_144	[p7l1354t804r1536b885],
46	Krajinovic	NNP	PERSON	Krajinovic	dep	101	SENT_144	[p7l1562t804r1937b885],
47	a	DT	O	a	dep	101	SENT_144	[p7l1953t786r2145b843],
48	’	NN	O	’	dep	101	SENT_144	[p7l1953t786r2145b843],
49	b	NN	O	b	dep	101	SENT_144	[p7l1953t786r2145b843],
50	’	CD	NUMBER	’	dep	101	SENT_144	[p7l1953t786r2145b843],
51	°	CD	NUMBER	°	dep	101	SENT_144	[p7l1953t786r2145b843],
52	’	CD	NUMBER	’	dep	101	SENT_144	[p7l1953t786r2145b843],
53	*	NN	O	*	dep	101	SENT_144	[p7l1953t786r2145b843],
54	a	DT	O	a	dep	101	SENT_144	[p7l310t908r339b940],
55	Research	NNP	O	Research	dep	101	SENT_144	[p7l358t911r686b974],
56	Center	NNP	O	Center	dep	101	SENT_144	[p7l715t912r956b984],
57	;	:	O	;	_	0	SENT_144	[p7l715t912r956b984],
58	Centre	NNP	ORGANIZATION	Centre	dep	101	SENT_144	[p7l994t912r1226b974],
59	Hospitalier	NNP	ORGANIZATION	Hospitalier	dep	101	SENT_144	[p7l1249t911r1660b991],
60	Universitaire	NNP	ORGANIZATION	Universitaire	dep	101	SENT_144	[p7l1689t913r2150b974],
61	Sainte-Justine	NNP	ORGANIZATION	Sainte-Justine	dep	101	SENT_144	[p7l653t1018r1167b1091],
62	,	,	O	,	_	0	SENT_144	[p7l653t1018r1167b1091],
63	Quebec	NNP	LOCATION	Quebec	dep	101	SENT_144	[p7l1204t1017r1471b1095],
64	H3	NN	O	h3	dep	101	SENT_144	[p7l1494t1018r1601b1080],
65	T	NN	O	t	dep	101	SENT_144	[p7l1609t1020r1661b1079],
66	1	CD	NUMBER	1	dep	101	SENT_144	[p7l1680t1018r1713b1079],
67	C5	NN	O	c5	dep	101	SENT_144	[p7l1726t1019r1837b1090],
68	,	,	O	,	_	0	SENT_144	[p7l1726t1019r1837b1090],
69	Canada	NNP	ORGANIZATION	Canada	dep	101	SENT_144	[p7l1875t1017r2151b1081],
70	b	NN	ORGANIZATION	b	dep	101	SENT_144	[p7l1175t1106r1208b1154],
71	Department	NNP	ORGANIZATION	Department	dep	101	SENT_144	[p7l1228t1126r1658b1204],
72	of	IN	ORGANIZATION	of	dep	101	SENT_144	[p7l1680t1124r1761b1204],
73	Pediatrics	NNPS	ORGANIZATION	Pediatrics	dep	101	SENT_144	[p7l1770t1124r2143b1197],
74	,	,	O	,	_	0	SENT_144	[p7l1770t1124r2143b1197],
75	University	NNP	ORGANIZATION	University	dep	101	SENT_144	[p7l1019t1234r1380b1311],
76	of	IN	ORGANIZATION	of	dep	101	SENT_144	[p7l1406t1232r1486b1312],
77	Montreal	NNP	ORGANIZATION	Montreal	dep	101	SENT_144	[p7l1494t1231r1837b1304],
78	,	,	O	,	_	0	SENT_144	[p7l1494t1231r1837b1304],
79	Canada	NNP	ORGANIZATION	Canada	dep	101	SENT_144	[p7l1875t1231r2151b1295],
80	C	NNP	ORGANIZATION	C	dep	101	SENT_144	[p7l1020t1334r1047b1367],
81	Department	NNP	ORGANIZATION	Department	dep	101	SENT_144	[p7l1068t1340r1497b1417],
82	of	IN	ORGANIZATION	of	dep	101	SENT_144	[p7l1520t1337r1601b1417],
83	Pharmacology	NNP	ORGANIZATION	Pharmacology	dep	101	SENT_144	[p7l1609t1337r2143b1417],
84	,	,	O	,	_	0	SENT_144	[p7l1609t1337r2143b1417],
85	University	NNP	ORGANIZATION	University	dep	101	SENT_144	[p7l1019t1446r1380b1524],
86	of	IN	ORGANIZATION	of	dep	101	SENT_144	[p7l1406t1444r1486b1524],
87	Montreal	NNP	ORGANIZATION	Montreal	dep	101	SENT_144	[p7l1494t1444r1837b1517],
88	,	,	O	,	_	0	SENT_144	[p7l1494t1444r1837b1517],
89	Canada	NNP	LOCATION	Canada	dep	101	SENT_144	[p7l1875t1444r2151b1507],
90	*	NNP	O	*	dep	101	SENT_144	[p7l321t1551r349b1583],
91	Corresponding	VBG	O	correspond	dep	101	SENT_144	[p7l371t1554r898b1635],
92	author	NN	O	author	dep	101	SENT_144	[p7l925t1554r1151b1617],
93	at	IN	O	at	dep	101	SENT_144	[p7l1176t1564r1255b1617],
94	:	:	O	:	_	0	SENT_144	[p7l1176t1564r1255b1617],
95	Research	NNP	O	Research	dep	101	SENT_144	[p7l1286t1554r1612b1617],
96	Center	NNP	O	Center	dep	101	SENT_144	[p7l1637t1555r1887b1628],
97	,	,	O	,	_	0	SENT_144	[p7l1637t1555r1887b1628],
98	Centre	NNP	ORGANIZATION	Centre	dep	101	SENT_144	[p7l1917t1555r2151b1617],
99	Hospitalier	NNP	ORGANIZATION	Hospitalier	dep	101	SENT_144	[p7l333t1661r729b1742],
100	Universitaire	NNP	ORGANIZATION	Universitaire	dep	101	SENT_144	[p7l752t1661r1212b1724],
101	Sainte	NNP	ORGANIZATION	Sainte	_	0	SENT_144	[p7l1240t1661r1756b1735],
102	.	.	O	.	_	0	SENT_144	[p7l1240t1661r1756b1735],

1	—	NN	O	—	_	0	SENT_145	[p7l1240t1661r1756b1735],
2	.	.	O	.	_	0	SENT_145	[p7l1240t1661r1756b1735],

1	Justine	NNP	PERSON	Justine	_	0	SENT_146	[p7l1240t1661r1756b1735],
2	,	,	O	,	_	0	SENT_146	[p7l1240t1661r1756b1735],
3	3175	CD	NUMBER	3175	num	5	SENT_146	[p7l1786t1660r1956b1724],
4	Cote	NNP	O	Cote	nn	5	SENT_146	[p7l1986t1660r2151b1724],
5	Ste	NNP	O	Ste	appos	1	SENT_146	[p7l282t1767r788b1842],
6	.	.	O	.	_	0	SENT_146	[p7l282t1767r788b1842],

1	—	NN	O	—	_	0	SENT_147	[p7l282t1767r788b1842],
2	.	.	O	.	_	0	SENT_147	[p7l282t1767r788b1842],

1	Catherine	NNP	PERSON	Catherine	nn	3	SENT_148	[p7l282t1767r788b1842],
2	,	,	O	,	_	0	SENT_148	[p7l282t1767r788b1842],
3	Montreal	NNP	LOCATION	Montreal	_	0	SENT_148	[p7l815t1766r1160b1842],
4	,	,	O	,	_	0	SENT_148	[p7l815t1766r1160b1842],
5	Quebec	NNP	LOCATION	Quebec	nn	7	SENT_148	[p7l1190t1767r1457b1845],
6	H3T	NN	O	h3t	nn	7	SENT_148	[p7l1484t1768r1645b1830],
7	1C5	NN	O	1c5	appos	3	SENT_148	[p7l1678t1767r1835b1842],
8	,	,	O	,	_	0	SENT_148	[p7l1678t1767r1835b1842],
9	Canada	NNP	LOCATION	Canada	appos	7	SENT_148	[p7l1864t1767r2147b1831],
10	.	.	O	.	_	0	SENT_148	[p7l1864t1767r2147b1831],

1	Tel.	NNP	O	Tel.	_	0	SENT_149	[p7l300t1874r451b1936],
2	:	:	O	:	_	0	SENT_149	[p7l300t1874r451b1936],
3	+1	CD	NUMBER	+1	number	4	SENT_149	[p7l483t1875r567b1935],
4	514 345 4931	CD	NUMBER	514 345 4931	dep	1	SENT_149	[p7l912t1874r1334b1947],[p7l601t1874r730b1936],
5	x6259	NN	O	x6259	dep	4	SENT_149	[p7l912t1874r1334b1947],
6	;	:	O	;	_	0	SENT_149	[p7l912t1874r1334b1947],
7	fax	NN	O	fax	dep	1	SENT_149	[p7l1362t1874r1491b1936],
8	:	:	O	:	_	0	SENT_149	[p7l1362t1874r1491b1936],
9	+1	CD	NUMBER	+1	number	10	SENT_149	[p7l1523t1875r1607b1935],
10	514 345 4731	CD	NUMBER	514 345 4731	dep	7	SENT_149	[p7l1952t1874r2147b1936],[p7l1641t1874r1771b1936],
11	.	.	O	.	_	0	SENT_149	[p7l1952t1874r2147b1936],

1	E-mail	NN	O	e-mail	nn	2	SENT_150	[p7l456t1980r700b2042],
2	address	NN	O	address	_	0	SENT_150	[p7l723t1980r1020b2043],
3	:	:	O	:	_	0	SENT_150	[p7l723t1980r1020b2043],
4	maja	NN	O	maja	dep	2	SENT_150	[p7l1050t1980r2153b2061],
5	.	.	O	.	_	0	SENT_150	[p7l1050t1980r2153b2061],

1	l	NN	O	l	_	0	SENT_151	[p7l1050t1980r2153b2061],
2	<	JJR	O	<	amod	3	SENT_151	[p7l1050t1980r2153b2061],
3	rajinoVic@umontrea1.ca	NN	O	rajinovic@umontrea1.ca	dep	1	SENT_151	[p7l1050t1980r2153b2061],
4	(	CD	NUMBER	(	num	7	SENT_151	[p7l1592t2088r1714b2164],
5	M.	NNP	NUMBER	M.	nn	7	SENT_151	[p7l1592t2088r1714b2164],
6	Krajinovic	NNP	PERSON	Krajinovic	nn	7	SENT_151	[p7l1745t2087r2149b2168],
7	)	NN	O	)	dep	1	SENT_151	[p7l1745t2087r2149b2168],

1	15	CD	DATE	15	_	0	SENT_152	[p7l1591t2247r1665b2311],
2	August	NNP	DATE	August	dep	1	SENT_152	[p7l1694t2248r1952b2329],
3	2006	CD	DATE	2006	num	2	SENT_152	[p7l1976t2247r2150b2311],

1	Available	JJ	O	available	amod	2	SENT_153	[p7l851t2408r1187b2471],
2	online	NN	O	online	_	0	SENT_153	[p7l1214t2408r1433b2471],
3	26	CD	DATE	26	dep	2	SENT_153	[p7l1460t2408r1544b2471],
4	September	NNP	DATE	September	tmod	3	SENT_153	[p7l1573t2408r1952b2489],
5	2006	CD	DATE	2006	num	4	SENT_153	[p7l1976t2408r2150b2471],

1	doi	FW	O	doi	_	0	SENT_154	[p7l9t2652r113b2702],
2	:	:	O	:	_	0	SENT_154	[p7l9t2652r113b2702],
3	10.1016	CD	NUMBER	10.1016	dep	1	SENT_154	[p7l144t2651r1005b2717],
4	/	:	O	/	punct	6	SENT_154	[p7l144t2651r1005b2717],
5	j.	NN	O	j.	nsubj	6	SENT_154	[p7l144t2651r1005b2717],
6	leukres	VBZ	O	leukre	dep	3	SENT_154	[p7l144t2651r1005b2717],
7	.2006.08.007	CD	NUMBER	.2006.08.007	dobj	6	SENT_154	[p7l144t2651r1005b2717],

1	Campath-1H	NN	O	campath-1h	nsubj	2	SENT_155	[p7l11t2879r508b2960],
2	induced	VBD	O	induce	_	0	SENT_155	[p7l541t2879r842b2943],
3	pure	JJ	O	pure	amod	6	SENT_155	[p7l876t2899r1050b2960],
4	red	JJ	O	red	amod	6	SENT_155	[p7l1086t2880r1209b2943],
5	cell	NN	O	cell	nn	6	SENT_155	[p7l1244t2880r1369b2943],
6	aplasia	NN	O	aplasium	dobj	2	SENT_155	[p7l1405t2879r1670b2960],
7	in	IN	O	in	_	0	SENT_155	[p7l1703t2879r1776b2942],
8	a	DT	O	a	det	9	SENT_155	[p7l1810t2899r1852b2943],
9	patient	NN	O	patient	prep_in	6	SENT_155	[p7l1886t2879r2153b2960],
10	with	IN	O	with	_	0	SENT_155	[p7l9t2986r174b3050],
11	chronic	JJ	O	chronic	amod	13	SENT_155	[p7l201t2986r483b3050],
12	lymphatic	JJ	O	lymphatic	amod	13	SENT_155	[p7l509t2986r888b3067],
13	leukaemia	NN	O	leukaemia	prep_with	2	SENT_155	[p7l913t2986r1303b3050],

1	We	PRP	O	we	nsubj	2	SENT_156	[p7l115t3202r230b3264],
2	present	VBP	DATE	present	_	0	SENT_156	[p7l275t3210r533b3282],
3	the	DT	O	the	det	4	SENT_156	[p7l577t3201r683b3263],
4	case	NN	O	case	nsubj	20	SENT_156	[p7l730t3220r880b3263],
5	of	IN	O	of	_	0	SENT_156	[p7l927t3201r1004b3263],
6	a	DT	O	a	det	8	SENT_156	[p7l1045t3220r1082b3263],
7	62-year-old	JJ	DURATION	62-year-old	amod	8	SENT_156	[p7l1128t3201r1540b3282],
8	gentleman	NN	O	gentleman	prep_of	4	SENT_156	[p7l1585t3201r1955b3282],
9	who	WP	O	who	nsubjpass	11	SENT_156	[p7l2000t3201r2150b3264],
10	was	VBD	O	be	auxpass	11	SENT_156	[p7l9t3328r142b3371],
11	diagnosed	VBN	O	diagnose	rcmod	8	SENT_156	[p7l191t3308r551b3389],
12	with	IN	O	with	_	0	SENT_156	[p7l596t3308r752b3371],
13	B	NN	O	b	prep_with	11	SENT_156	[p7l798t3310r850b3370],
14	cell	NN	O	cell	nn	20	SENT_156	[p7l902t3308r1028b3371],
15	chronic	JJ	O	chronic	amod	20	SENT_156	[p7l1075t3308r1338b3371],
16	lymphatic	JJ	O	lymphatic	amod	20	SENT_156	[p7l1386t3308r1739b3389],
17	leukaemia	NN	O	leukaemia	nn	20	SENT_156	[p7l1787t3308r2153b3371],
18	(	NN	O	(	nn	20	SENT_156	[p7l11t3415r231b3492],
19	CLL	NN	O	cll	nn	20	SENT_156	[p7l11t3415r231b3492],
20	)	NN	O	)	xcomp	2	SENT_156	[p7l11t3415r231b3492],
21	in	IN	O	in	_	0	SENT_156	[p7l269t3415r336b3477],
22	1996	CD	DATE	1996	prep_in	20	SENT_156	[p7l378t3415r564b3479],
23	.	.	O	.	_	0	SENT_156	[p7l378t3415r564b3479],

1	He	PRP	O	he	nsubjpass	4	SENT_157	[p7l603t3417r704b3478],
2	was	VBD	O	be	auxpass	4	SENT_157	[p7l739t3435r872b3478],
3	initially	RB	O	initially	advmod	4	SENT_157	[p7l908t3415r1183b3496],
4	treated	VBN	O	treat	_	0	SENT_157	[p7l1218t3415r1460b3478],
5	with	IN	O	with	_	0	SENT_157	[p7l1494t3415r1650b3478],
6	chlorambucil	NN	O	chlorambucil	prep_with	4	SENT_157	[p7l1685t3415r2151b3478],
7	but	CC	O	but	_	0	SENT_157	[p7l7t3521r120b3583],
8	had	VBD	O	have	conj_but	4	SENT_157	[p7l158t3521r286b3583],
9	multiple	JJ	O	multiple	amod	10	SENT_157	[p7l324t3521r619b3602],
10	relapses	NNS	O	relapse	dobj	8	SENT_157	[p7l658t3521r943b3602],
11	needing	VBG	O	need	partmod	10	SENT_157	[p7l984t3521r1264b3602],
12	treatment	NN	O	treatment	dobj	11	SENT_157	[p7l1305t3530r1642b3583],
13	with	IN	O	with	_	0	SENT_157	[p7l1680t3521r1837b3583],
14	ﬂudara	NN	O	ﬂudara	nn	16	SENT_157	[p7l1877t3521r2149b3583],
15	—	CD	NUMBER	—	num	16	SENT_157	[p7l1877t3521r2149b3583],
16	bine/cyclophosphamide	NN	O	bine/cyclophosphamide	prep_with	11	SENT_157	[p7l7t3629r873b3710],
17	,	,	O	,	_	0	SENT_157	[p7l7t3629r873b3710],
18	R	NN	O	r	appos	16	SENT_157	[p7l952t3630r1213b3692],
19	.	.	O	.	_	0	SENT_157	[p7l952t3630r1213b3692],

1	—	NN	O	—	_	0	SENT_158	[p7l952t3630r1213b3692],
2	.	.	O	.	_	0	SENT_158	[p7l952t3630r1213b3692],

1	COP	NN	O	cop	nn	3	SENT_159	[p7l952t3630r1213b3692],
2	(	CD	NUMBER	(	num	3	SENT_159	[p7l1292t3629r1683b3707],
3	rituximab	NN	O	rituximab	nsubj	6	SENT_159	[p7l1292t3629r1683b3707],
4	,	,	O	,	_	0	SENT_159	[p7l1292t3629r1683b3707],
5	cyclophos	NNS	O	cyclopho	appos	3	SENT_159	[p7l1764t3629r2149b3710],
6	—	VBP	O	—	_	0	SENT_159	[p7l1764t3629r2149b3710],

1	phamide	NN	O	phamide	_	0	SENT_160	[p8l7t20r332b101],
2	,	,	O	,	_	0	SENT_160	[p8l7t20r332b101],
3	vincristine	NN	O	vincristine	appos	1	SENT_160	[p8l407t20r781b83],
4	and	CC	O	and	_	0	SENT_160	[p8l854t20r980b83],
5	prednisolone	JJ	O	prednisolone	amod	6	SENT_160	[p8l1048t20r1536b101],
6	)	NN	O	)	appos	1	SENT_160	[p8l1048t20r1536b101],
7	and	CC	O	and	_	0	SENT_160	[p8l1611t20r1736b83],
8	rituximab	NN	O	rituximab	nn	9	SENT_160	[p8l1805t20r2150b83],
9	montherapy	NN	O	montherapy	conj_and	3	SENT_160	[p8l8t126r444b207],
10	.	.	O	.	_	0	SENT_160	[p8l8t126r444b207],

1	A	DT	O	a	det	3	SENT_161	[p8l465t126r527b187],
2	further	JJ	O	further	amod	3	SENT_161	[p8l544t125r787b188],
3	relapse	NN	O	relapse	nsubj	7	SENT_161	[p8l800t126r1052b207],
4	with	IN	O	with	_	0	SENT_161	[p8l1069t126r1225b188],
5	p53	NN	O	p53	nn	6	SENT_161	[p8l1241t125r1369b207],
6	mutation	NN	O	mutation	prep_with	3	SENT_161	[p8l1390t126r1705b188],
7	necessitated	VBD	O	necessitate	_	0	SENT_161	[p8l1722t126r2152b188],
8	the	DT	O	the	det	9	SENT_161	[p8l8t234r115b297],
9	introduction	NN	O	introduction	dobj	7	SENT_161	[p8l145t234r580b297],
10	of	IN	O	of	_	0	SENT_161	[p8l610t234r687b297],
11	Campath	NNP	O	Campath	prep_of	9	SENT_161	[p8l711t234r1048b315],
12	.	.	O	.	_	0	SENT_161	[p8l711t234r1048b315],

1	Approximately	RB	O	approximately	advmod	13	SENT_162	[p8l1083t234r1635b315],
2	,	,	O	,	_	0	SENT_162	[p8l1083t234r1635b315],
3	4	CD	DURATION	4	num	4	SENT_162	[p8l1667t235r1709b296],
4	weeks	NNS	NUMBER	week	nsubj	13	SENT_162	[p8l1740t234r1958b297],
5	after	IN	O	after	_	0	SENT_162	[p8l1992t234r2153b297],
6	the	DT	O	the	det	7	SENT_162	[p8l7t341r113b403],
7	start	NN	O	start	prep_after	4	SENT_162	[p8l138t350r288b403],
8	of	IN	O	of	_	0	SENT_162	[p8l309t341r386b403],
9	treatment	NN	O	treatment	prep_of	7	SENT_162	[p8l401t350r755b415],
10	,	,	O	,	_	0	SENT_162	[p8l401t350r755b415],
11	the	DT	O	the	det	12	SENT_162	[p8l779t341r886b403],
12	patient	NN	O	patient	appos	9	SENT_162	[p8l907t341r1149b422],
13	required	VBN	O	require	_	0	SENT_162	[p8l1168t341r1465b422],
14	hospital	NN	O	hospital	nn	15	SENT_162	[p8l1485t341r1765b422],
15	admission	NN	O	admission	dobj	13	SENT_162	[p8l1789t341r2147b403],
16	for	IN	O	for	_	0	SENT_162	[p8l8t448r110b511],
17	a	DT	O	a	det	19	SENT_162	[p8l132t468r168b511],
18	pyrexial	JJ	O	pyrexial	amod	19	SENT_162	[p8l187t448r475b529],
19	episode	NN	O	episode	prep_for	15	SENT_162	[p8l497t448r784b529],
20	.	.	O	.	_	0	SENT_162	[p8l497t448r784b529],

1	The	DT	O	the	det	7	SENT_163	[p8l810t448r946b511],
2	mean	NN	O	mean	nn	7	SENT_163	[p8l967t468r1158b511],
3	haemoglobin	NN	O	haemoglobin	nn	7	SENT_163	[p8l1178t448r1642b529],
4	concentration	NN	O	concentration	nn	7	SENT_163	[p8l1664t448r2147b511],
5	(	CD	NUMBER	(	num	7	SENT_163	[p8l10t555r171b632],
6	Hb	NN	O	hb	nn	7	SENT_163	[p8l10t555r171b632],
7	)	NN	O	)	nsubj	12	SENT_163	[p8l10t555r171b632],
8	on	IN	O	on	_	0	SENT_163	[p8l218t575r304b618],
9	admission	NN	O	admission	prep_on	7	SENT_163	[p8l350t555r707b618],
10	was	VBD	O	be	cop	12	SENT_163	[p8l752t575r885b618],
11	6.9	CD	NUMBER	6.9	num	12	SENT_163	[p8l932t555r1037b619],
12	g/dl	NN	O	g/dl	_	0	SENT_163	[p8l1058t555r1212b636],
13	,	,	O	,	_	0	SENT_163	[p8l1058t555r1212b636],
14	with	IN	O	with	_	0	SENT_163	[p8l1260t555r1416b618],
15	a	DT	O	a	det	22	SENT_163	[p8l1462t575r1498b618],
16	white	JJ	O	white	amod	22	SENT_163	[p8l1541t555r1736b618],
17	cell	NN	O	cell	nn	22	SENT_163	[p8l1782t555r1907b618],
18	count	NN	O	count	nn	22	SENT_163	[p8l1952t564r2148b618],
19	(	CD	NUMBER	(	num	22	SENT_163	[p8l10t663r265b740],
20	WCC	NN	O	wcc	nn	22	SENT_163	[p8l10t663r265b740],
21	)	NN	O	)	nn	22	SENT_163	[p8l10t663r265b740],
22	of2	NN	O	of2	prep_with	12	SENT_163	[p8l285t663r480b726],
23	.0	CD	NUMBER	.0	num	24	SENT_163	[p8l285t663r480b726],
24	X	NN	O	x	dep	36	SENT_163	[p8l509t682r555b724],
25	109	CD	NUMBER	109	num	26	SENT_163	[p8l592t645r703b726],
26	l	NN	O	l	dep	24	SENT_163	[p8l726t646r1295b744],
27	—	CD	NUMBER	—	number	28	SENT_163	[p8l726t646r1295b744],
28	1	CD	NUMBER	1	num	32	SENT_163	[p8l726t646r1295b744],
29	,	,	O	,	_	0	SENT_163	[p8l726t646r1295b744],
30	lymphocyte	NN	O	lymphocyte	dep	32	SENT_163	[p8l726t646r1295b744],
31	count	NN	O	count	nn	32	SENT_163	[p8l1313t672r1509b725],
32	ofO	NN	O	ofo	dep	26	SENT_163	[p8l1525t663r1764b726],
33	.19	CD	NUMBER	.19	num	34	SENT_163	[p8l1525t663r1764b726],
34	X	NN	O	x	dep	36	SENT_163	[p8l1794t682r1840b724],
35	109	CD	NUMBER	109	num	36	SENT_163	[p8l1877t645r1988b726],
36	r1	NN	O	r1	dep	47	SENT_163	[p8l2011t645r2144b737],
37	,	,	O	,	_	0	SENT_163	[p8l2011t645r2144b737],
38	and	CC	O	and	_	0	SENT_163	[p8l9t770r134b833],
39	platelets	NNS	O	platelet	dep	47	SENT_163	[p8l169t770r463b851],
40	(	CD	NUMBER	(	num	42	SENT_163	[p8l506t770r651b851],
41	plt	NN	O	plt	nn	42	SENT_163	[p8l506t770r651b851],
42	)	NN	O	)	dep	39	SENT_163	[p8l506t770r651b851],
43	of	IN	O	of	_	0	SENT_163	[p8l692t770r769b833],
44	29	CD	NUMBER	29	num	45	SENT_163	[p8l801t771r885b834],
45	X	NN	O	x	prep_of	36	SENT_163	[p8l915t790r961b831],
46	1091	CD	DATE	1091	num	47	SENT_163	[p8l997t753r1235b833],
47	”	NN	O	”	dep	22	SENT_163	[p8l997t753r1235b833],
48	while	IN	O	while	mark	58	SENT_163	[p8l1282t770r1477b833],
49	his	PRP$	O	he	poss	50	SENT_163	[p8l1514t770r1615b833],
50	counts	NNS	O	count	nsubj	58	SENT_163	[p8l1655t780r1882b833],
51	before	IN	O	before	_	0	SENT_163	[p8l1920t770r2146b833],
52	the	DT	O	the	det	53	SENT_163	[p8l7t878r113b940],
53	administration	NN	O	administration	prep_before	50	SENT_163	[p8l173t878r684b940],
54	of	IN	O	of	_	0	SENT_163	[p8l743t878r820b940],
55	the	DT	O	the	det	57	SENT_163	[p8l871t878r977b940],
56	monoclonal	JJ	O	monoclonal	amod	57	SENT_163	[p8l1035t878r1454b940],
57	antibody	NN	O	antibody	prep_of	53	SENT_163	[p8l1513t878r1821b959],
58	showed	VBD	O	show	dep	22	SENT_163	[p8l1882t878r2148b941],
59	a	DT	O	a	det	61	SENT_163	[p8l9t1005r46b1048],
60	mean	JJ	O	mean	amod	61	SENT_163	[p8l98t1005r289b1048],
61	Hb	NN	O	hb	dobj	58	SENT_163	[p8l342t985r447b1048],
62	of	IN	O	of	_	0	SENT_163	[p8l503t985r579b1048],
63	9.0	CD	NUMBER	9.0	number	64	SENT_163	[p8l628t986r936b1049],
64	—	CD	NUMBER	—	prep_of	61	SENT_163	[p8l628t986r936b1049],
65	10.0	CD	NUMBER	10.0	num	66	SENT_163	[p8l628t986r936b1049],
66	g/dl	NN	O	g/dl	dep	64	SENT_163	[p8l955t985r1109b1066],
67	,	,	O	,	_	0	SENT_163	[p8l955t985r1109b1066],
68	WCC	NN	O	wcc	conj_and	64	SENT_163	[p8l1165t986r1365b1048],
69	of	IN	O	of	_	0	SENT_163	[p8l1422t985r1498b1048],
70	26-29	CD	NUMBER	26-29	prep_of	68	SENT_163	[p8l1547t985r1764b1049],
71	x	CC	O	x	_	0	SENT_163	[p8l1795t1005r1840b1046],
72	10914	CD	NUMBER	10914	conj_and	64	SENT_163	[p8l1877t968r2144b1059],
73	,	,	O	,	_	0	SENT_163	[p8l1877t968r2144b1059],
74	lymphocytes	NNS	O	lymphocyte	appos	72	SENT_163	[p8l7t1091r458b1172],
75	of	IN	O	of	_	0	SENT_163	[p8l485t1091r562b1154],
76	22-25	CD	NUMBER	22-25	prep_of	74	SENT_163	[p8l581t1091r796b1154],
77	x	CC	O	x	_	0	SENT_163	[p8l829t1111r875b1152],
78	1091-1	CD	NUMBER	1091-1	prep_of	74	SENT_163	[p8l911t1074r1149b1154],
79	and	CC	O	and	_	0	SENT_163	[p8l1185t1091r1310b1154],
80	plt	NN	O	plt	conj_and	64	SENT_163	[p8l1332t1091r1427b1172],
81	of	IN	O	of	_	0	SENT_163	[p8l1451t1091r1527b1154],
82	40-50	CD	NUMBER	40-50	prep_of	80	SENT_163	[p8l1545t1091r1766b1154],
83	x	CC	O	x	_	0	SENT_163	[p8l1794t1111r1840b1152],
84	1091-1	CD	NUMBER	1091-1	conj_x	82	SENT_163	[p8l1877t1074r2142b1154],
85	.	.	O	.	_	0	SENT_163	[p8l1877t1074r2142b1154],

1	He	PRP	O	he	nsubj	2	SENT_164	[p8l7t1200r108b1261],
2	required	VBD	O	require	_	0	SENT_164	[p8l140t1199r437b1280],
3	a	DT	O	a	det	4	SENT_164	[p8l471t1218r508b1261],
4	total	NN	O	total	dobj	2	SENT_164	[p8l539t1199r695b1261],
5	of	IN	O	of	_	0	SENT_164	[p8l729t1199r806b1261],
6	11	CD	NUMBER	11	num	8	SENT_164	[p8l841t1199r911b1261],
7	blood	NN	O	blood	nn	8	SENT_164	[p8l951t1199r1154b1261],
8	transfusions	NNS	O	transfusion	prep_of	4	SENT_164	[p8l1185t1199r1612b1261],
9	in	IN	O	in	_	0	SENT_164	[p8l1647t1199r1714b1261],
10	a	DT	O	a	det	11	SENT_164	[p8l1749t1218r1785b1261],
11	period	NN	O	period	prep_in	2	SENT_164	[p8l1815t1199r2043b1280],
12	of	IN	O	of	_	0	SENT_164	[p8l2076t1199r2153b1261],
13	7	CD	DURATION	7	num	14	SENT_164	[p8l8t1308r46b1369],
14	days	NNS	NUMBER	day	prep_of	11	SENT_164	[p8l82t1306r240b1387],
15	for	IN	O	for	_	0	SENT_164	[p8l275t1306r378b1369],
16	symptomatic	JJ	O	symptomatic	amod	17	SENT_164	[p8l411t1306r865b1387],
17	anaemia	NN	O	anaemia	prep_for	14	SENT_164	[p8l900t1306r1211b1369],
18	.	.	O	.	_	0	SENT_164	[p8l900t1306r1211b1369],

1	Investigations	NNS	O	investigation	nsubj	14	SENT_165	[p8l1248t1306r1739b1387],
2	to	TO	O	to	aux	3	SENT_165	[p8l1773t1316r1839b1369],
3	identify	VB	O	identify	infmod	1	SENT_165	[p8l1872t1306r2146b1387],
4	haemolytic	JJ	O	haemolytic	amod	5	SENT_165	[p8l7t1413r400b1494],
5	anaemia	NN	O	anaemia	dobj	3	SENT_165	[p8l436t1413r748b1487],
6	,	,	O	,	_	0	SENT_165	[p8l436t1413r748b1487],
7	a	DT	O	a	det	10	SENT_165	[p8l786t1433r822b1476],
8	usual	JJ	O	usual	amod	10	SENT_165	[p8l853t1413r1039b1476],
9	adverse	JJ	O	adverse	amod	10	SENT_165	[p8l1074t1413r1340b1476],
10	event	NN	O	event	appos	5	SENT_165	[p8l1374t1422r1562b1476],
11	associated	VBN	O	associate	partmod	10	SENT_165	[p8l1595t1413r1959b1476],
12	with	IN	O	with	_	0	SENT_165	[p8l1991t1413r2147b1476],
13	Campath	NNP	MISC	Campath	prep_with	11	SENT_165	[p8l8t1519r327b1600],
14	revealed	VBD	O	reveal	_	0	SENT_165	[p8l365t1519r663b1581],
15	a	DT	O	a	det	20	SENT_165	[p8l703t1538r739b1581],
16	weakly	RB	O	weakly	advmod	17	SENT_165	[p8l778t1519r1032b1600],
17	positive	JJ	O	positive	amod	20	SENT_165	[p8l1070t1519r1348b1600],
18	direct	JJ	O	direct	amod	20	SENT_165	[p8l1388t1519r1589b1581],
19	antiglobin	NN	O	antiglobin	nn	20	SENT_165	[p8l1628t1519r1987b1600],
20	test	NN	O	test	dobj	14	SENT_165	[p8l2025t1528r2148b1581],
21	against	IN	O	against	_	0	SENT_165	[p8l9t1627r259b1708],
22	complement	NN	O	complement	prep_against	14	SENT_165	[p8l312t1627r752b1708],
23	but	CC	O	but	_	0	SENT_165	[p8l804t1627r916b1690],
24	not	RB	O	not	_	0	SENT_165	[p8l969t1637r1082b1690],
25	against	IN	O	against	_	0	SENT_165	[p8l1137t1627r1387b1708],
26	immunoglobulin	NN	O	immunoglobulin	nn	27	SENT_165	[p8l1440t1627r2031b1708],
27	G	NN	O	g	conj_negcc	22	SENT_165	[p8l2086t1628r2148b1690],
28	while	IN	O	while	mark	34	SENT_165	[p8l8t1734r203b1797],
29	lactate	NN	O	lactate	nn	30	SENT_165	[p8l228t1734r458b1796],
30	dehydrogenase	NN	O	dehydrogenase	nsubj	34	SENT_165	[p8l485t1734r1017b1815],
31	and	CC	O	and	_	0	SENT_165	[p8l1044t1734r1169b1796],
32	haptoglobins	NNS	O	haptoglobin	conj_and	30	SENT_165	[p8l1193t1734r1650b1815],
33	were	VBD	O	be	cop	34	SENT_165	[p8l1679t1753r1848b1797],
34	normal	JJ	O	normal	advcl	14	SENT_165	[p8l1874t1734r2142b1797],
35	.	.	O	.	_	0	SENT_165	[p8l1874t1734r2142b1797],

1	An	DT	O	a	det	3	SENT_166	[p8l7t1840r114b1901],
2	autoimmune	JJ	O	autoimmune	amod	3	SENT_166	[p8l149t1840r590b1902],
3	screen	NN	O	screen	nsubj	6	SENT_166	[p8l626t1859r849b1902],
4	was	VBD	O	be	cop	6	SENT_166	[p8l882t1859r1015b1903],
5	also	RB	O	also	advmod	6	SENT_166	[p8l1052t1840r1190b1902],
6	negative	JJ	O	negative	_	0	SENT_166	[p8l1224t1840r1537b1921],
7	.	.	O	.	_	0	SENT_166	[p8l1224t1840r1537b1921],

1	Microbiological	JJ	MISC	microbiological	amod	2	SENT_167	[p8l1574t1840r2147b1921],
2	investigations	NNS	O	investigation	_	0	SENT_167	[p8l7t1948r493b2029],
3	including	VBG	O	include	_	0	SENT_167	[p8l536t1948r870b2029],
4	bacteriology	NN	O	bacteriology	nn	5	SENT_167	[p8l910t1948r1354b2029],
5	cultures	NNS	O	culture	prep_including	2	SENT_167	[p8l1396t1948r1694b2022],
6	,	,	O	,	_	0	SENT_167	[p8l1396t1948r1694b2022],
7	polymerase	NN	O	polymerase	nn	12	SENT_167	[p8l1737t1948r2146b2029],
8	chain	NN	O	chain	nn	12	SENT_167	[p8l8t2055r198b2117],
9	reaction	NN	O	reaction	nn	12	SENT_167	[p8l249t2055r535b2117],
10	(	CD	NUMBER	(	num	12	SENT_167	[p8l589t2055r809b2132],
11	PCR	NN	O	pcr	nn	12	SENT_167	[p8l589t2055r809b2132],
12	)	NN	O	)	appos	5	SENT_167	[p8l589t2055r809b2132],
13	for	IN	O	for	_	0	SENT_167	[p8l864t2055r966b2117],
14	cytomegalovirus	NN	O	cytomegalovirus	prep_for	12	SENT_167	[p8l1017t2055r1624b2136],
15	,	,	O	,	_	0	SENT_167	[p8l1017t2055r1624b2136],
16	Epstein	NN	PERSON	epstein	appos	14	SENT_167	[p8l1678t2055r2149b2136],
17	.	.	O	.	_	0	SENT_167	[p8l1678t2055r2149b2136],

1	—	NN	O	—	_	0	SENT_168	[p8l1678t2055r2149b2136],
2	.	.	O	.	_	0	SENT_168	[p8l1678t2055r2149b2136],

1	Barr	NN	O	barr	nn	2	SENT_169	[p8l1678t2055r2149b2136],
2	virus	NN	O	virus	nsubj	6	SENT_169	[p8l7t2162r181b2225],
3	and	CC	O	and	_	0	SENT_169	[p8l211t2162r337b2225],
4	parvovirus	NN	O	parvovirus	nsubj	6	SENT_169	[p8l362t2162r737b2243],
5	were	VBD	O	be	cop	6	SENT_169	[p8l766t2182r936b2225],
6	negative	JJ	O	negative	_	0	SENT_169	[p8l963t2162r1276b2243],
7	.	.	O	.	_	0	SENT_169	[p8l963t2162r1276b2243],

1	Bone	NN	O	bone	nn	3	SENT_170	[p8l1307t2164r1492b2225],
2	marrow	NN	O	marrow	nn	3	SENT_170	[p8l1519t2182r1791b2225],
3	examination	NN	O	examination	nsubj	14	SENT_170	[p8l1820t2162r2145b2225, p8l7t2269r144b2332],
4	revealed	VBD	O	reveal	_	0	SENT_170	[p8l165t2269r463b2332],
5	pure	JJ	O	pure	amod	8	SENT_170	[p8l483t2289r640b2350],
6	red	JJ	O	red	amod	8	SENT_170	[p8l662t2269r776b2332],
7	cell	NN	O	cell	nn	8	SENT_170	[p8l798t2269r923b2332],
8	aplasia	NN	O	aplasium	dobj	4	SENT_170	[p8l948t2269r1192b2350],
9	with	IN	O	with	_	0	SENT_170	[p8l1214t2269r1370b2332],
10	adequate	JJ	O	adequate	amod	12	SENT_170	[p8l1394t2269r1706b2350],
11	granulocyte	NN	O	granulocyte	nn	12	SENT_170	[p8l1730t2269r2146b2350],
12	maturation	NN	O	maturation	prep_with	8	SENT_170	[p8l7t2375r392b2437],
13	and	CC	O	and	_	0	SENT_170	[p8l412t2375r538b2437],
14	reduced	VBD	O	reduce	conj_and	4	SENT_170	[p8l555t2375r837b2437],
15	megakaryopoiesis	NN	O	megakaryopoiesis	dobj	14	SENT_170	[p8l856t2375r1494b2456],
16	while	IN	O	while	mark	20	SENT_170	[p8l1516t2375r1711b2438],
17	the	DT	O	the	det	19	SENT_170	[p8l1731t2375r1837b2437],
18	trephine	NN	O	trephine	nn	19	SENT_170	[p8l1857t2375r2146b2456],
19	biopsy	NN	O	biopsy	nsubj	20	SENT_170	[p8l6t2483r242b2564],
20	conﬁrmed	VBD	O	conﬁrmed	advcl	14	SENT_170	[p8l262t2483r621b2546],
21	the	DT	O	the	det	22	SENT_170	[p8l638t2483r745b2546],
22	ﬁndings	NNS	O	ﬁndings	dobj	20	SENT_170	[p8l765t2483r1047b2564],
23	with	IN	O	with	_	0	SENT_170	[p8l1067t2483r1223b2546],
24	few	JJ	O	few	amod	26	SENT_170	[p8l1242t2483r1370b2546],
25	lymphoid	JJ	O	lymphoid	amod	26	SENT_170	[p8l1389t2483r1729b2564],
26	aggregates	NNS	O	aggregate	prep_with	20	SENT_170	[p8l1749t2493r2142b2564],
27	.	.	O	.	_	0	SENT_170	[p8l1749t2493r2142b2564],

1	Treatment	NN	O	treatment	nsubjpass	3	SENT_171	[p8l7t2591r370b2652],
2	was	VBD	O	be	auxpass	3	SENT_171	[p8l428t2609r561b2653],
3	commenced	VBN	O	commence	_	0	SENT_171	[p8l622t2590r1051b2652],
4	with	IN	O	with	_	0	SENT_171	[p8l1110t2590r1266b2653],
5	steroids	NNS	O	steroid	prep_with	3	SENT_171	[p8l1327t2590r1597b2652],
6	(	CD	NUMBER	(	num	9	SENT_171	[p8l1661t2590r2146b2671],
7	prednisolone	JJ	O	prednisolone	amod	9	SENT_171	[p8l1661t2590r2146b2671],
8	1mg/kg	NN	O	1mg/kg	nn	9	SENT_171	[p8l16t2696r319b2777],
9	)	NN	O	)	dep	5	SENT_171	[p8l16t2696r319b2777],
10	and	CC	O	and	_	0	SENT_171	[p8l377t2696r502b2758],
11	immunoglobulin	NN	O	immunoglobulin	nn	12	SENT_171	[p8l554t2696r1145b2777],
12	(	NN	O	(	conj_and	5	SENT_171	[p8l1200t2696r1262b2773],
13	1	CD	NUMBER	1	num	14	SENT_171	[p8l1200t2696r1262b2773],
14	g/kg	NN	O	g/kg	dep	12	SENT_171	[p8l1287t2696r1442b2777],
15	for	IN	O	for	_	0	SENT_171	[p8l1496t2696r1599b2758],
16	2	CD	DURATION	2	num	17	SENT_171	[p8l1651t2696r1691b2757],
17	days	NNS	NUMBER	day	prep_for	14	SENT_171	[p8l1745t2696r1953b2777],
18	)	RB	O	)	advmod	3	SENT_171	[p8l1745t2696r1953b2777],
19	.	.	O	.	_	0	SENT_171	[p8l1745t2696r1953b2777],

1	The	DT	O	the	det	2	SENT_172	[p8l2011t2696r2146b2758],
2	anaemia	NN	O	anaemia	nsubj	3	SENT_172	[p8l9t2804r304b2867],
3	improved	VBD	O	improve	_	0	SENT_172	[p8l357t2804r695b2885],
4	considerably	RB	O	considerably	advmod	3	SENT_172	[p8l751t2804r1203b2885],
5	and	CC	O	and	_	0	SENT_172	[p8l1261t2804r1386b2867],
6	it	PRP	O	it	nsubj	8	SENT_172	[p8l1441t2804r1490b2867],
7	was	VBD	O	be	cop	8	SENT_172	[p8l1544t2824r1677b2867],
8	possible	JJ	O	possible	conj_and	3	SENT_172	[p8l1733t2804r2024b2885],
9	to	TO	O	to	aux	10	SENT_172	[p8l2080t2814r2146b2867],
10	taper	VB	O	taper	dep	8	SENT_172	[p8l7t2920r185b2992],
11	the	DT	O	the	det	12	SENT_172	[p8l221t2911r327b2973],
12	steroids	NNS	O	steroid	dobj	10	SENT_172	[p8l368t2911r638b2973],
13	after	IN	O	after	_	0	SENT_172	[p8l680t2911r841b2973],
14	2	CD	DURATION	2	num	15	SENT_172	[p8l878t2911r918b2973],
15	weeks	NNS	NUMBER	week	prep_after	10	SENT_172	[p8l957t2911r1175b2974],
16	and	CC	O	and	_	0	SENT_172	[p8l1217t2911r1342b2973],
17	to	TO	O	to	aux	19	SENT_172	[p8l1379t2920r1445b2973],
18	completely	RB	O	completely	advmod	19	SENT_172	[p8l1484t2911r1877b2992],
19	stop	VB	O	stop	conj_and	10	SENT_172	[p8l1919t2920r2061b2992],
20	it	PRP	O	it	dobj	19	SENT_172	[p8l2100t2911r2148b2973],
21	after	IN	O	after	_	0	SENT_172	[p8l9t3018r170b3081],
22	2	CD	DURATION	2	num	23	SENT_172	[p8l200t3019r240b3080],
23	months	NNS	NUMBER	month	prep_after	19	SENT_172	[p8l271t3018r549b3081],
24	.	.	O	.	_	0	SENT_172	[p8l271t3018r549b3081],

1	The	DT	O	the	det	2	SENT_173	[p8l584t3018r720b3081],
2	patient	NN	O	patient	nsubjpass	10	SENT_173	[p8l750t3018r993b3099],
3	has	VBZ	O	have	aux	6	SENT_173	[p8l1021t3018r1136b3081],
4	not	RB	O	not	neg	6	SENT_173	[p8l1168t3028r1281b3081],
5	been	VBN	O	be	auxpass	6	SENT_173	[p8l1309t3018r1477b3081],
6	rechallenged	VBN	O	rechallenge	_	0	SENT_173	[p8l1506t3018r1961b3099],
7	with	IN	O	with	_	0	SENT_173	[p8l1991t3018r2147b3081],
8	Campath	NN	MISC	campath	prep_with	6	SENT_173	[p8l8t3125r327b3206],
9	but	CC	O	but	_	0	SENT_173	[p8l354t3125r466b3188],
10	had	VBD	O	have	conj_but	6	SENT_173	[p8l492t3125r620b3188],
11	another	DT	O	another	det	12	SENT_173	[p8l649t3125r914b3188],
12	relapse	NN	O	relapse	dobj	10	SENT_173	[p8l940t3125r1190b3206],
13	after	IN	O	after	_	0	SENT_173	[p8l1221t3125r1382b3188],
14	6	CD	DURATION	6	num	15	SENT_173	[p8l1410t3125r1449b3188],
15	months	NNS	NUMBER	month	prep_after	10	SENT_173	[p8l1479t3125r1737b3188],
16	though	IN	O	though	mark	20	SENT_173	[p8l1767t3125r2012b3206],
17	the	DT	O	the	det	18	SENT_173	[p8l2040t3125r2146b3188],
18	Hb	NN	MISC	hb	nsubj	20	SENT_173	[p8l7t3231r112b3293],
19	remains	VBZ	O	remain	cop	20	SENT_173	[p8l138t3231r417b3293],
20	stable	JJ	O	stable	advcl	10	SENT_173	[p8l447t3231r649b3293],
21	over	IN	O	over	_	0	SENT_173	[p8l675t3250r829b3294],
22	11	CD	PERCENT	11	number	23	SENT_173	[p8l861t3231r931b3292],
23	g	NN	PERCENT	g	num	24	SENT_173	[p8l957t3231r1091b3312],
24	%	NN	PERCENT	%	prep_over	20	SENT_173	[p8l957t3231r1091b3312],
25	.	.	O	.	_	0	SENT_173	[p8l957t3231r1091b3312],

1	Discussion	NN	O	discussion	_	0	SENT_174	[p8l7t3473r406b3536],

1	PRCA	NNP	ORGANIZATION	PRCA	nsubj	4	SENT_175	[p8l114t3687r345b3750],
2	is	VBZ	O	be	cop	4	SENT_175	[p8l387t3687r442b3749],
3	a	DT	O	a	det	4	SENT_175	[p8l488t3706r525b3749],
4	syndrome	NN	O	syndrome	_	0	SENT_175	[p8l568t3687r915b3768],
5	characterized	VBN	O	characterize	partmod	4	SENT_175	[p8l958t3687r1431b3749],
6	by	IN	O	by	_	0	SENT_175	[p8l1471t3687r1559b3768],
7	normochromic	JJ	O	normochromic	agent	5	SENT_175	[p8l1601t3687r2144b3761],
8	,	,	O	,	_	0	SENT_175	[p8l1601t3687r2144b3761],

1	normocytic	JJ	O	normocytic	amod	2	SENT_176	[p9l7t20r408b101],
2	anaemia	NN	O	anaemia	_	0	SENT_176	[p9l435t20r747b95],
3	,	,	O	,	_	0	SENT_176	[p9l435t20r747b95],
4	reticulocytopenia	NN	O	reticulocytopenia	appos	2	SENT_176	[p9l773t20r1391b101],
5	and	CC	O	and	_	0	SENT_176	[p9l1415t20r1540b83],
6	almost	RB	O	almost	advmod	7	SENT_176	[p9l1565t20r1800b83],
7	complete	JJ	O	complete	amod	8	SENT_176	[p9l1823t20r2146b101],
8	absence	NN	O	absence	appos	2	SENT_176	[p9l9t127r287b190],
9	of	IN	O	of	_	0	SENT_176	[p9l308t127r385b190],
10	erythroblasts	NNS	O	erythroblast	prep_of	8	SENT_176	[p9l398t127r854b208],
11	from	IN	O	from	_	0	SENT_176	[p9l876t127r1048b190],
12	the	DT	O	the	det	17	SENT_176	[p9l1066t127r1172b190],
13	bone	NN	O	bone	nn	17	SENT_176	[p9l1191t127r1363b190],
14	marrow	NN	O	marrow	nn	17	SENT_176	[p9l1382t147r1654b190],
15	[	NN	O	[	nn	17	SENT_176	[p9l1681t128r1794b203],
16	1	CD	NUMBER	1	num	17	SENT_176	[p9l1681t128r1794b203],
17	]	NN	O	]	prep_from	10	SENT_176	[p9l1681t128r1794b203],
18	.	.	O	.	_	0	SENT_176	[p9l1681t128r1794b203],

1	It	PRP	O	it	nsubjpass	3	SENT_177	[p9l1818t129r1872b190],
2	is	VBZ	O	be	auxpass	3	SENT_177	[p9l1890t127r1944b190],
3	associated	VBN	O	associate	_	0	SENT_177	[p9l1968t147r2144b190, p9l8t233r219b295],
4	with	IN	O	with	_	0	SENT_177	[p9l248t232r404b296],
5	various	JJ	O	various	amod	7	SENT_177	[p9l433t233r689b295],
6	haematologic	JJ	O	haematologic	amod	7	SENT_177	[p9l720t233r1197b314],
7	malignancies	NNS	O	malignancy	prep_with	3	SENT_177	[p9l1228t233r1694b314],
8	and	CC	O	and	_	0	SENT_177	[p9l1728t233r1853b295],
9	chronic	JJ	O	chronic	amod	12	SENT_177	[p9l1883t233r2145b295],
10	lymphocytic	JJ	O	lymphocytic	amod	12	SENT_177	[p9l7t341r448b422],
11	leukaemia	NN	O	leukaemia	nn	12	SENT_177	[p9l469t341r834b404],
12	(	NN	O	(	nsubj	21	SENT_177	[p9l854t342r1075b419],
13	CLL	NN	O	cll	nn	14	SENT_177	[p9l854t342r1075b419],
14	)	NN	O	)	nsubj	16	SENT_177	[p9l854t342r1075b419],
15	is	VBZ	O	be	cop	16	SENT_177	[p9l1096t341r1151b404],
16	one	CD	NUMBER	one	rcmod	12	SENT_177	[p9l1173t361r1297b404],
17	of	IN	O	of	_	0	SENT_177	[p9l1318t341r1395b404],
18	the	DT	O	the	det	20	SENT_177	[p9l1408t341r1514b404],
19	commonest	JJS	O	commonest	amod	20	SENT_177	[p9l1534t351r1944b404],
20	types	NNS	O	type	prep_of	16	SENT_177	[p9l1961t351r2145b422],
21	[	VBP	O	[	conj_and	3	SENT_177	[p9l13t448r193b524],
22	2,3	CD	NUMBER	2,3	number	23	SENT_177	[p9l13t448r193b524],
23	]	CD	NUMBER	]	dobj	21	SENT_177	[p9l13t448r193b524],
24	.	.	O	.	_	0	SENT_177	[p9l13t448r193b524],

1	The	DT	O	the	det	3	SENT_178	[p9l234t448r370b511],
2	estimated	VBN	O	estimate	amod	3	SENT_178	[p9l407t448r747b511],
3	incidence	NN	O	incidence	nsubj	14	SENT_178	[p9l781t448r1120b511],
4	of	IN	O	of	_	0	SENT_178	[p9l1158t448r1235b511],
5	erythroid	JJ	O	erythroid	amod	6	SENT_178	[p9l1265t448r1590b529],
6	aplasia	NN	O	aplasium	prep_of	3	SENT_178	[p9l1627t448r1872b529],
7	among	IN	O	among	_	0	SENT_178	[p9l1908t468r2146b529],
8	patients	NNS	O	patient	prep_among	6	SENT_178	[p9l6t554r280b635],
9	with	IN	O	with	_	0	SENT_178	[p9l304t553r460b616],
10	CLL	NN	O	cll	prep_with	8	SENT_178	[p9l482t554r648b617],
11	may	MD	O	may	aux	14	SENT_178	[p9l669t573r820b635],
12	be	VB	O	be	cop	14	SENT_178	[p9l840t554r923b616],
13	as	RB	O	as	advmod	14	SENT_178	[p9l947t573r1015b616],
14	high	JJ	O	high	_	0	SENT_178	[p9l1038t554r1195b635],
15	as	IN	O	as	_	0	SENT_178	[p9l1218t573r1286b616],
16	6	CD	PERCENT	6	num	17	SENT_178	[p9l1311t553r1445b628],
17	%	NN	PERCENT	%	prep_as	14	SENT_178	[p9l1311t553r1445b628],
18	,	,	O	,	_	0	SENT_178	[p9l1311t553r1445b628],
19	and	CC	O	and	_	0	SENT_178	[p9l1471t554r1596b616],
20	many	JJ	O	many	amod	21	SENT_178	[p9l1617t573r1811b635],
21	cases	NNS	O	case	nsubjpass	23	SENT_178	[p9l1834t573r2017b616],
22	are	VBP	O	be	auxpass	23	SENT_178	[p9l2042t573r2147b616],
23	missed	VBN	O	miss	conj_and	14	SENT_178	[p9l7t661r253b723],
24	because	IN	O	because	_	0	SENT_178	[p9l290t661r571b723],
25	severe	JJ	O	severe	amod	27	SENT_178	[p9l613t681r832b723],
26	normochromic	JJ	O	normochromic	amod	27	SENT_178	[p9l871t661r1392b723],
27	anaemia	NN	O	anaemia	prep_because	23	SENT_178	[p9l1434t661r1729b723],
28	with	IN	O	with	_	0	SENT_178	[p9l1767t661r1923b723],
29	reticulocytopenia	NN	O	reticulocytopenia	prep_with	27	SENT_178	[p9l1960t661r2144b723, p9l7t768r466b849],

1	is	VBZ	O	be	cop	4	SENT_179	[p9l497t768r551b830],
2	a	DT	O	a	det	4	SENT_179	[p9l587t787r624b830],
3	frequent	JJ	O	frequent	amod	4	SENT_179	[p9l655t768r951b849],
4	manifestation	NN	O	manifestation	_	0	SENT_179	[p9l982t768r1465b830],
5	of	IN	O	of	_	0	SENT_179	[p9l1499t768r1575b830],
6	advanced	JJ	O	advanced	amod	9	SENT_179	[p9l1603t768r2146b849],
7	—	JJ	O	—	amod	9	SENT_179	[p9l1603t768r2146b849],
8	stage	NN	O	stage	nn	9	SENT_179	[p9l1603t768r2146b849],
9	CLL	NN	O	cll	prep_of	4	SENT_179	[p9l8t876r173b938],
10	and	CC	O	and	_	0	SENT_179	[p9l202t875r327b938],
11	are	VBP	O	be	auxpass	13	SENT_179	[p9l355t895r459b938],
12	usually	RB	O	usually	advmod	13	SENT_179	[p9l485t875r741b956],
13	attributed	VBN	O	attribute	conj_and	4	SENT_179	[p9l770t875r1107b938],
14	to	TO	O	to	_	0	SENT_179	[p9l1133t885r1198b938],
15	the	DT	O	the	det	17	SENT_179	[p9l1226t875r1332b938],
16	marrow	NN	O	marrow	nn	17	SENT_179	[p9l1359t895r1632b938],
17	inﬁltration	NN	O	inﬁltration	prep_to	13	SENT_179	[p9l1659t875r2034b938],
18	by	IN	O	by	_	0	SENT_179	[p9l2059t875r2146b956],
19	CLL	NN	O	cll	agent	13	SENT_179	[p9l8t982r191b1045],
20	.	.	O	.	_	0	SENT_179	[p9l8t982r191b1045],

1	The	DT	O	the	det	2	SENT_180	[p9l224t982r360b1045],
2	development	NN	O	development	nsubj	7	SENT_180	[p9l389t982r845b1063],
3	of	IN	O	of	_	0	SENT_180	[p9l872t982r949b1045],
4	erythroid	JJ	O	erythroid	amod	5	SENT_180	[p9l972t982r1296b1063],
5	aplasia	NN	O	aplasium	prep_of	2	SENT_180	[p9l1326t982r1571b1063],
6	may	MD	O	may	aux	7	SENT_180	[p9l1597t1002r1748b1063],
7	depend	VB	O	depend	_	0	SENT_180	[p9l1778t982r2033b1063],
8	on	IN	O	on	_	0	SENT_180	[p9l2061t1002r2147b1045],
9	the	DT	O	the	det	10	SENT_180	[p9l7t1088r113b1150],
10	stage	NN	O	stage	prep_on	7	SENT_180	[p9l152t1097r330b1169],
11	of	IN	O	of	_	0	SENT_180	[p9l366t1088r443b1150],
12	CLL	NN	O	cll	prep_of	10	SENT_180	[p9l474t1088r658b1162],
13	,	,	O	,	_	0	SENT_180	[p9l474t1088r658b1162],
14	but	CC	O	but	_	0	SENT_180	[p9l695t1088r807b1150],
15	it	PRP	O	it	nsubj	29	SENT_180	[p9l841t1088r890b1150],
16	does	VBZ	O	do	aux	18	SENT_180	[p9l925t1088r1083b1150],
17	not	RB	O	not	neg	18	SENT_180	[p9l1120t1097r1233b1150],
18	affect	VB	O	affect	conj_but	7	SENT_180	[p9l1269t1088r1467b1150],
19	its	PRP$	O	its	poss	20	SENT_180	[p9l1501t1088r1581b1150],
20	prognosis	NN	O	prognosis	dobj	18	SENT_180	[p9l1617t1088r1961b1169],
21	and	CC	O	and	_	0	SENT_180	[p9l2000t1088r2144b1162],
22	,	,	O	,	_	0	SENT_180	[p9l2000t1088r2144b1162],
23	in	IN	O	in	dep	18	SENT_180	[p9l7t1196r74b1258],
24	most	JJS	O	most	amod	25	SENT_180	[p9l102t1205r274b1259],
25	cases	NNS	O	case	pobj	23	SENT_180	[p9l301t1216r505b1270],
26	,	,	O	,	_	0	SENT_180	[p9l301t1216r505b1270],
27	does	VBZ	O	do	aux	29	SENT_180	[p9l536t1196r694b1259],
28	not	RB	O	not	neg	29	SENT_180	[p9l724t1206r837b1259],
29	seem	VB	O	seem	conj_and	18	SENT_180	[p9l866t1216r1046b1259],
30	to	TO	O	to	aux	32	SENT_180	[p9l1071t1206r1137b1259],
31	be	VB	O	be	auxpass	32	SENT_180	[p9l1165t1196r1247b1259],
32	related	VBN	O	relate	xcomp	29	SENT_180	[p9l1274t1196r1516b1259],
33	to	TO	O	to	_	0	SENT_180	[p9l1543t1206r1609b1259],
34	previous	JJ	O	previous	amod	36	SENT_180	[p9l1636t1196r1938b1277],
35	cytotoxic	JJ	O	cytotoxic	amod	36	SENT_180	[p9l1968t1206r2144b1277, p9l7t1303r182b1366],
36	chemotherapy	NN	O	chemotherapy	prep_to	32	SENT_180	[p9l204t1303r705b1384],
37	[	CD	NUMBER	[	number	38	SENT_180	[p9l733t1303r912b1379],
38	2,4	CD	NUMBER	2,4	num	39	SENT_180	[p9l733t1303r912b1379],
39	]	NN	O	]	dep	36	SENT_180	[p9l733t1303r912b1379],
40	.	.	O	.	_	0	SENT_180	[p9l733t1303r912b1379],

1	It	PRP	O	it	nsubj	4	SENT_181	[p9l937t1305r991b1366],
2	is	VBZ	O	be	cop	4	SENT_181	[p9l1009t1303r1064b1366],
3	more	RBR	O	more	advmod	4	SENT_181	[p9l1087t1323r1267b1366],
4	likely	JJ	O	likely	_	0	SENT_181	[p9l1288t1303r1487b1384],
5	that	IN	O	that	complm	16	SENT_181	[p9l1508t1303r1641b1366],
6	in	IN	O	in	_	0	SENT_181	[p9l1660t1303r1727b1365],
7	our	PRP$	O	we	poss	8	SENT_181	[p9l1749t1323r1866b1366],
8	patient	NN	O	patient	prep_in	16	SENT_181	[p9l1883t1303r2144b1384],
9	,	,	O	,	_	0	SENT_181	[p9l1883t1303r2144b1384],
10	Campath	NNP	MISC	Campath	nsubj	16	SENT_181	[p9l8t1409r327b1490],
11	rather	RB	O	rather	advmod	10	SENT_181	[p9l368t1409r577b1471],
12	than	IN	O	than	_	0	SENT_181	[p9l617t1409r768b1471],
13	CLL	NN	O	cll	prep_than	10	SENT_181	[p9l812t1409r977b1472],
14	would	MD	O	would	aux	16	SENT_181	[p9l1020t1409r1240b1472],
15	have	VB	O	have	aux	16	SENT_181	[p9l1281t1409r1444b1471],
16	contributed	VBN	O	contribute	ccomp	4	SENT_181	[p9l1487t1409r1890b1471],
17	to	TO	O	to	_	0	SENT_181	[p9l1931t1418r1997b1471],
18	the	DT	O	the	det	19	SENT_181	[p9l2040t1409r2146b1471],
19	development	NN	O	development	prep_to	16	SENT_181	[p9l8t1517r464b1598],
20	of	IN	O	of	_	0	SENT_181	[p9l488t1517r565b1580],
21	PRCA	NNP	ORGANIZATION	PRCA	prep_of	19	SENT_181	[p9l583t1518r832b1580],
22	.	.	O	.	_	0	SENT_181	[p9l583t1518r832b1580],

1	There	EX	O	there	expl	6	SENT_182	[p9l114t1624r319b1686],
2	has	VBZ	O	have	aux	6	SENT_182	[p9l361t1624r476b1686],
3	been	VBN	O	be	cop	6	SENT_182	[p9l518t1624r686b1686],
4	two	CD	NUMBER	two	num	6	SENT_182	[p9l726t1633r856b1687],
5	case	NN	O	case	nn	6	SENT_182	[p9l899t1643r1049b1686],
6	reports	NNS	O	report	_	0	SENT_182	[p9l1090t1633r1334b1705],
7	of	IN	O	of	_	0	SENT_182	[p9l1379t1624r1456b1686],
8	PRCA	NNP	ORGANIZATION	PRCA	prep_of	6	SENT_182	[p9l1491t1624r1722b1687],
9	in	IN	O	in	_	0	SENT_182	[p9l1763t1624r1830b1686],
10	patients	NNS	O	patient	prep_in	6	SENT_182	[p9l1870t1624r2145b1705],
11	receiving	VBG	O	receive	partmod	10	SENT_182	[p9l6t1731r333b1812],
12	Campath	NNP	MISC	Campath	dobj	11	SENT_182	[p9l377t1731r696b1812],
13	one	CD	NUMBER	one	num	12	SENT_182	[p9l738t1751r862b1794],
14	where	WRB	O	where	advmod	17	SENT_182	[p9l904t1731r1119b1794],
15	the	DT	O	the	det	16	SENT_182	[p9l1160t1731r1267b1794],
16	patient	NN	O	patient	nsubj	17	SENT_182	[p9l1307t1731r1550b1812],
17	had	VBD	O	have	rcmod	12	SENT_182	[p9l1589t1731r1717b1794],
18	T	NN	O	t	nn	20	SENT_182	[p9l1757t1731r1959b1794],
19	—	JJ	O	—	amod	20	SENT_182	[p9l1757t1731r1959b1794],
20	cell	NN	O	cell	dobj	17	SENT_182	[p9l1757t1731r1959b1794],
21	prolymphocytic	JJ	O	prolymphocytic	amod	22	SENT_182	[p9l1999t1751r2144b1812, p9l7t1838r448b1919],
22	leukaemia	NN	O	leukaemia	dep	20	SENT_182	[p9l479t1838r845b1901],
23	and	CC	O	and	_	0	SENT_182	[p9l875t1838r1000b1901],
24	the	DT	O	the	det	31	SENT_182	[p9l1028t1838r1135b1901],
25	other	JJ	O	other	amod	31	SENT_182	[p9l1166t1838r1347b1901],
26	with	IN	O	with	_	0	SENT_182	[p9l1376t1838r1532b1901],
27	cutaneous	JJ	O	cutaneous	amod	29	SENT_182	[p9l1561t1847r1913b1901],
28	T	NN	O	t	nn	29	SENT_182	[p9l1944t1838r2147b1901],
29	—	NN	O	—	prep_with	25	SENT_182	[p9l1944t1838r2147b1901],
30	cell	NN	O	cell	nn	31	SENT_182	[p9l1944t1838r2147b1901],
31	lymphoma	NN	O	lymphoma	conj_and	20	SENT_182	[p9l7t1944r406b2025],
32	,	,	O	,	_	0	SENT_182	[p9l7t1944r406b2025],
33	and	CC	O	and	_	0	SENT_182	[p9l443t1944r568b2006],
34	in	IN	O	in	_	0	SENT_182	[p9l599t1944r666b2005],
35	both	DT	O	both	predet	37	SENT_182	[p9l697t1944r855b2006],
36	these	DT	O	these	det	37	SENT_182	[p9l887t1944r1067b2006],
37	cases	NNS	O	case	prep_in	41	SENT_182	[p9l1101t1963r1305b2018],
38	,	,	O	,	_	0	SENT_182	[p9l1101t1963r1305b2018],
39	parvovirus	NN	O	parvovirus	nsubjpass	41	SENT_182	[p9l1339t1944r1715b2025],
40	was	VBD	O	be	auxpass	41	SENT_182	[p9l1749t1963r1882b2006],
41	identiﬁed	VBN	O	identiﬁed	conj_and	6	SENT_182	[p9l1916t1944r2144b2006, p9l8t2052r139b2115],
42	as	IN	O	as	_	0	SENT_182	[p9l164t2072r233b2115],
43	a	DT	O	a	det	46	SENT_182	[p9l261t2072r297b2115],
44	causative	JJ	O	causative	amod	46	SENT_182	[p9l321t2052r646b2115],
45	factor	NN	O	factor	nn	46	SENT_182	[p9l671t2052r877b2115],
46	[	NN	O	[	prep_as	41	SENT_182	[p9l906t2052r967b2128],
47	5	CD	NUMBER	5	number	48	SENT_182	[p9l906t2052r967b2128],
48	,6	CD	NUMBER	,6	num	49	SENT_182	[p9l977t2052r1086b2128],
49	]	NN	O	]	dep	41	SENT_182	[p9l977t2052r1086b2128],
50	.	.	O	.	_	0	SENT_182	[p9l977t2052r1086b2128],

1	The	DT	O	the	det	3	SENT_183	[p9l1114t2052r1250b2115],
2	immunosuppressed	JJ	O	immunosuppressed	amod	3	SENT_183	[p9l1275t2052r1962b2133],
3	state	NN	O	state	nsubjpass	15	SENT_183	[p9l1989t2062r2146b2115],
4	induced	VBN	O	induce	partmod	3	SENT_183	[p9l7t2159r288b2222],
5	by	IN	O	by	_	0	SENT_183	[p9l315t2159r402b2240],
6	the	DT	O	the	det	7	SENT_183	[p9l432t2159r538b2222],
7	suppression	NN	O	suppression	agent	4	SENT_183	[p9l570t2159r986b2240],
8	of	IN	O	of	_	0	SENT_183	[p9l1016t2159r1093b2222],
9	CD4/8	NN	O	cd4/8	nn	10	SENT_183	[p9l1117t2159r1348b2222],
10	cells	NNS	O	cell	prep_of	7	SENT_183	[p9l1381t2159r1539b2222],
11	by	IN	O	by	_	0	SENT_183	[p9l1569t2159r1656b2240],
12	the	DT	O	the	det	13	SENT_183	[p9l1685t2159r1792b2222],
13	drug	NN	O	drug	agent	4	SENT_183	[p9l1822t2159r1981b2240],
14	was	VBD	O	be	auxpass	15	SENT_183	[p9l2012t2179r2145b2222],
15	postulated	VBN	O	postulate	_	0	SENT_183	[p9l6t2265r373b2346],
16	to	TO	O	to	aux	18	SENT_183	[p9l406t2274r472b2327],
17	have	VB	O	have	aux	18	SENT_183	[p9l506t2265r669b2328],
18	led	VBN	O	lead	xcomp	15	SENT_183	[p9l704t2265r811b2327],
19	to	TO	O	to	_	0	SENT_183	[p9l844t2274r910b2327],
20	the	DT	O	the	det	21	SENT_183	[p9l945t2265r1051b2327],
21	emergence	NN	O	emergence	prep_to	18	SENT_183	[p9l1086t2284r1467b2346],
22	of	IN	O	of	_	0	SENT_183	[p9l1503t2265r1580b2327],
23	the	DT	O	the	det	24	SENT_183	[p9l1608t2265r1714b2327],
24	parvovirus	NN	O	parvovirus	prep_of	21	SENT_183	[p9l1747t2265r2144b2346],
25	,	,	O	,	_	0	SENT_183	[p9l1747t2265r2144b2346],
26	which	WDT	O	which	nsubj	27	SENT_183	[p9l8t2373r223b2436],
27	caused	VBD	O	cause	rcmod	24	SENT_183	[p9l248t2373r489b2436],
28	the	DT	O	the	det	31	SENT_183	[p9l512t2373r619b2436],
29	red	JJ	O	red	amod	31	SENT_183	[p9l643t2373r757b2436],
30	cell	NN	O	cell	nn	31	SENT_183	[p9l781t2373r906b2436],
31	aplasia	NN	O	aplasium	dobj	27	SENT_183	[p9l934t2373r1195b2454],
32	.	.	O	.	_	0	SENT_183	[p9l934t2373r1195b2454],

